Model no.	Breast cancer type	Disease area	Disease features	Category	Type	Cells	Source	Cell culture type	Cell culture dimensions	3D type	Ex vivo	Applications	Biological endpoints	Throughput	Potential	Relevance	DOI or link	First author name	Year
1	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	DCIS	Co-culture/MPS	3D	Spheroids	n/a	Drug develop./testing	cytotoxicity, morphology	Low	Yes	Direct	10.1039/c5lc00514k	Choi, Yoonseok	2015
2	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	T47D	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.); Disease therapy develop.	progesterone receptor	Low	Yes	Direct	10.1186/s13045-017-0462-7	Knutson, Todd P.	2017
3	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	3D	Spheroids	n/a	Model/method develop.(exp.)	cytotoxicity	Low	n/a	n/a	https://www.rjme.ro/RJME/resources/files/560115071076.pdf	Abuelba, Hussam	2015
4	BC	BC	Immunotherapy	In vitro	Cells	Immortalised cells	SKBR3	Culture	3D	Spheroids	n/a	Drug develop./testing; Model/method qualification	morphology, cytotoxicity	Low	Yes	Direct	10.32607/20758251-2017-9-1-38-43	Balalaeva, IV	2017
5	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	BT474 , MCF7	Culture	3D	Spheroids	n/a	Drug develop./testing	apoptosis	Low	Yes	Direct	10.1371/journal.pone.0137920	Rodriguez, Cristina E.	2015
6	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231, MCF10A	Culture/Co-culture	2.5D/3D	Spheroids	n/a	Drug develop./testing; Model/method develop. (exp.)	cytotoxicity	Low	n/a	Direct	10.1007/s10616-016-0062-3	Yildiz-Ozturk, Ece	2017
7	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7	Culture	3D	Spheroids	n/a	Model/method develop.(exp.)	morphology, viability, cytotoxicity	High	Yes	Direct	10.1039/c5lc01139f	Sabhachandani, P.	2016
10	BC	BC	Cancer Initiation and Development	In vitro/In silico	Cells/Simulation	Immortalised cells	MCF7	Culture	3D	Spheroids	n/a	Model/method develop.(exp.)	cell viability	Low	n/a	Direct	10.1039/c8an00729b	Wu, Hancong	2018
12	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7	Culture	3D	Spheroids	n/a	Model/method develop.(exp.)	BRCA1, HER2, cytotoxicity	Low	Yes	Direct	10.1088/1758-5090/aae270	Li, Wenfang	2019
13	BC	BC	Metastasis; Microenvironment	In vitro	Cells	Immortalised cells	GFP-expressing MDA-MB-231	MPS	3D	Spheroids	n/a	Model/method develop.(exp.)	cancer cell migration	Low	Yes	Direct	10.1063/1.5027183	Sano, Emi	2018
14	BC	BC	Metastasis; Microenvironment	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231	Co-culture/MPS	3D	Scaffolds	n/a	Disease therapy develop.	cell morphology, anti-cancer drug efficacy and endothelial cytotoxicity	Low	Yes	Direct	10.1038/s41598-018-21075-9	Pradhan, Shantanu	2018
15	BC	BC	Metastasis; Microenvironment	In vitro	Cells	Immortalised cells	MCF7	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	S6K1	Low	No	Direct	10.12688/f1000research.15447.1	Kosach, Viktoriia	2018
16	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231, CAFs	Culture/Co-culture	3D	Spheroids	n/a	Drug develop./testing	nanoparticle penetration	Low	Yes	n/a	10.1016/j.jconrel.2016.09.004	Priwitaningrum, Dwi L.	2016
17	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-453, MDA-MB-231 , HCC1937	MPS	3D	n/a	n/a	Disease therapy develop.	cytotoxicity	High	Yes	n/a	10.1186/s12885-017-3709-3	Lanz, Henriette L.	2017
19	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	M13SV1, M13SV1-R2-2 , M13SV1-R2-N1	Culture	3D	Spheroids	n/a	Model/method qualification	omics, morphology, viability	Low	n/a	Direct	10.1186/s12935-015-0262-5	Stempin, Sandra	2015
20	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	BT549 , T47D	Culture/MPS	3D	Spheroids	n/a	Drug develop./testing	drug delivery monitoring and cytotoxicity	High	Yes	Direct	10.1016/j.aca.2018.06.038	Chen, Yongli	2018
23	BC	BC	Cancer Initiation and Development	In vitro/In silico	Cells/Mathematical	Immortalised cells/Stem-cell like	SUM149	Culture	3D	Organoids	n/a	Disease mechanism (exp./theor.); Model/method qualification	viability, EMT	Low	n/a	Direct	10.1073/pnas.1815345116	Bocci, Federico	2019
24	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	SK-BR-3, BT474, T-47D, MDA-MB-231, MDA-MB-468, MCF7	Culture/MPS	2D	n/a	n/a	Disease mechanism (exp./theor.); Model/method develop. (exp.); Model/method qualification	HER2/Cytokeratin ratio	High	Yes	Direct	10.1117/1.JBO.24.2.021204	Migliozzi, Daniel	2019
25	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7 , BT474	Culture	3D	Spheroids	n/a	Model/method develop.(exp.)	morphology, SOX-1, SOX-17, brachyury	Low	Yes	Direct	10.1039/c5lc00159e	Hribar, K. C.	2015
26	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells/Primary cell culture	MCF7, MCF10A , MDA-MB-231,	Culture	2D	n/a	n/a	Disease therapy develop.	gene expression	Low	Yes	n/a	10.3390/ijms19041084	Bravata, Valentina	2018
27	BC	BC	Cancer Initiation and Development	In vitro	Cells	Primary cell culture	BC	Culture	3D	Spheroids	n/a	Disease therapy develop.; Drug develop./testing	viability, omics	Low	Yes	Direct	10.1016/j.breast.2018.08.002	Orditura, M.	2018
29	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7	Culture	3D	Spheroids	n/a	Model/method develop.(exp.)	viability	Low	Yes	Direct	10.1007/s10544-018-0260-1	Karamikamkar, Solmaz	2018
30	BC	BC	Metastasis; Microenvironment	In vitro	Cells	Immortalised cells	MCF7, NF	Culture	3D	Scaffolds	n/a	Disease mechanism (exp./theor.)	SMA, PDGF, MMP-2, MMP-9	Low	n/a	Direct	10.1002/adhm.201600772	Gioiella, Filomena	2016
31	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	SK-BR-3, MDA-MB-231, T-47D	Culture	2D/3D	Spheroids	n/a	Drug develop./testing; Model/method qualification	cytotoxicity	Low	No	n/a	10.3109/14756366.2015.1101093	Brajsa, Karmen	2016
32	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	BT20, BT474, MCF7, SK-BR-3, MDA-MB-231, MDA-MB-453, MDA-MB-468, JIMT1, KPL4	Co-culture	3D	Spheroids	n/a	Disease therapy develop.; Model/method qualification	viability, EGF, HGF, IL6 quantification by the Human cytokine/chemokine 96-well plate assay, cytotoxicity	Low	Yes	Direct	10.1371/journal.pone.0127948	Majety, Meher	2015
33	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7 , T-47D	Culture	2D/3D	Spheroids	n/a	Disease mechanism (exp./theor.); Disease therapy develop.	cell proliferation, apoptosis	Low	No	Direct	10.1186/s12885-016-2915-8	Geiger, Pamina	2016
34	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Co-culture	2D/3D	Spheroids	n/a	Model/method develop.(exp.)	cytotoxicity	Low	Yes	Direct	10.1166/jnn.2015.10508	Privalova, Anna M	2015
36	BC	BC	Metastasis; Microenvironment	In vitro	Cells	Immortalised cells	MCF7	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	viability, invasion and angiogenesis	Low	Yes	Direct	10.1016/j.actbio.2016.03.017	Taubenberger, Anna V.	2016
37	BC	BC	Cancer Initiation and Development	In vitro	Cells	Stem cells/Stem-cell like	n/a	Culture	2D/3D	Spheroids	n/a	Disease therapy develop.	cytotoxicity	Low	No	Direct	10.7603/s40730-016-0034-4	Ngu Van Trinh	2016
38	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	BrM2a, BT474, BT549, HCC70, HCC1395, HCC1419, HCC1428, HCC1806, LM2, MCF7, MDA-MB-231, MDA-MB-468, SkBr3, ZR-75-1	Culture	3D	Spheroids	n/a	Drug develop./testing; Model/method qualification	morphology, viability, cytotoxicity, TRAIL, DR4, DR5 RNA expression	Low	No	Direct	10.1021/acsbiomaterials.7b00069	Gencoglu, Maria F.	2018
39	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7	Culture	2D/3D	Spheroids	n/a	Drug develop./testing	cytotoxicity	Low	No	Supportive	10.15171/apb.2017.071	Akasov, Roman	2017
40	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, T47D, MDA-MB-453, MDA-MB-468, MDA-MB-231 , BT474	Culture/Co-culture	3D	Spheroids	n/a	Model/method qualification	morphology, viability	Low	Yes	n/a	10.1371/journal.pone.0157004	Roberts, Grace C.	2016
41	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231, IMR-90 MCTS	Co-culture	3D	Spheroids	n/a	Model/method develop.(exp.)	morphology, viability	Low	n/a	n/a	10.1038/s41598-017-04691-9	Jiang, Tao	2017
42	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	BT474 , 21MT-1, MSCs	Co-culture	2D	n/a	n/a	Drug develop./testing; Model/method develop. (exp.).; Model/method qualification	ERC, HER2, CD166, PTEN, PI3K, AKT, protein quantification, phosphorylation status 	Low	n/a	Direct	10.1038/srep13744	Daverey, Amita	2015
43	BC	BC	Metastasis; Microenvironment	In vitro	Cells	Immortalised cells	MDA-MB-231, MCF7	Co-culture	3D	Scaffolds	n/a	Disease mechanism (exp./theor.); Model/method develop. (exp.); Model/method qualification	viability, proliferation, secreted IL-8 protein quantification	Low	Yes	Direct	10.1088/0957-4484/27/31/315103	Zhu, Wei	2016
44	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231	Culture	2D/3D	Scaffolds	n/a	Disease mechanism (exp./theor.); Drug develop./testing	cytotoxicity	Low	n/a	Direct	10.1038/s41416-018-0267-7	Beckwitt, Colin H.	2018
45	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7	Culture	2D/3D	Spheroids	n/a	Model/method qualification	morphology, viability	High	Yes	n/a	10.1007/s10404-014-1373-3	Sun, Duanping	2014
46	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	BT474, MCF7, CAFs	Co-culture/MPS	3D	Scaffolds	n/a	Disease mechanism (exp./theor.); Drug develop./testing; Model/method qualification	cell migration, time of interaction between cell types	Low	Yes	Direct	10.1016/j.celrep.2018.12.015	Nguyen, Marie	2018
49	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF10A, BT474	Culture/Co-culture	2D/3D	Spheroids	n/a	Drug develop./testing; Model/method develop. (exp.).; Model/method qualification	cytotoxicity, EGFR and HER2 protein quantification and localization	High	Yes	Direct	10.1371/journal.pone.0108283	Howes, Amy L.	2014
50	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7	Culture	3D	Scaffolds/Spheroids	n/a	Model/method qualification	morphology, viability	Low	n/a	n/a	10.1016/j.bioelechem.2018.08.006	Brun, Paola	2019
52	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MCF7,  fibroblasts and endothelial cells	Co-culture/MPS	3D	Scaffolds	n/a	Drug develop./testing; Model/method develop. (exp.).; Model/method qualification	cytotoxicity, viability	Low	No	Direct	10.1016/j.talanta.2018.08.016	Wang, Shiqi	2019
53	BC	BC	Metastasis	In vitro	Cells	Immortalised cells	MDA-MB-231	Co-culture/MPS	3D	Scaffolds	n/a	Drug develop./testing; Model/method develop. (exp.).; Model/method qualification	cell migration, invasion, extravasation	Low	Yes	n/a	10.1002/adhm.201701257	Nagaraju, Supriya	2018
54	BC	BC	Cancer Initiation and Development; Metastasis	In vitro	Cells	Immortalised cells	MDA-MB-231, 	MPS	3D	Scaffolds	n/a	Disease mechanism (exp./theor.); Model/method qualification	viability, invasion	Low	Yes	Supportive	10.1002/smll.201702787	Hao, Sijie	2018
56	BC	BC	Cancer Initiation and Development	In vitro	Cells	Primary cell culture	BC	Culture	3D	Spheroids	n/a	Drug develop./testing	cytotoxicity, morphology and viability (only for primary cell line)	Low	Yes	Direct	10.1186/s12967-016-0855-3	Halfter, Kathrin	2016
57	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	2D/3D	Spheroids	n/a	Drug develop./testing; Model/method develop. (exp.)	cytotoxicity	Low	Yes	Direct	10.1002/biot.201800268	Nunes, Ana S.	2018
58	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	BT474,BT549,MCF7,MDA-MB-231,T47D	Culture	3D	Spheroids	n/a	Model/method develop.(exp.)	morphology, viability, cytotoxicity, MIB-1, pancytokeratin, E-cadherin and vimentin protein localization	Low	Yes	Direct	10.1039/c7lc00832e	Thomsen, Andreas R.	2018
59	BC	BC	Cancer Initiation and Development; Pharmacological/Physical Treatment	In vitro	Cells/Ex vivo	Primary cell culture	MCF7, MDA-MB-231, MCF10A / BC	Culture	2D	n/a	Organ slice	Drug develop./testing; Model/method develop. (exp.)	viability, cell migration, morphology, complex karyotype determination, α-smooth muscle 1A4, CD24, CD234 (E-Cadherin), CD44, CD227, EpCAM (EBA-1), HER2, CD49c, CD116, SSEA-1, CD45, CD47, ALDH1 (LSBio), cytokeratin 18 (CK18) and SSEA-1 (CD15) protein immuno-localization, gene expression changes of 84 genes	Low	n/a	Direct	10.1186/s12885-017-3812-5	Ali, Rizwan	2017
60	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MDA-MB-453, HCC1954, MCF7, T47DMCF10DCIS.com, SUM149PT, CAFs	Co-culture	3D	Spheroids	n/a	Drug develop./testing; Model/method qualification	cytotoxicity, omics, viability (by Luciferase assay), Ki67 and SMA protein localization,HER2 nad EGFR protein quantification	Low	Yes	Direct	10.1158/0008-5472.CAN-16-1457	Marusyk, Andriy	2016
61	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7	Culture	2D/3D	Spheroids	n/a	Model/method qualification	morphology, viability	Low	No	Direct	10.1038/srep35367	Cavo, Marta	2016
62	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	MAP3K1, AKT, PRAS40, JNK, IRS1, ERK protein quantification, morphology, c-c3, S6 and RB protein localization, cytotoxicity	Low	No	Supportive	10.18632/oncotarget.25118	Avivar-Valderas, Alvaro	2018
63	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7	Culture	3D	Spheroids	n/a	Disease therapy develop.; Model/method develop. (exp.)	fluorescent staining intensity	High	Yes	Direct	10.1063/1.4959031	Grist, S. M.	2016
64	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231, MCF7, BT474	Culture	2D/3D	Spheroids	n/a	Drug develop./testing	cytotoxicity	Low	No	Direct	10.1007/s00432-015-1950-1	Lovitt, Carrie J.	2015
66	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, NK92	Culture	3D	Spheroids	n/a	Drug develop./testing; Model/method develop. (exp.)	NK-92 migration and tumor penetration	Low	Yes	Direct	10.1080/2162402X.2018.1553477	Ayuso, Jose M.	2019
67	BC	BC	Cancer Initiation and Development	In vitro/In silico	Cells/Mathematical	Immortalised cells	MCF10A, MCF10AT, MCF10 DCIS.COM (DCIS.COM)	Culture	2D/3D	Spheroids	n/a	Disease mechanism (exp./theor.); Model/method qualification	filopodia density and lenght measurement	Low	Yes	Direct	10.1083/jcb.201704045	Jacquemet, Guillaume	2017
69	BC	BC	Metastasis; Microenvironment	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	3D	Scaffolds	n/a	Disease mechanism (exp./theor.); Model/method develop. (exp.)	morphology, viability	Low	Yes	Direct	10.1038/s41598-018-23250-4	Cavo, Marta	2018
70	BC	BC	Metastasis; Microenvironment	In vitro	Cells	Immortalised cells/Primary cell culture	MDA-MB-231, MCF7,T47D, adipocytes	Culture/Co-culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	IL6, IL8, CCL5, CCL2 and IP10 RNA quantification, viability, morphology	High	No	Direct	10.1158/0008-5472.CAN-15-0927	Picon-Ruiz, Manuel	2016
71	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, A-549	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	n/a	n/a	10.1007/s00044-014-1156-0	Kumar, Rajesh	2015
72	BC	BC	Cancer Initiation and Development	In vitro/In silico	Cells/Computational	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Disease therapy develop.; Model/method develop. (exp.)	rate of electroporated cells	Low	Yes	Direct	10.1177/1533033818764498	Ongaro, Alessia	2018
73	BC	BC	Metastasis; Microenvironment	In vitro	Cells	Immortalised cells/Primary cell culture	MDA-MB-231,MCF7	Co-culture/MPS	3D	Scaffolds	n/a	Disease mechanism (exp./theor.)	extravasation	Low	Yes	Direct	10.1016/j.biomaterials.2013.11.050	Bersini, Simone	2014
76	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF10A, MCF10aDCIS	MPS	3D	Scaffolds	n/a	Disease mechanism (exp./theor.); Model/method develop. (exp.)	E-cadherin and collagen-I quantification and localization, migration, morphology	Low	Yes	Direct	10.1186/s12885-015-1007-5	Bischel, Lauren L.	2015
77	BC	BC	Metastasis; Microenvironment	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	Invasion	Low	Yes	Direct	10.1016/j.actbio.2018.11.010	Liu, Chun	2019
78	BC	BC	Metastasis; Microenvironment	In vitro	Cells	Immortalised cells	BC derived tumor-initiating cells (MCFS)	Culture	3D	Scaffolds	n/a	Disease mechanism (exp./theor.)	morphology, E-cadherin staining	Low	Yes	Direct	10.1016/j.actbio.2017.09.017	Angeloni, Valentina	2017
79	BC	BC	Tumor Landscape	In vitro	Cells	Primary cell culture	BC	Co-culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	Genome and miRNA profiling	Low	Yes	Direct	10.1371/journal.pone.0186190	Mahajan, Akanksha S.	2017
80	BC	BC	Metastasis; Microenvironment	In vitro	Cells	Immortalised cells	MCF	Culture/MPS	2D	n/a	n/a	Disease mechanism (exp./theor.); Model/method develop. (exp.)	E-cadherine and Collagen localization, migration	Medium	Yes	Direct	10.3390/bioengineering5020029	Toh, Yi-Chin	2018
81	BC	BC	Metastasis; Microenvironment	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture/MPS	3D	Scaffolds	n/a	Disease mechanism (exp./theor.); Model/method develop. (exp.)	angiogenesis, invasion (by luciferase assay)	Low	Yes	Direct	10.1073/pnas.1714282115	Marturano-Kruik, Alessandro	2018
82	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	BT474	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.); Disease therapy develop.; Drug develop./testing	HER2 expression quantification (protein and RNA), viability, cytotoxicity	Low	No	Direct	10.1002/jcb.26298	Rodriguez, Cristina E.	2018
83	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231, MSCs	Co-culture	3D	Scaffolds/Spheroids	n/a	Model/method develop.(exp.)	invasion, morphology	Low	Yes	Direct	10.1016/j.nano.2015.09.010	Zhu, Wei	2016
84	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Supportive	10.1002/jcb.28147	Rambabu, Majji	2019
85	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	HCC1806	Culture	3D	Spheroids	n/a	Disease therapy develop.; Model/method develop. (exp.)	cell attachment, viability, metabolic activity, migration	Low	Yes	n/a	10.1088/1748-605X/aa5d5c	Casey, John	2017
86	BC	BC	Cancer Initiation and Development	In vitro/In silico	Cells/Computational	Immortalised cells	MDA-MB-231	Co-culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity, Stromal Fibroblasts Ratios	Low	Yes	Direct	10.1007/s12195-017-0498-3	Logsdon, Daniel K.	2017
87	BC	BC	Metastasis; Microenvironment	In vitro	Cells	Immortalised cells	MCF10A, MCF7 , MDA-MB-231	MPS	3D	Scaffolds	n/a	Disease mechanism (exp./theor.); Model/method develop. (exp.)	viability, E-cadherine and vimentine protein localization, extravasation	Low	Yes	Direct	10.1038/s41598-018-36381-5	Song, Jiho	2018
91	BC	BC	Cancer Initiation and Development; Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7, primary adipose-derived stromal cells (ASCs)	Co-culture	3D	Scaffolds	n/a	Model/method develop.(exp.)	cytotoxicity	Low	Yes	Direct	10.1039/c4lc01065e	Yang, Yamin	2015
92	BC	BC	Metastasis; Microenvironment	In vitro	Cells	Immortalised cells	MDA-MB-231	MPS	3D	Scaffolds	n/a	Disease mechanism (exp./theor.); Model/method develop. (exp.)	invasion, transmigration dynamics across lymphatic endothelium	Low	Yes	Direct	10.1039/c5ib00085h	Pisano, M.	2015
93	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF10A	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity, migration, Brk phosphorylation quantification	Low	Yes	Direct	10.1016/j.ejmech.2013.11.039	Foudah, Ahmed I.	2014
94	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF-7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity, migration, invasion	Low	Yes	Supportive	10.1039/c8bm00486b	Sun, Haifeng	2018
95	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7	Culture	3D	Spheroids	n/a	Model/method develop.(exp.)	morphology, viability	Low	Yes	n/a	10.1115/1.4031898	Li, Y.	2015
96	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231, CAFs	Co-culture	3D	Organoids	n/a	Disease mechanism (exp./theor.)	YAP/TAZ, b-CAF spreading, CAF RNA profile	Low	Yes	n/a	10.1021/acs.langmuir.8b02649	Cao, Huan	2018
97	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	JIMT-1	Culture	3D	n/a	n/a	Disease therapy develop.; Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.3389/fphar.2018.00403	Ande, Anusha	2018
98	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF10A, MSCs	Co-culture	3D	Scaffolds	n/a	Disease therapy develop.	changes in the miRNA signature, HER2 and Ki67 expression quantification	Low	Yes	n/a	10.1021/acs.langmuir.5b02227	Daverey, Amita	2015
99	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231, MCF-7	Culture	3D	Scaffolds	n/a	Disease mechanism (exp./theor.)	cell migration vs collagen alignment in the matrix, number of cell protrusions	Low	Yes	n/a	10.1016/j.bpj.2014.10.035	Riching, Kristin M.	2014
100	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells/Stem-cell like	MDA–MB–231	Culture	3D	Scaffolds/Spheroids	n/a	Model/method develop.(exp.)	morphology (phalloidin, DAPI staining), viability, stemness level determination by ALDEFLUOR assay	Low	Yes	n/a	10.3390/polym9080328	Rabionet, Marc	2017
101	BC	BC	Metastasis; Microenvironment	In vitro	Cells	Immortalised cells	MSCs, SUM159PT, MDA–MB–231	Co-culture/MPS	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	viability, change in cell metabolism assessed by the inhibitor oATP, morphology, migration	Low	Yes	n/a	10.1038/s41598-017-13460-7	Maffey, A.	2017
102	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MD-231	Culture	3D	Scaffolds	n/a	Disease mechanism (exp./theor.)	morphology, cell adhesion, invasion, ER, PR and HER-2 protein localization	Low	Yes	n/a	10.3390/polym10060581	Wang, Jing	2018
103	BC	BC	Metastasis; Microenvironment	In vitro	Cells	Immortalised cells	MCF7, SUM149, SUM159, BT474, MDA-MB-231	Co-culture	3D	Scaffolds	n/a	Disease mechanism (exp./theor.)	survival, dormancy and proliferation, cytotoxicity	Low	Yes	n/a	10.1007/978-1-4939-2519-3_12	Marlow, Rebecca	2015
105	BC	BC	Metastasis	In vitro	Cells	Immortalised cells/Primary cell culture	MDA-MB-231 BR, tissue samples of breast cancer brain metastases (BCBM), glial cells	Co-culture	n/a	n/a	n/a	Disease mechanism (exp./theor.)	PTEN, AKY, ERK1/2, migration, invasion	High	n/a	n/a	10.18632/oncotarget.14047	Hohensee, Ina	2017
106	BC	BC	Cancer Initiation and Development	In vitro	Cells/Ex vivo	Immortalised cells	MCF10A	Culture	3D	Spheroids	Biopsies	Disease mechanism (exp./theor.)	proliferation, EGF, ERK, GPER	Low	No	Direct	10.1007/s12672-014-0174-1	Scaling, Allison L.	2014
107	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF10A	Culture	3D	Spheroids	n/a	Model/method develop.(exp.)	morphology, CK5/6, CK14,  CK17, E-cadherin, pCAM, Muc1, ALDH1A3, CD49, SMA, P63	Low	n/a	n/a	10.1371/journal.pone.0131285	Qu, Ying	2015
110	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	SK-BR-3, MDA-MB-231, T-47D	Culture	2D	n/a	n/a	Drug develop./testing	morphology, cytotoxicity	High	n/a	Supportive	10.5562/cca3139	Zlatar, Ivo	2017
112	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7	Culture	3D	Scaffolds	n/a	Model/method develop.(exp.)	cell adhesion, cell proliferation, morphology, VEGF, IL-8, bFGF	Low	Yes	Direct	10.1016/j.actbio.2016.01.027	Xu, Weijun	2016
113	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7-C3 , MDA-MB-231-C3	Culture	3D	Spheroids	n/a	Drug develop./testing	viability, morphology, caspase‐3, MMP‐9, SOX2,  OCT4A	Low	Yes	Direct	10.1002/bit.25572	Anand, Padmaja	2015
114	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells/Primary cell culture	MCF7 , MDA-MB-231, BT474, MCF10A	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	miR-124, SNAI2, cell proliferation, colony formation, migration, invasion	Low	Yes	Supportive	10.3892/or.2016.5163	Du, Shanmei	2016
115	BC	BC	Metastasis; Microenvironment	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.); Drug develop./testing	Axl, PI3K/Akt, cytotoxicity, E‐cadherin, N‐cadherin, Snail,  Slug	Medium Low	Yes	Supportive	10.1002/iub.1285	Li, Yanyan	2014
117	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-468, MCF7, BT474, SKBR3, RPMI1640, HCC1806, HCC1143, HCC1937, HCC1954, HCC1187, MB468, T47D), or DMEM (MB231, BT549, MB436), MCF10CA1a	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	Morphology, EpCAM	Low	Yes	Supportive	10.1158/1535-7163.MCT-15-0201-T	Gilboa-Geffen, Adi	2015
118	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7/HER2	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	FASN, HER2, cytotoxicity	Low	Yes	Supportive	10.14670/HH-11-830	Corominas-Faja, Bruna	2017
119	BC	DCIS	Cancer Initiation and Development; Pharmacological/Physical Treatment	In vitro	Cells	Primary cell culture	DCIS, SUM255, BC	Culture	3D	Spheroids	n/a	Disease therapy develop.; Drug develop./testing	morphology, Ki67	Low	Yes	Direct	10.4161/cc.27201	Farnie, Gillian	2014
120	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	BT474 , MCF/HER2	Culture	3D	Spheroids	n/a	Disease therapy develop.	morphology, HER2, HER3, cell-cycle	Low	Yes	n/a	10.3892/ol.2017.7493	Kitowska, Kamila	2018
121	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7	Culture	2D/3D	Spheroids	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Supportive	10.1021/acs.organomet.8b00415	Starha, Pavel	2018
122	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	BT474 , MCF7	Culture	2D	n/a	n/a	Disease therapy develop.	Her-2/neu	Low	Yes	Supportive	10.1063/1.5001586	Bragina, O.	2017
123	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF10A	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	Ig58/59 and Ig65/66, morphology, Adherent Junction, cell migration	Low	Yes	Supportive	10.1038/onc.2014.358	Shriver, M.	2015
124	BC	BC	Cancer Initiation and Development	In silico	Algorithms	n/a	n/a	n/a	n/a	n/a	n/a	Disease mechanism (exp./theor.)	ER and HER-2, cancer incidence, mutation load	High	n/a	n/a	10.1371/journal.pone.0152298	Chapa, Joaquin	2016
125	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	T47D	MPS	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	morphology, viability, tumorigenicity	Low	n/a	n/a	10.1039/c6lc00062b	Chen, Yu-Chih	2016
126	BC	BC	Metastasis; Microenvironment	In vitro	Cells	Immortalised cells	MDA-MB-231	MPS	3D	Scaffolds	n/a	Disease mechanism (exp./theor.)	invasion	Low	Yes	Direct	10.1007/s10544-017-0234-8	Amirabadi, H. Eslami	2017
127	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF10A	Culture	3D	Organoids	n/a	Model/method develop.(exp.)	transfection efficiency, P63, PTEN	High	Yes	n/a	10.1093/nar/gky030	Laperrousaz, Bastien	2018
129	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-134, SUM44, MDA-MB-330, BCK4, MCF7, T47D, MDA-MB-231	Culture	2D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	morphology, cell-adherence, cell migration	Low	Yes	Direct	10.1158/0008-5472.CAN-18-1416	Tasdemir, Nilgun	2018
130	BC	IDC / ILC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7 , MDA-MB-231	Culture	2D/3D	Spheroids	n/a	Drug develop./testing	cytotoxicity, Wnt/β-catenin	Low	Yes	Direct	10.1097/CAD.0000000000000511	Aouad, Patrick	2017
131	BC	BC	Metastasis; Microenvironment	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231 , HBL-100	Culture	2D/3D	Spheroids	n/a	Drug develop./testing	cytotoxicity, HIF-1, HIF-2, CAIX, NHE1, genome-wide protein profiling	Low	Yes	Supportive	10.18632/oncotarget.17143	Meehan, James	2017
132	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	3D	Spheroids	n/a	Drug develop./testing	invasion, NF-κB/MMP-2	Low	Yes	Direct	10.1016/j.bbrc.2017.02.022	Ukaji, Tamami	2017
133	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231, CAFs	Co-culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	morphology, invasion, RhoA/ROCK	Low	Yes	Supportive	10.18632/oncotarget.23735	Daubriac, Julien	2018
134	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, CAF	Co-culture	3D	Spheroids	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.1016/j.actbio.2018.05.055	Brancato, Virginia	2018
135	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells/Stem-cell like	MDA-MB-231	Culture	3D	Spheroids	n/a	Drug develop./testing	colony formation, CD44, CD24, ESA, PI3K/Akt, MEK/ERK, GSK3β/β-catenin and TGF-β/Smad, E-cadherin, α-smooth muscle actin (α-SMA) and Claudin-1, Slug, Snail and Fibronectin	Low	Yes	Supportive	10.3892/ijo.2016.3351	Liu, Yanchen	2016
138	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231 , MCF10A-NeuN	Co-culture	3D	Scaffolds/Spheroids	n/a	Drug develop./testing; Model/method develop. (exp.)	morphology	Low	Yes	Direct	10.1088/1758-5090/aafc49	Swaminathan, Swathi	2019
139	BC	BC	Cancer Initiation and Development; Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	SUM149PT , SUM190PT, SUM1315MO2, SUM1315MO2, SUM149PT	Culture	3D	Spheroids	n/a	Drug develop./testing	morphology, OPG, angiogenesis, CD24, CD44, survival kinases	Low	Yes	n/a	10.1186/s12885-015-1837-1	Goswami, Sudeshna	2015
140	BC	BC	Cancer Initiation and Development	In silico	Computational	n/a	n/a	n/a	n/a	n/a	n/a	Disease mechanism (exp./theor.); Model/method develop. (theor.)	breast tumor mass structure	Low	Yes	n/a	10.1118/1.4905232	de Sisternes, Luis	2015
141	BC	BC	Cancer Initiation and Development	In vitro	Cells	Primary cell culture	HUVEC	Co-culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	viability, morphology, proteolytic activity, number of cellular branch points, cytokines, CD95L, phospho-Src, phosphos-FAK(Y)397, phospho-ERK1/2, TGF-β1, of E-cadherin, N-cadherin, EMT	Low	Yes	Supportive	10.18632/oncotarget.15170	Andrade, Sheila Siqueira	2017
143	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231	MPS	3D	Organoids	n/a	Model/method develop.(exp.)	cell proliferation, angiogenesis, cell migration, intravasation	Low	Yes	Direct	10.1039/c8lc00596f	Shirure, Venktesh S.	2018
144	BC	BC	Metastasis	In silico	Simulation	n/a	n/a	n/a	n/a	n/a	n/a	Model/method develop.(theor.)	cell aggregation, cooperative migration, CSF-1/CSF-1R autocrine signaling	Low	n/a	n/a	10.1016/j.jtbi.2014.04.031	Knutsdottir, Hildur	2014
145	BC	BC	Cancer Initiation and Development	In silico	Computational	n/a	n/a	n/a	n/a	n/a	n/a	Model/method develop.(theor.)	CDK, cyclin E1	Low	n/a	n/a	10.1021/bi5004052	Rath, Soumya Lipsa	2014
147	BC	BC	Cancer Initiation and Development	In vitro	Cells	Primary cell culture	MDA-MB-231, MCF10A	MPS	3D	Spheroids	n/a	Disease mechanism (exp./theor.); Disease therapy develop.; Model/method develop. (exp.)	invasion, AURKA, ERK1/2	Low	Yes	Direct	10.1038/s41598-017-02623-1	Xia, Jiang-Long	2017
148	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7	Culture	3D	Scaffolds	n/a	Model/method develop.(exp.)	morphology	Low	Yes	Direct	10.1016/j.matchemphys.2019.01.022	Luo, Honglin	2019
149	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	LM2-4175, HUVEC	Co-culture/MPS	3D	Scaffolds	n/a	Model/method develop.(exp.)	cell migration	Low	Yes	Direct	10.1038/s41598-018-30776-0	Bertulli, Cristina	2018
150	BC	BC	Cancer Initiation and Development	In vitro	Cell free	n/a	MCF7	n/a	n/a	n/a	n/a	Disease mechanism (exp./theor.)	Single Nucleotide Variants	Low	Yes	Direct	10.1186/s13073-016-0382-0	Bahreini, Amir	2016
151	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	morphology, CYP1A1, MMP-1, AHR, NF-κB	Low	Yes	Direct	10.1093/hmg/ddw329	Chi Huu Nguyen	2016
152	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231,	Culture	2D	n/a	n/a	Diagnosis of disease; Disease mechanism (exp./theor.)	PCK, ING1	High	Yes	Supportive	10.18632/oncotarget.1988	Thakur, Satbir	2014
153	BC	BC	Cancer Initiation and Development; Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	cellular proliferation, migration,  invasion, HSF2, ALG3	Low	Yes	Direct	10.12659/MSM.907461	Yang, Yongde	2018
154	BC	BC	Metastasis; Microenvironment	In vitro	Cells	Immortalised cells	HBL-100	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	cytotoxicity, cell migration, cell proliferation, morphology, CD44, CD24	Low	Yes	Direct	10.1002/tox.22659	Fararjeh, Abdul-Fattah Salah	2019
156	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells/Primary cell culture	SKBR3 , MCF7	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	HER2, HER3	High	Yes	Direct	10.18632/oncotarget.9963	Weitsman, Gregory	2016
157	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	HCC70	Culture	3D	Spheroids	n/a	Model/method develop.(exp.)	morphology	Low	Yes	Direct	10.7717/peerj.4340	Jogalekar, Manasi P.	2018
158	BC	BC	Cancer Initiation and Development; Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells/Stem-cell like	MDA-MB-231, MCF7	Culture	2D/3D	Spheroids	n/a	Model/method develop.(exp.)	morphology, cytotoxicity, ALDH1A3, SOX2, OCT4, NANOG	Low	Yes	Direct	10.1038/s41598-017-10863-4	Reynolds, Daniel S.	2017
161	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	BT474	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.1016/j.biologicals.2016.12.006	Dakshinamurthy, Pravinkumar	2017
162	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7	Culture	3D	Spheroids	n/a	Disease therapy develop.	nanotube penetration, morphology	Low	Yes	Direct	10.1016/j.carbon.2015.08.024	Jena, Prakrit V.	2016
163	BC	BC	Cancer Initiation and Development; Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	SUM159, MDA-MB-231, 293T, Hs785bst , Hs371.tCAFs	Co-culture	3D	Spheroids	n/a	Model/method develop.(exp.)	morphology, drug penetration, cytotoxicity	Low	Yes	Direct	10.1038/srep06468	Jaganathan, Hamsa	2014
164	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	BT549, MDA-MB-468CAL120	Culture	3D	Spheroids	n/a	Model/method qualification	morphology, proliferation, cell meatbolism	Low	Yes	Direct	10.1126/sciadv.aau7314	Voorde, Johan Vande	2019
165	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-468	Culture	3D	Scaffolds	n/a	Model/method develop.(exp.)	invasion, cytotoxicity	Low	Yes	Direct	10.1021/acsami.6b06309	Arya, Anuradha D.	2016
166	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	3D	Scaffolds	n/a	Model/method develop.(exp.)	morphology, proliferation, genome-wide RNA profile, 	Low	Yes	Direct	10.1073/pnas.1410996111	Dudley, David T.	2014
167	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231, MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity, PI3K, Src, EGFR, Tie2, lck, lyn, RTK5, FGFR1, Abl,  Flt	Low	Yes	Direct	10.1021/tx500518j	Wang, Hui-Chun	2015
168	BC	BC	Metastasis; Microenvironment	In vitro	Cells	Immortalised cells	MCF10	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	Giant obscurin, PI3K pathway, β-catenin, E-cadherin, proliferation, motility and invasion, EMT	Low	Yes	Direct	10.18632/oncotarget.9985	Shriver, Marey	2016
169	BC	BC	Metastasis; Microenvironment	In vitro	Cells	Immortalised cells	MDA-MB-231, MCF7	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	viability, migration, invasion	Low	Yes	Direct	10.1158/1535-7163.MCT-15-0907	Kashyap, Abhishek S.	2016
170	BC	BC	Metastasis; Microenvironment	In vitro	Cells	Immortalised cells	MDA-MB-231, MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity, cell adhesion, proliferation, MCAM, ITGA2, ITGA3, ITGA4, ITGAV, ITGB1, ITGB3, FGF1, NFKB1, PI3K/Akt pathway	Low	Yes	Direct	10.1038/s41598-017-07082-2	Gimenes, Sarah N. C.	2017
171	BC	BC	Cancer Initiation and Development; Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity, PARP, BAX, Bcl2, ROS, Pi3K/AKT pathway	Low	Yes	Direct	10.1016/j.sajb.2014.03.010	Esmaeili, Mohammad Ali	2014
172	BC	BC	Cancer Initiation and Development; Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7 , MDA-MB-231	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.1002/pros.23162	Akinboye, Emmanuel S.	2016
173	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.1002/cmdc.201800098	Boscutti, Giulia	2018
174	BC	BC	Cancer Initiation and Development; Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	SKBR3, MDA-MB-231	Culture	2D/3D	Spheroids	n/a	Drug develop./testing	morphology, cytotoxicity, MMP2	Low	Yes	Direct	10.1016/j.jcis.2015.03.049	Parhi, Priyambada	2015
175	BC	BC	Pharmacological/Physical Treatment; Microenvironment	In vitro	Cells	Immortalised cells/Primary cell culture	MCF10, MCF7	Culture	3D	Spheroids	n/a	Drug develop./testing; Model/method develop. (exp.)	cytotoxicity, MMP2	Medium	Yes	Supportive	10.1016/j.actbio.2017.05.004	Brancato, Virginia	2017
176	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF10, MCF10-Neun, HUVEC	Co-culture	3D	Spheroids	n/a	Model/method develop.(exp.)	morphology, tube-like structure fomation	Low	Yes	Direct	10.1021/acsbiomaterials.6b00624	Swaminathan, Swathi	2017
177	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	SKBR3, BT474, HCC1569, MCF7, MCF10A	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	cytotoxicity, RNA profile, cell cylce, PERK, phospho-PERK, PDI, BiP, eIF2α, phospho-eIF2α, DDIT3/CHOP, HER2, phospho-HER2, HER3, phospho-HER3, EGFR, phospho-EGFR	Low	Yes	Direct	10.1186/s12885-016-2611-8	Baumann, Jan	2016
183	BC	BC	Cancer Initiation and Development; Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	2D/3D	Spheroids	n/a	Drug develop./testing; Model/method develop. (exp.)	morphology, cytotoxicity	Low	Yes	Direct	10.1007/s10544-014-9918-5	Yu, Linfen	2015
185	BC	BC	Metastasis; Microenvironment	In vitro	Cells	Immortalised cells	MCF7, SUM159 , mCherry-labeled SUM159	Co-culture/MPS	3D	Scaffolds	n/a	Disease mechanism (exp./theor.); Model/method develop. (exp.)	invasion, migration, EGF Receptors, morphology, GFR and pEGFR	Low	Yes	Direct	10.1038/srep34094	Danh Truong	2016
188	BC	BC	Circulating Cancer Cells/DNA Identification and Profiling	In vitro	Cells	Primary cell culture	liquid biopsy	Culture	2D	n/a	Biopsies	Diagnosis of disease; Model/method develop. (exp.); Model/method qualification	HER2, EpCAM	High	Yes	Direct	10.1039/c3lc51039e	Galletti, Giuseppe	2014
189	BC	BC	Cancer Initiation and Development	In vitro	Ex vivo	n/a	BC	n/a	n/a	n/a	Organ slice	Drug develop./testing	morphology, viability, Ki67, cytotoxicity, LDH	Low	Yes	Direct	10.1155/2015/618021	Edith Carranza-Torres, Irma	2015
191	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	3D	Spheroids	n/a	Drug develop./testing; Model/method develop. (exp.)	morphology, cytotoxicity	Low	Yes	Direct	10.1016/j.nano.2015.02.009	Kang, AhRan	2015
192	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	T47D, MDA-MB-231	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.); Model/method qualification	metabolic activity	Low	Yes	Direct	10.18383/j.tom.2016.00157	Cavnar, Stephen P.	2016
194	BC	BC	Metastasis; Microenvironment	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	BST-2, cell migration, invasion	Low	Yes	Direct	10.18632/oncotarget.22753	Naushad, Wasifa	2017
197	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231	Co-culture/MPS	3D	Spheroids	n/a	Disease mechanism (exp./theor.); Model/method develop. (exp.)	morphology, migration	Low	Yes	Direct	10.1063/1.5016433	Rogers, Matthew	2018
198	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2D/3D	Scaffolds	n/a	Model/method develop.(exp.)	morphology, Infra-red spectral responses	Low	Yes	Supportive	10.1039/c4an01833h	Smolina, Margarita	2015
199	BC	BC	Cancer Initiation and Development	In silico	Algorithms	n/a	n/a	n/a	n/a	n/a	n/a	Model/method develop.(theor.)	metabolic activity, NAD(P)H and FAD	Low	Yes	Supportive	10.1117/12.2252499	Heaster, Tiffany M.	2017
200	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, T47D	Culture	3D	Spheroids	n/a	Model/method develop.(exp.)	morphology, viability	Low	Yes	Direct	10.1021/acs.biomac.7b01422	Baker, Alexander E. G.	2017
202	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	BT474, MCF7, HCC1428, MDA-MB-175, MCF12A, T47D, MCF10A, HCC1954, MDA-MB-157, HCC1806, MDA-MB-436, MDA-MB-231, HCC1569, SUM-159PT, HCC38, HS578T	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	ITGA1, ITGA11, ITGB1, ITGA5, ITGB1, HIF-1,HIF-2, migration, invasion	Medium	Yes	Direct	10.1158/1541-7786.MCR-16-0338	Ju, Julia A.	2017
203	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	SKBR3 , T47D	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity, α-ESA, HER2/HER3, PTEN, Akt, GSK-3β, Bcl-2, NF-κB, Akt, BAD, Bcl-2	Low	Yes	Direct	10.3892/mmr.2014.1892	Zhuo, Ren-Jie	2014
204	IBC/BC	IBC/DCIS	Cancer Initiation and Development	In vitro	Cells	Primary cell culture	liquid biopsy	Culture	2D	n/a	n/a	Drug develop./testing	anti-HER3 Th1 and correlation with clinical outcome	Medium	Yes	Direct	10.1245/s10434-016-5584-6	Fracol, Megan	2017
205	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	DFs, MDA-MB-231	Co-culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	morphology, CD90, viability, cell proliferation, cell cycle	Low	Yes	Direct	10.1073/pnas.1612290113	Bartosh, Thomas J.	2016
206	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MDA-MB-231, MCF7, MDA-MB-157 , BT549, MDA-MB-231 , MCF7	MPS	2D	n/a	n/a	Model/method develop.(exp.)	migration, extravasation, ROS, ERK1/2	Low	Yes	Direct	10.1016/j.canlet.2016.12.001	Ma, Shijun	2017
207	BC	BC	Cancer Initiation and Development; Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	2D/3D	Spheroids	n/a	Drug develop./testing	nanostructures penetration, cytotoxicity	Low	Yes	Direct	10.1016/j.ejpb.2019.02.016	Alves, Catia G.	2019
208	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, T47D, MDA-MB-231, BT549	Culture	2D	n/a	n/a	Drug develop./testing	Chk1, cytotoxicity, γ-H2AX, H3K9me3/S10p, CHEK1 	Low	Yes	Direct	10.1007/s10549-018-05079-7	Dinkelborg, Patrick H.	2019
209	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231	Culture	3D	Scaffolds	n/a	Disease mechanism (exp./theor.)	YP4Z2P, CYP4Z1, miR-211, miR-125a-3p, miR-197, miR-1226, miR-204, ERK1/2, PI3K/Akt, angiogenesis	Medium	Yes	Direct	10.1007/s10549-015-3298-2	Zheng, Lufeng	2015
210	BC	BC	Cancer Initiation and Development	In vitro	Ex vivo	n/a	BC	n/a	n/a	n/a	Organ slice	Diagnosis of disease; Model/method qualification	ERBB2, ESR1, PGR, MKI67 mRNA levels	Medium	Yes	Direct	10.1186/s12885-016-2476-x	Laible, Mark	2016
212	BC	BC	Cancer Initiation and Development	In vitro	Cells/Ex vivo	Immortalised cells	MCF7, MDA-MB-231, endothelial cells	Co-culture	2D	n/a	Biopsies	Disease mechanism (exp./theor.)	miR-20a expression and correlation with clinical outcome, VEGFA, THBS1	Medium Low	Yes	Supportive	10.1371/journal.pone.0194638	Luengo-Gil, Gines	2018
213	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-468MCF7, MDA-MB-231, HCC70, HID-28, BT474	Culture	2D	n/a	n/a	Drug develop./testing	morphology, cytotoxicity, AKT, ERK, AKT, PRA S40, GSK3B, S6	Low	Yes	n/a	10.1158/1535-7163.MCT-14-0406	Hancox, Urs	2015
214	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	SKBr3	Culture	2D	n/a	n/a	Drug develop./testing	EGFR, HER2, HER3, HER4, ERK1/2, AKT, TOR, FASN, cytotoxicity	Low	Yes	Direct	10.1371/journal.pone.0131241	Blancafort, Adriana	2015
215	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7, T47D, MDA-MB-415, and HCC712	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.1158/1078-0432.CCR-15-2160	Ma, Cynthia X.	2016
218	BC	BC	Metastasis; Microenvironment	In vitro	Cells	Immortalised cells	MDA-MB-231	MPS	2D	n/a	n/a	Disease mechanism (exp./theor.); Model/method develop. (exp.)	cell migration	Low	Yes	Direct	10.3390/mi7050084	Che, Xiangchen	2016
221	BC	BC	Cancer Initiation and Development; Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231, BT424	Culture	2D	n/a	n/a	Drug develop./testing; Model/method qualification	HS-27 fluorescence uptake, HSP90, AKT	Low	Yes	Direct	10.1117/12.2285210	Crouch, Brian T.	2018
222	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	 STAT3, GLI1/tGLI1, R-Ras2, Cep70, UPF3A	Low	n/a	n/a	10.1038/s41388-018-0132-4	Sirkisoon, Sherona R.	2018
223	BC	BC	Circulating Cancer Cells/DNA Identification and Profiling	In silico	Algorithms	n/a	n/a	n/a	n/a	n/a	n/a	Model/method develop.(exp.)	the false positive rate, false negative rate, precision, recall, F-measure, accuracy and error	Low	Yes	n/a	10.1007/s10586-018-2183-2	Umamaheswari, T. S.	2018
224	BC	BC	Cancer Initiation and Development; Pharmacological/Physical Treatment	In vitro	Cells	Primary cell culture	BC	Culture	3D	Spheroids	n/a	Drug develop./testing	cytotoxicity	Medium	Yes	Direct	10.1186/s12885-015-1491-7	Halfter, Kathrin	2015
225	BC	BC	Cancer Initiation and Development	In vitro	Ex vivo	n/a	BC	n/a	n/a	n/a	Organ slice	Model/method develop.(exp.)	HER2 	Low	Yes	Direct	10.1186/s40364-016-0062-7	Hofmann, Elisabeth	2016
228	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7	Culture	3D	Spheroids	n/a	Model/method develop.(exp.)	fluorescent dye uptake	Low	Yes	n/a	10.1039/c8sc00994e	Nicolson, Fay	2018
229	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-468, MDA-MB-175, MDA-MB-453, MDA-MB-361, ZR-75-1, JIMT-1, BT474, SKBR3.	Culture	2D	n/a	n/a	Drug develop./testing	HER2, HER3, PI3K/AKT pathway	Low	Yes	Direct	10.1016/j.ccell.2018.04.003	Geuijen, Cecile A. W.	2018
230	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231, SK-BR-3, ZR-75-30, EVSA-T, ADSC	Co-culture	2D	n/a	n/a	Disease mechanism (exp./theor.); Model/method develop. (exp.)	migration, invasion, viability, angiogenesis	Low	Yes	Direct	10.1186/s13287-017-0579-1	Koellensperger, Eva	2017
231	BC	BC	Cancer Initiation and Development	In vitro/In silico	Cells/Mathematical	Immortalised cells	MCF10A	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	MASTL, Ki67, chromosome stability, cell proliferation, genome wide phosphoprotein profiling, cell migration, cell-cell interaction, morphology DNA damage	Low	Yes	Direct	10.1038/s41388-018-0295-z	Rogers, Samuel	2018
232	BC	BC	Cancer Initiation and Development	In vitro/In silico	Cells/Simulation	Immortalised cells/Stem-cell like	MCF7, SUM159	Culture	3D	Spheroids	n/a	Drug develop./testing	cytotoxicity, percentage of ALDH1A1-positive BCSCs	Low	Yes	Direct	10.1007/s13277-013-1099-y	Pandrangi, Santhi Latha	2014
235	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells/Primary cell culture	MDA-MB-231, MCF7, BC80, 31, 30, 29, 16, 12, 10	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	SALL1, viability, Cyclin A2, B1, D1,E1, CDK2, 4, 6, cell proliferation, colony formation, NuRD	Medium	Yes	Direct	10.1186/s12943-018-0824-y	Ma, Chunling	2018
236	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231, MSCs	Co-culture	3D	Scaffolds	n/a	Disease mechanism (exp./theor.); Model/method develop. (exp.)	viability, proliferation	Low	Yes	Direct	10.1021/acsami.6b10673	Zhou, Xuan	2016
237	BC	BC	Metastasis; Microenvironment	In vitro	Cells	Immortalised cells/Stem cells	MDA-MB-231	Co-culture	3D	Scaffolds	n/a	Disease therapy develop.; Model/method develop. (exp.)	migration, invasion, EMT 	Low	Yes	Direct	10.1021/acsbiomaterials.7b00237	Mooney, Bridget	2017
238	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-435S	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	migration,LPL, ERK/MAPK pathway, RSK1, RSK2, kinases	Low	Yes	Direct	10.1096/fj.15-276311	Lommel, Maiti J.	2016
239	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231, T47D	Culture	2D	n/a	n/a	Drug develop./testing	apoptosis, DNA fragmentation	Low	Yes	n/a	10.2174/1568026614666140324121606	Kalani, Komal	2014
240	BC	BC	Pharmacological/Physical Treatment	In silico	Simulation	n/a	n/a	n/a	n/a	n/a	n/a	Model/method develop.(exp.)	cytotoxicity	Low	Yes	Direct	10.1007/978-3-319-13117-7_231	Carvalho, Daniela S.	2014
241	BC	BC	Cancer Initiation and Development	In silico	Computational	n/a	n/a	n/a	n/a	n/a	n/a	Model/method develop.(exp.)	BRCA1 	Low	Yes	n/a	10.1371/journal.pgen.1006096	Thouvenot, Pierre	2016
242	BC	BC	Metastasis; Microenvironment	In vitro	Cells	Immortalised cells	HCC1806 , HCC1937, MCF7	Co-culture	2D	n/a	n/a	Drug develop./testing	invasion, proliferation, ER α, ER β, CXCR4 	Low	Yes	n/a	10.3892/ijo.2014.2778	Hinsche, Oliver	2015
243	BC	BC	Metastasis; Microenvironment	In vitro	Cells	Immortalised cells	HCC1143, HCC1937	Culture/Co-culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.); Drug develop./testing	 TGFalpha, EGFR	Low	Yes	Direct	10.1038/bjc.2015.163	Caiazza, Francesco	2015
245	BC	BC	Cancer Initiation and Development; Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7, MDA-MB-231 , BT474	Co-culture	3D	Scaffolds	n/a	Drug develop./testing; Model/method qualification	morphology, cytotoxicity, CD44, CD24	Low	Yes	Direct	10.21873/anticanres.11496	Das, Tuhin	2017
246	BC	BC	Metastasis; Microenvironment	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	cytotoxicity, ABC transporters	Low	Yes	Direct	10.1007/s13205-018-1412-y	Yilmazer, Acelya	2018
247	BC	BC	Metastasis; Microenvironment	In vitro	Cells	Immortalised cells	BT549 , MDA-MB-231	Culture	3D	Spheroids	n/a	Drug develop./testing	migration, cell-adhesion, morphology, c-MET, JAK2, STAT3, MMP2, MMP9	Low	Yes	Direct	10.1186/s12967-018-1660-y	Parr, Christian	2018
248	IBC	IBC	Metastasis; Microenvironment	In vitro	Cells	Immortalised cells	SUM149 , MDA-IBC3	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.); Model/method develop. (exp.)	migration, invasion, morphology, cytotoxicity, IL-6 secretion	Low	Yes	Supportive	10.18632/oncotarget.12694	Wolfe, Adam R.	2016
249	BC	BC	Metastasis; Angiogenesis	In vitro	Cells	Immortalised cells	MDA-MB-231, macrophages	Co-culture/MPS	3D	Scaffolds	n/a	Model/method develop.(exp.)	tube formation, Transendothelial Migration,  Metastasi	Low	Yes	Direct	10.1097/PRS.0000000000002470	Hooper, Rachel C.	2016
250	BC	BC	Cancer Initiation and Development	In vitro/In silico	Cells/Mathematical	Immortalised cells	MDA-MB-231	Co-culture	3D	Scaffolds	n/a	Disease mechanism (exp./theor.); Model/method develop. (exp.)	invasion	Low	Yes	Direct	10.1039/c7ib00152e	Ray, Arja	2018
251	BC	BC	Cancer Initiation and Development	In vitro	Cells	Primary cell culture/Stem cells	BC	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	colony composition in response to hypoxia, CD44, CD24, apoptosis	Low	Yes	Direct	10.7603/s40730-015-0014-0	Phuc Van Pham	2015
253	BC	BC	Cancer Initiation and Development; Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	3D	Spheroids	n/a	Drug develop./testing	morphology, cytotoxicity	Low	Yes	Direct	10.3390/nano8080588	Li, Xia	2018
254	BC	BC	Metastasis; Microenvironment	In vitro	Cells	Immortalised cells	BT474, MDA-MB-361, SKBR3	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	RICTOR, AKT, HER2, RhoGDI2, invasion, cytotoxicity	Low	Yes	Supportive	10.1186/s13058-017-0868-8	Joly, Meghan Morrison	2017
255	BC	BC	Metastasis; Microenvironment	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	COL13, invasion, migration, PARP, morphology, TGF-β pathway	Low	Yes	Supportive	10.1186/s13058-018-1030-y	Zhang, Hui	2018
257	BC	BC	Cancer Initiation and Development; Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	PTEN, AKT, CD44/CD24, viability, colony formation	Low	Yes	Supportive	10.1016/j.biopha.2016.01.045	Li, Bailong	2016
258	IBC	IBC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF10A, MCF10DCIS.com , T47D	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	miRNA profiling	Low	Yes	Supportive	10.1007/s10585-017-9868-4	Soon, Patsy S.	2018
261	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Primary cell culture	BC	Culture	3D	Spheroids	n/a	Drug develop./testing	cytotoxicity, CD44/CD24/ESA, viability	Low	Yes	Direct	10.1007/s12282-012-0356-z	Shimo, Toshiro	2014
262	BC	BC	Microenvironment-Tumor Interactions	In vitro/In silico	Cells/Simulation	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.3390/molecules23061398	Borik, Rita M.	2018
267	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB468 , MDA-MB-231	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	ER, PR, MMP2, USP2, migration, invasion	Low	Yes	Supportive	10.1007/s13277-015-3207-7	Qu, Qing	2015
269	BC	BC	Metastasis; Microenvironment	In vitro	Cells	Immortalised cells	MDA-MB-231, endothelial cells	Co-culture/MPS	3D	Scaffolds	n/a	Disease mechanism (exp./theor.)	genome-wide RNA profile, ADAMs, MMPs	Low	Yes	Direct	10.18632/oncotarget.26306	Bersini, Simone	2018
271	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MDA-MB-231 , MCF7	Co-culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	invasion	Low	Yes	Direct	10.1039/c4ib00022f	Shin, Yoojin	2014
272	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MDA-MB-231	Co-culture	3D	Scaffolds	n/a	Disease mechanism (exp./theor.)	drug uptake, cytotoxicity	Low	Yes	Direct	10.1021/acsbiomaterials.8b00877	Wong, Andrew D.	2019
273	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MCF7	MPS	3D	Scaffolds	n/a	Model/method develop.(exp.)	estrogen receptor-α (ER-α), integrin β1, E-cadherin	Low	Yes	Direct	10.1021/acsbiomaterials.6b00379	Clay, Nicholas Edwin	2016
274	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MCF7	Culture	2.5D/3D	Spheroids	n/a	Model/method develop.(exp.)	viability, colony formation	Low	Yes	Direct	10.1039/c6tb00511j	Xu, Weijun	2016
275	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture/Co-culture	3D	Scaffolds	n/a	Model/method develop.(exp.)	migration, cytotoxicity, angiogenesis, glucose consumption, lactate production	Low	Yes	Supportive	10.1021/am506094c	Subia, Bano	2015
278	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	CAFs, MDA‐MB‐231, MDA‐MB‐231‐LvBr3	Co-culture	3D	Scaffolds	n/a	Model/method develop.(exp.)	cell-adhesion, migration, integrin β1, integrin β2, integrin β3, cMET, ERK1/2	Low	Yes	Direct	10.1002/ijc.28848	Choi, Yoon Pyo	2014
279	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MDA-MB-231(LUC+))	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	migration, invasion, NK1R, NK2R, RAMP1, CALCRL, High molecular weight kininogen (HMWK) content	Low	Yes	Direct	10.1186/s12935-018-0707-8	Gutierrez, Silvia	2018
280	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MCF10A, MCF10F, trMCF, bsMCF, bsMCFluciferase (bsMCFluc), XtMCF, LmMCF, MCF7, T47D, BT474, SKBr3, BT549, MDA-MB-468, MDA-MB-231, HSS78t, HCC1994, SUM49py, SUM59pt,	Culture	2.5D/3D	Spheroids	n/a	Disease mechanism (exp./theor.); Drug develop./testing	viability, DNMT, HDAC, migration, invasion, colony formation, EMT	Low	Yes	Supportive	10.1186/s13046-018-0988-8	Su, Yanrong	2018
281	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells/Ex vivo	Immortalised cells	CAFs, MCF7	Co-culture	2D	n/a	Biopsies	Disease mechanism (exp./theor.); Model/method develop. (exp.)	Genome-wide RNA, S100A2 	Low	Yes	Direct	10.1186/s12885-015-1117-0	Hosein, Abdel Nasser	2015
282	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7	Culture	2D/3D	Spheroids	n/a	Diagnosis of disease; Disease mechanism (exp./theor.)	miRNA expression profile, viability, migration, invasion	Low	Yes	Direct	10.1016/j.bbamcr.2017.05.023	Ayerim Mandujano-Tinoco, Edna	2017
283	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MDA-MB-231 , MCF7, ZR-75.1, Osteocytes 	Co-culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	Proliferation, Migration and Invasion	Low	Yes	Direct	http://ar.iiarjournals.org/content/36/3/1193.short	Cui, YX	2016
284	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity, migration, invasion, EMT	Low	Yes	Supportive	10.1016/j.pharep.2016.09.012	Chen, Xia	2017
286	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	SK-BR-3 , HCC1954	Culture	2.5D	n/a	n/a	Drug develop./testing	cytotoxicity	Medium	Yes	Supportive	10.1186/s13058-017-0900-z	Baldassarre, Tomas	2017
287	BC	BC	Pharmacological/Physical Treatment	In vitro/In silico	Cells/Simulation	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Medium	Yes	Direct	https://www.academia.edu/32429037/15_10_14_International_Journal_of_Pharmacy_and_Pharmaceutical_Sciences_Vol_6_Issue_8_2014_pdf	Diyah, N.W.	2014
290	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231, MCF7	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	let-7A, MAGE-A1, cell proliferation, migration and invasion	Low	Yes	Supportive	10.4149/neo_2018_180302N146	Mi, Y. Z.	2019
291	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7 , MDA-MB-231,	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	MMP-1, cell migration, invasion, c-Myc, p-AKT, AKT, Bcl-2, BAX, caspase 3	Low	Yes	Direct	10.3892/ol.2018.9779	Wang, Qi-Min	2019
293	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	SUM1315, MDA-MB-231, MDA-MB-231BO, MDA-MB-231	Culture	2D/3D	Scaffolds	n/a	Disease mechanism (exp./theor.)	integrin β1, cell migration	Low	Yes	Supportive	10.18632/oncotarget.2788	Thibaudeau, Laure	2015
294	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231	MPS	3D	Scaffolds	n/a	Model/method develop.(exp.)	morphology, Ki67	Low	Yes	Direct	10.1177/2041731416660739	Goliwas, Kayla F.	2016
295	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MCF7, SK‐BR‐3, MDA‐MB‐231.	Culture	2.5D/3D	Spheroids	n/a	Model/method develop.(exp.)	morphology, viability, Ki67, colony formation	Low	Yes	Direct	10.1002/jbm.a.35899	Pradhan, Shantanu	2017
296	BC	BC	Cancer landscape	In silico	Algorithms	n/a	n/a	n/a	n/a	n/a	n/a	Model/method qualification	RNA expression profile	High	Yes	Supportive	10.1186/s13058-015-0613-0	Vincent, Krista Marie	2015
297	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231, MDA-MB-231HM MDA-MB-468,	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	CrKL, SDF-1, Erk1/2, PI3K/Akt, migration, invasion	Low	Yes	Supportive	10.1007/s12032-014-0411-z	Lian, Xin	2015
298	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7	Culture	3D	Spheroids	n/a	Drug develop./testing	IL‐6/STAT3 signaling pathway, ALDH1A1, Sox2,  Oct4, proliferation, colony formation, cytotoxicity	Low	Yes	Supportive	10.1002/ptr.6172	Liu, Chuanlan	2018
299	IBC	IBC	Microenvironment-Tumor Interactions	In vitro	Cells/Ex vivo	Immortalised cells	SUM149, macrophages	Culture	3D	Spheroids	Biopsies	Disease mechanism (exp./theor.)	secreted cytokines, CD14, CD68, tumor necrosis factor-α; monocyte chemoattractant protein-1/CC-chemokine ligand 2; interleukin-8 and interleukin-10	Low	Yes	Supportive	10.1016/j.biocel.2013.11.015	Mohamed, Mona M.	2014
300	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	T47D, Adipose Fibroblasts	Co-culture	2D	n/a	n/a	Drug develop./testing	proliferation, cytotoxicity, CYP19	Low	Yes	Direct	10.1016/j.toxrep.2017.03.004	Chottanapund, Suthat	2017
301	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF10F	Culture	2.5D/3D	Spheroids	n/a	Drug develop./testing	morphology	Low	Yes	Direct	10.3892/ijo.2014.2354	Arisi, Maria F.	2014
302	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231, osteoblasts	Co-culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	RANKL/OPG, morphology, migration, proliferation	Low	Yes	Direct	10.1186/1476-4598-13-238	Arrigoni, Chiara	2014
303	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF10A, MCF7, MDA-MB-231	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Supportive	10.1177/1534735418801528	Maimon, Yair	2018
305	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, ZR-75-1 , MDA-MB-231	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	MDM4, MDM2, ER-α, MYC, P53	Low	Yes	Supportive	10.18632/oncotarget.7533	Swetzig, Wendy M.	2016
307	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Primary cell culture	BC	Culture	3D	Spheroids	n/a	Model/method develop.(exp.)	morphology, EpCAM, CK8, CK19, CK14, P63, CALPONIN, HER2	Low	Yes	Direct	10.1186/s13058-017-0843-4	Carter, Edward P.	2017
308	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells/Stem-cell like	MCF10A	Culture	2D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	mir-200c, miRNA profile, CD44/CD24	Low	Yes	Direct	10.1186/s12885-015-1655-5	Feng, Zhong-Ming	2015
309	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7 , immortalised stromal cell line Hs27a, MDA-MB-231, MDA-MB-231-H2N, MDA-MB-231-SCP2	Co-culture	2D	n/a	n/a	Drug develop./testing	citoxicity, TGF-β1, SMAD2	Low	Yes	Supportive	10.18632/oncotarget.4421	Nienhuis, Hilde H.	2015
311	BC	BC	Cancer Initiation and Development	In vitro	Cells	Primary cell culture	BC	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	Nestin, Wnt/β-catenin pathway, cell proliferation, viability, invasion, morphology, EMT	Low	Yes	Supportive	10.1186/s13058-014-0408-8	Zhao, Zuowei	2014
312	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2D/2.5D	n/a	n/a	Disease mechanism (exp./theor.)	HMGN5, cell proliferation, invasion	Low	Yes	Direct	10.1007/s13277-014-2715-1	Weng, Mingzhe	2015
313	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231, MCF7	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	G3BP1, E-cadherin, Keratin19, Vimentin, Fibronectin, Slug, SNAIL, zEB-1, invasion, migration, SMAD1, SMAD2, SMAD3, SMAD4, EMT	Low	Yes	Supportive	10.18632/oncotarget.3636	Zhang, Hao	2015
314	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF‐7, T47D, MDA‐MB‐231, MDA‐MB‐361 , SKBR‐3	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	FOXP3 expression and its correlation with metastatic potential, cell-adhesion, invasion, CD44	Low	Yes	Supportive	10.1002/ijc.29482	Zhang, Cun	2015
315	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-453, MDA-MB-453R, BT474 , BT474R	Culture	2.5D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Supportive	10.3892/mmr.2016.4990	Li, Xin	2016
316	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7, MDA-MB-231	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	VEGF-A/Neuropilin 1 Pathway, Wnt/β-Catenin, morphology, CD44/CD24	Low	Yes	Supportive	10.1159/000485455	Zhang, Lansheng	2017
317	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	SUM159PT , MDA-MB-231, ZR-75-1 , T47D	Co-culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	metabolic activity, CPT1A, adipose triglyceride lipase–dependent (ATGL-dependent) lipolytic pathway	Low	Yes	Supportive	10.1172/jci.insight.87489	Wang, Yuan Yuan	2017
319	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7 , MDA-MB-231	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity, morphology, invasion	Low	Yes	Supportive	10.1038/s41598-018-37796-w	Abd Razak, Nursyamirah	2019
320	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells/Stem-cell like	SKBR3, MCF7, T47D, MDA-MB-231, HS578T	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	CYP1A1, CYP1B1, ALDH, morphology, colony formation, cytotoxicity, Wnt, Notch, β-Catenin, Cyclin D1	Low	Yes	Supportive	10.1186/s12943-016-0570-y	Al-Dhfyan, Abdullah	2017
321	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-453	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	High	Yes	Supportive	10.1155/2019/2905840	Pantelic, Nebojsa D.	2019
322	BC	BC	Angiogenesis	In vitro	Cells	Immortalised cells	MDA-MB-231, MCF7, ECFC-ECs	Co-culture/MPS	3D	Scaffolds	n/a	Model/method develop.(exp.)	tube formation	Low	Yes	Direct	10.1038/srep31589	Sobrino, Agua	2016
324	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MCF7	Culture	3D	Scaffolds	n/a	Model/method develop.(exp.)	VEGF, IL-8, bFGF, migration, invasion	Low	Yes	Direct	10.1016/j.carbpol.2019.01.115	Suo, Aili	2019
325	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	DA-MB-231 , Hs578t, SUM159 cells , MCF7, adipocites	Co-culture	3D	Spheroids	n/a	Model/method develop.(exp.)	migration, EMT	Low	Yes	Direct	10.1007/s10911-018-9420-4	Pallegar, Nikitha K.	2018
326	BC	BC	Metastasis	In silico	Computational	n/a	n/a	n/a	n/a	n/a	n/a	Model/method develop.(theor.)	invasion	Low	Yes	n/a	10.1016/j.cnsns.2016.10.013	Ganesan, Sashikumaar	2017
327	BC	BC	Tumor Detection and Classification	In silico	Computational	n/a	n/a	n/a	n/a	n/a	n/a	Model/method develop.(exp.)	Genomic Copy Number Alterations	High	Yes	n/a	10.1155/2016/5237827	Li, Xiao-Chen	2016
328	BC	BC	Pharmacological/Physical Treatment	In vitro/In silico	Cells/Mathematical	Immortalised cells	MCF7, MCF10A, MDA-MB-231, MDA-MB-361	Culture	2D/3D	Spheroids	n/a	Drug develop./testing; Model/method develop. (theor.); Model/method qualification	morphology, cytotoxicity	Low	Yes	Supportive	10.1371/journal.pone.0134999	Geltmeier, Annette	2015
329	BC	BC	Pharmacological/Physical Treatment	In silico	Algorithms	n/a	n/a	n/a	n/a	n/a	n/a	Model/method develop.(exp.)	Signaling network	Low	Yes	Direct	10.1093/bioinformatics/btu382	Zhu, Fan	2014
330	BC	BC	Tumor Detection and Classification	In silico	Computational	n/a	n/a	n/a	n/a	n/a	n/a	Model/method develop.(exp./theor.)	morphology	Low	Yes	Direct	10.1126/scitranslmed.3009850	Greenbaum, Alon	2014
332	BC	BC	Cancer stem cells	In vitro	Cells	Immortalised cells/Stem-cell like	MDA-MB-231	Culture	3D	Scaffolds/Spheroids	n/a	Model/method qualification	morphology, CD133, NANOG	Low	Yes	Direct	10.1039/c6tb01713d	Florczyk, Stephen J.	2016
333	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	invasion, morphology, Cbl-b, E-Cadherin, Vimentin, ZEB1, ZEB2, SLUG, SNAIL, TWIST1, TWIST2, EGFR pathway, ERK, AKT, EMT	Low	Yes	Supportive	10.1016/j.neo.2017.01.011	Xu, Ling	2017
334	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, BT474 , SKBR3, MCF10A	Culture	2D/2.5D	n/a	n/a	Disease mechanism (exp./theor.)	βig-h3, viability, cytotoxicity, migration, invasion PI3K/AKT pathway 	Medium	Yes	Supportive	10.3892/etm.2018.5786	Zhang, Jiaxin	2018
335	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	HCC1428 , T-47D	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.1007/s10616-018-0249-x	Varol, Mehmet	2018
336	BC	BC	Pharmacological/Physical Treatment	In silico	Computational	n/a	n/a	n/a	n/a	n/a	n/a	Model/method develop.(theor.)	Intra-tumor heterogeneity, morphology	Low	Yes	Direct	10.1038/s41467-019-08593-4	Caswell-Jin, Jennifer L.	2019
337	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	SKBR3, MDA-MB-468, 293A	Culture	2D	n/a	n/a	Drug develop./testing	Proteomic profiling, Cy5.5-P51, Cy5.5-P25, cytotoxicity	Low	Yes	Supportive	10.7150/thno.14302	Geng, Lingling	2016
338	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	OCT4, invasion, viability	Low	Yes	Supportive	10.1371/journal.pone.0174912	Goehring, Axel R.	2017
340	BC	BC	Pharmacological/Physical Treatment; Microenvironment	In vitro	Cells	Immortalised cells	MDA-MB-231	MPS	3D	Spheroids	n/a	Disease mechanism (exp./theor.); Model/method develop. (exp.)	α-SMA and Snail, VE-cadherin, viability	Low	Yes	Direct	10.1063/1.4991738	Mina, Sara G.	2017
341	BC	BC	Cancer stem cells	In vitro	Cells	Immortalised cells/Stem-cell like	AS-B145-1R	Culture	3D	Spheroids	n/a	Drug develop./testing	morphology, colony formation, fluorescent nanodiamonds uptake	Low	Yes	n/a	10.1002/smll.201500878	Lin, Hsin-Hung	2015
343	BC	BC	Cancer Initiation and Development	In vitro	Ex vivo	n/a	BC	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	IL-8, integrin β3, cell invasion, PI3K/Akt/NF-κB pathway, ER, invasion	Low	Yes	Supportive	10.1016/j.canlet.2015.05.009	Shao, Nan	2015
344	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	SKBR‐3 and BT474	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	cytotoxicity, Nrf2 signaling pathway, H3K27, Long non‐coding RNA SNHG14, PABPC1	Low	Yes	Supportive	10.1111/jcmm.13758	Dong, Huaying	2018
345	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells/Stem-cell like	CK5Pro-GFP-T47D	Culture	3D	Spheroids	n/a	Model/method develop.(exp.)	Cytokeratin 5, cytotoxicity	Low	Yes	Supportive	10.2174/2213988501408010027	Reid, Brian G	2014
346	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MCF7	Co-culture	3D	Scaffolds	n/a	Model/method develop.(exp.)	proliferation, migration, EMT	Low	Yes	Direct	10.1002/jcp.26782	Jin, Qin	2019
347	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF10A , MDA-MB-231	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	EcSOD, stellate colony formation	Low	Yes	Supportive	10.1038/onc.2012.582	Teoh-Fitzgerald, M. L.	2014
348	BC	BC	Pharmacological/Physical Treatment	In vitro	Ex vivo	n/a	BC	n/a	n/a	n/a	Organ slice	Disease mechanism (exp./theor.)	Ki67, DNA damage, cleaved CASPASE 3, p2, p53, MADM2, survivin, viability, cytotoxicity	Low	Yes	Supportive	10.1186/bcr3666	Faversani, Alice	2014
350	BC	BC	Pharmacological/Physical Treatment	In vitro/In silico	Cells/Computational	Immortalised cells	MDA-MB-231 SA	Culture	3D	Spheroids	n/a	Model/method develop.(exp.)	morphology	Medium	Yes	Direct	10.1371/journal.pone.0096426	Harma, Ville	2014
351	BC	BC	Cancer Initiation and Development	In vitro	Cells/Cell free	Immortalised cells	M1-M4MCF10A	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	Long noncoding RNAs expression, PDCD4, viability, migration	Low	Yes	Direct	10.1371/journal.pgen.1007802	Jadaliha, Mahdieh	2018
352	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF10A	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	morphology, Mineralized particles intensity	Low	Yes	Supportive	10.1016/j.biomaterials.2018.06.030	Vidavsky, Netta	2018
354	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MCF10a	Culture	2D/3D	Scaffolds	n/a	Disease mechanism (exp./theor.)	cell traction force, FAs signaling and cell contractility	Low	Yes	Supportive	10.1016/j.jbiomech.2015.10.003	Bordeleau, Francois	2016
355	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	BT474 , MCF7/ADM	Culture	2D	n/a	n/a	Drug develop./testing	invasion, viability, MED23, HER2	Low	Yes	Direct	10.3892/ol.2017.6036	Lin, Benrui	2017
356	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	SKBR3	Culture	2D/3D	Scaffolds/Spheroids	n/a	Disease mechanism (exp./theor.)	invasion, cell migration, EMT	Low	Yes	Direct	10.1021/acsami.6b15187	Zhao, Yu-fang	2017
357	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2D/3D	Spheroids	n/a	Drug develop./testing	cytotoxicity, p53, DRAM-1	Low	Yes	Supportive	10.1038/onc.2014.461	Gomes, L. R.	2015
358	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF10A1 , MCF10CA1a	Culture	2D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	p53, TGF-β3, EPHB2, TGF-β, invasion,EPHB2, EMT	Low	Yes	Direct	10.1007/s10549-014-3147-8	Lam, Suzanne	2014
359	BC	BC	Cancer Initiation and Development	In vitro	Ex vivo	n/a	BC	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	Intratumor cholesteryl ester (CE), triglyceride (TG) and free cholesterol content (FC), Ki67, LDLR, SCARB1, CD36, ACAT1, 	Low	Yes	Direct	10.1186/s12885-015-1469-5	de Gonzalo-Calvo, David	2015
360	BC	BC/DCIS	Cancer Initiation and Development	In vitro	Cells/Ex vivo	Immortalised cells	MDA-MB-231	Culture	2D	n/a	Biopsies	Disease mechanism (exp./theor.)	TIAM1	Medium	Yes	Supportive	10.1186/s12885-016-2724-0	Li, Zhenling	2016
362	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	21T series	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	miRNA profiling miR-205-5p, invasion	Low	Yes	Direct	10.1371/journal.pone.0173756	Stankevicins, L.	2017
363	BC	IDC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	COL5A1, PR, viability, migration, invasion, TGF-β signaling	Low	Yes	Supportive	10.3892/ijo.2018.4317	Ren, Weimin	2018
366	BC	BC	Pharmacological/Physical Treatment	In vitro/In silico	Cells/Mathematical	Immortalised cells	MDA-MB-231	Culture	2D	n/a	n/a	Model/method develop.(theor.)	ROS, cytotoxicity	Low	Yes	Direct	10.1038/srep27439	Molavian, Hamid R.	2016
367	BC	BC	Pharmacological/Physical Treatment	In vitro/In silico	Cells/Mathematical	Immortalised cells	T47D	Culture	2D	n/a	n/a	Drug develop./testing	c-MYC, viability	Medium	Yes	Supportive	10.1021/acsomega.6b00531	Bhat, Jyotsna	2017
368	BC	BC	Cancer Initiation and Development	In vitro/In silico	Cells/Computational/Ex vivo	Immortalised cells	A549, HCT116, MDA‐MB468, T‐47D, ZR‐75‐1, HS‐578 T, MCF‐7, MDA‐MB231, SKBR3, BT474, MDA‐MB453	Culture	2D	n/a	Biopsies	Disease mechanism (exp./theor.)	LINE1‐MET	Low	Yes	Supportive	10.1002/ijc.31831	Miglio, Umberto	2018
369	BC	BC	Pharmacological/Physical Treatment	In vitro/In silico	Cells/Simulation	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Supportive	10.1111/cbdd.13322	Viswanath, Ambily Nath Indu	2018
371	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF10, MDA-MB-231	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.1039/c5cc02756j	Edwards, Stacey L.	2015
372	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7 , MDA-MB-231	Culture/MPS	3D	Scaffolds	n/a	Model/method develop.(exp.)	morphology, drug penetration, cytotoxicity, eIF3A, 14–3-3σ, CD44	Low	Yes	Direct	10.1016/j.jconrel.2017.09.024	Ozcelikkale, Altug	2017
376	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7 , MDA-MB-231	Culture	2D/3D	Spheroids	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Supportive	10.1016/j.actbio.2015.12.020	Lu, Hongxu	2016
377	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	T47D	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.1071/CH16430	Alhalili, Zahrah	2016
378	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231, A549, A375	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	invasion, proliferation, GM-CSF	Low	Yes	Supportive	10.1016/j.celrep.2014.06.011	Vilalta, Marta	2014
379	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231, SK-BR-3, MDA-MB-468	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Supportive	10.1007/s11030-015-9645-8	Anantaraju, Hasitha Shilpa	2016
380	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7 , MDA-MB-231	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	migration, invasion, miRNA-200b, Ezrin, Radixin, Moesin	Low	Yes	Supportive	10.12659/MSM.896551	Hong, Hong	2016
381	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231 , MDA-MB-436	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	Long non‑coding RNA HOXA11‑AS, proliferation, invasion	Low	Yes	Supportive	10.3892/mmr.2017.7163	Su, Jian-Chun	2017
382	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Supportive	10.3390/ijms19113692	Schexnayder, Chandler	2018
384	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-134 , MDA-MB-453	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	BCAR4, cytotoxicity	Medium	Yes	Direct	10.1371/journal.pone.0136845	van Agthoven, Ton	2015
385	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	TROP-2, AKT, morphology	Medium	Yes	Supportive	10.1158/1078-0432.CCR-15-1701	Guerra, Emanuela	2016
386	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	SUM44	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.); Model/method qualification	cell proliferation, WHSC1L1, MYCN, ESR1, CXCR4, ID2, RET, MYB, CD24, ALDH2, ERBB3, ERBB4, ER-alpha	Low	Yes	Supportive	10.1016/j.molonc.2016.02.003	Irish, Jonathan C.	2016
389	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	LCC9	Culture	2D/3D	Organoids	n/a	Disease mechanism (exp./theor.)	Long Non-Coding RNA H19, cytotoxicity, NOTCH4, c-MET, H19, dTOM	Low	Yes	Supportive	10.1159/000495643	Basak, Pratima	2018
390	BC	BC	Pharmacological/Physical Treatment	In vitro/In silico	Cells/Computational	Immortalised cells	MDA-MB-231	Culture	2D	n/a	n/a	Model/method develop.(exp./theor.)	Gold Nanoparticles uptake	Low	n/a	n/a	10.1667/RR15134.1	Sung, Wonmo	2018
391	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells/Primary cell culture	MCF7 , MDA-MB-231, BC	Culture	3D	Spheroids	n/a	Drug develop./testing	YM155, autophage, DNA repair, morphology	Low	Yes	Supportive	10.18632/oncotarget.3638	Vequaud, Eloise	2015
392	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF10A, MCF7, HCC1954, HCC1428, MDA-MB-468, MDA-MB-231, BT549 , Hs578T	Culture	2.5D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	HOXC8, homeobox genes, CD44, CD24, cytotoxicity, morphology	High	Yes	Supportive	10.1186/s12943-017-0605-z	Shah, Mansi	2017
394	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7 , MDA-MB-231	Culture	3D	Spheroids	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.1186/s12885-017-3953-6	Lovitt, Carrie J.	2018
395	IBC	IBC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	SUM149 , SUM190	Culture	2D	n/a	n/a	Disease therapy develop.	morphology, nanoparticle penetration, proliferation, viability	Low	No	Supportive	10.2147/IJN.S141164	Crawford, Bridget M.	2017
397	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	Hs578T	Culture	2D	n/a	n/a	Disease therapy develop.; Drug develop./testing	cytotoxicity, genome-wide RNA profile	Low	Yes	Direct	10.1371/journal.pone.0120936	Braicu, Cornelia	2015
401	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7 , MDA-MB-231	Culture	2.5D	n/a	n/a	Drug develop./testing	cytotoxicity	Medium	Yes	Direct	10.1371/journal.pone.0105244	Abu, Nadiah	2014
402	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7 , MDA-MB-231	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	neprilysin, invasion, NEP, ERK, MAPKAPK2, correlation with clinical outcome	Low	Yes	Supportive	10.1038/oncsis.2016.16	Stephen, H. M.	2016
404	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	21T, 21PT, 21NT, 212Mt-1	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	TBX3, morphology, invasion, migration, EMT	Low	Yes	Direct	10.1186/s12885-016-2697-z	Krstic, Milica	2016
406	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	2.5D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.1007/s10811-018-1422-5	Lezcano, V.	2018
407	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231 , SUM149	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.); Model/method develop. (exp.)	PD-L1, cytotoxicity	Low	Yes	Supportive	10.1021/acs.bioconjchem.6b00348	Lesniak, Wojciech G.	2016
408	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7 , MDA-MB-231	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Supportive	10.1021/acs.inorgchem.8b01270	Lenis-Rojas, Oscar A.	2018
409	BC	BC	Tumor Detection and Classification	In silico	Computational	n/a	n/a	n/a	n/a	n/a	n/a	Disease mechanism (exp./theor.)	genome wide DNA profiling	Low	n/a	n/a	10.1186/S13015-016-0073-9	Lu, S.	2016
410	BC	BC	Tumor Detection and Classification	In silico	Computational	n/a	n/a	n/a	n/a	n/a	n/a	Diagnosis of disease; Model/method develop. (exp.)	breast cancer mass morphology	Low	n/a	n/a	10.1007/978-3-319-02931-3_14	Dheeba, V.	2014
411	BC	BC	Cancer Initiation and Development	In silico	Computational	n/a	MCF7	n/a	n/a	n/a	n/a	Disease mechanism (exp./theor.)	miRNA-mRNA profile	Low	Yes	n/a	10.1186/gb-2014-15-1-r9	Farazi, Thalia A.	2014
413	BC	BC	Tumor Detection and Classification	In silico	Computational/Simulation	n/a	n/a	n/a	n/a	n/a	n/a	Diagnosis of disease	cytoskeleton degradation rate	Low	Yes	n/a	10.1016/j.jmbbm.2017.05.030	Katti, Dinesh R.	2017
415	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells/Primary cell culture	MCF7 , MDA-MB-231	Co-culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	genome-wide RNA profile, CXCL12, migration	Low	Yes	Supportive	10.1002/ijc.28960	Wobus, Manja	2015
416	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-361, MCF7, SKBr3	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	HER2, HER3, ERBB3, NRG1, HER4, AKT, ERK, ICAM-1, proliferation, invasion, migration	Medium	Yes	Direct	10.18632/oncotarget.2846	Momeny, Majid	2015
417	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cell free	n/a	ZR-75-1	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	genome-wide protein profile	Low	Yes	Direct	10.1021/pr500727h	Groessl, Michael	2014
418	BC	BC	Cancer Initiation and Development	In vitro	Ex vivo	n/a	n/a	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	ER, HER2, morphology	High	Yes	Direct	10.1002/1878-0261.12375	Rye, Inga H.	2018
419	BC	BC	Tumor Detection and Classification	In silico	Algorithms	n/a	n/a	n/a	n/a	n/a	n/a	Model/method develop.(exp.)	sensitivity, specificity	Low	Yes	n/a	10.1007/s10278-014-9757-1	Wu, Wen-Jie	2015
421	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231, HCC1395, Hs578T, MCF7 , T47D	Culture	2D	n/a	n/a	Drug develop./testing	TPH, 5-HT7 receptor, viability, invasion cAMP, VEGF, cytotoxicity	Medium	Yes	Supportive	10.1186/s12943-016-0559-6	Gautam, Jaya	2016
422	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MECs, MCF7, MDA-MB-231, SUM159	Culture	3D	Organoids	n/a	Disease mechanism (exp./theor.)	MMP8, cell-adhesion, migration, integrin α6β4, MMP9, TGF-β signaling	Low	Yes	Direct	10.1186/s13058-017-0822-9	Sarper, Muge	2017
423	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231, HCC38, MDA-MB-157 , MDAMB-468	Culture	2D	n/a	n/a	Drug develop./testing	Wnt/β-catenin signaling, cytotoxicity, EMT	Low	Yes	Direct	10.1371/journal.pone.0189864	Fatima, Iram	2017
424	BC	BC	Cancer Initiation and Development	In vitro	Ex vivo	n/a	BC	n/a	2D	n/a	Organ slice	Model/method develop.(exp.)	HER2, nanoparticle penetration, cytotoxicity	Low	Yes	Direct	10.1186/s12885-018-5172-1	Hicks, David G.	2018
428	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	21PT, 21MT-2	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.); Model/method qualification	viability, SNAIL, SLUG, VIMENTIN, E-Cadherin, TWIST, LOx and LOX-like enzymes, migration, EMT	Low	Yes	Direct	10.18632/oncotarget.25891	Wang, Ying	2018
429	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	HBTAEC, MDA-MB-231 , MCF7	Co-culture	3D	Spheroids	n/a	Drug develop./testing	morphology, small dye penetration, VE-Cadherin, F-actin, ZO-1	Low	Yes	Direct	10.1038/s41598-017-09815-9	Tang, Yuan	2017
430	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	SUM1315 , MDA-MB-231	Culture	2D/3D	Spheroids	n/a	Drug develop./testing	Extracellular matrix protein concentration, morphology,  viability	Low	Yes	Direct	10.18632/oncotarget.20517	Dubois, Clemence	2017
431	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	BT474, HCC1954, EFM192A	Culture	2D/3D	Organoids	n/a	Drug develop./testing	viability, pAkt, Akt, pErk,Erk, EGFR, pEGFR, HER2, pHER2, HER3, HER4, CYP34A	Low	Yes	Direct	10.18632/oncotarget.9935	Breslin, Susan	2016
432	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF10F	Culture	2D	n/a	n/a	Diagnosis of disease	estrogen receptor α (ERα), Neu, c‑H‑Ras	Low	Yes	Direct	10.3892/ol.2016.4461	Calaf, Gloria M.	2016
433	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF10A	Culture	2D/3D	Organoids	n/a	Disease mechanism (exp./theor.)	BAG1, HER2, cytotoxicity, morphology, ERK, AKT 	Low	Yes	Direct	10.1038/oncsis.2016.10	Papadakis, E. S.	2016
434	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MDA-MB-231, Hs 578T, MDA-MB-157, MDA-MB-468, ZR-75-1, MDA-MB-453	Culture	2D/3D	Spheroids	n/a	Diagnosis of disease; Disease mechanism (exp./theor.)	morphology, invasion	Low	No	Direct	10.1371/journal.pone.0139523	Ziperstein, Michelle J.	2015
435	BC	BC	Cancer Initiation and Development	In vitro	Cells	Primary cell culture	BC	Culture	2D/2.5D	n/a	n/a	Disease mechanism (exp./theor.)	HER1, HER2, HER3, HER4, PDGFR, c-Kit, c-Met, IGF1R, VEGFR2, cell proliferation, cell migration, cell-adhesion, cytotoxicity	Low	Yes	Direct	10.1186/s12885-016-2769-0	Esparza-Lopez, Jose	2016
436	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MDA-MB-231 , Hs578T	Culture	2.5D/3D	Organoids	n/a	Disease mechanism (exp./theor.)	HOAXA9, BRD4	Low	Yes	Direct	10.18632/oncotarget.10491	Li, Miao	2016
437	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231 , MDA-MB-435, MCF7	Culture	2.5D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	microRNA-29, N-myc, NMI, invasion, morphology, GSK3β 	Low	Yes	Direct	10.1186/1476-4598-13-200	Rostas, Jack W., III	2014
438	BC	BC	Cancer Initiation and Development	In vitro	Ex vivo	n/a	BC	n/a	n/a	n/a	Organ slice	Disease mechanism (exp./theor.)	SIRT1, apoptosis	Low	Yes	Direct	10.1007/s00428-015-1815-7	Kim, Hyojin	2015
439	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2D/2.5D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	www.ijcem.com/files/ijcem0022022.pdf	Zhou, BG	2016
440	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7/PTX	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity, SET/PP2A/Akt pathway	Low	Yes	Direct	10.3892/mmr.2015.3468	Zhang, Weipeng	2015
442	BC	BC	Cancer Initiation and Development	In vitro	Cells/Ex vivo	Immortalised cells	MDA-MB-231	Culture	2D	n/a	Biopsies	Disease mechanism (exp./theor.)	PinX1, cell proliferation, migration, apoptosis	Medium	Yes	Direct	10.3892/or.2017.5696	Feng, Yu-Zhen	2017
443	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, KAT III	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	p53	Low	Yes	Direct	10.1016/j.ijbiomac.2017.07.165	Hasanzadeh, Mohammad	2017
444	BC	BC	Metastasis	In vitro	Cells/Ex vivo	Immortalised cells	BT474, MDA-MB-231, BC	Co-culture	3D	Spheroids	Biopsies	Disease mechanism (exp./theor.)	Reelin, HER2, viability	Low	Yes	Supportive	10.1007/s10585-017-9839-9	Jandial, Rahul	2017
445	BC	BC	Cancer Initiation and Development	In vitro	Ex vivo	n/a	n/a	n/a	n/a	n/a	Biopsies	Diagnosis of disease; Disease mechanism (exp./theor.)	miRNA expression profile	Low	Yes	Direct	10.3892/ijo.2016.3435	Do Canto, Luisa Matos	2016
446	BC	BC	Cancer Initiation and Development	In vitro	Ex vivo	n/a	n/a	n/a	n/a	n/a	Biopsies	Diagnosis of disease; Disease mechanism (exp./theor.)	DNA Repair via Homologous Recombination	Low	Yes	Direct	10.1007/s10549-017-4624-7	Telli, Melinda L.	2018
447	BC	BC	Pharmacological/Physical Treatment	In vitro/In silico	Cells/Mathematical	Immortalised cells	MDA-MB-231	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.1016/j.bmcl.2014.07.058	Kilaru, Ravendra Babu	2014
448	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.1007/s11164-015-2412-8	Kamath, Pooja R.	2016
449	BC	BC	Cancer Initiation and Development	In vitro	Cells/Ex vivo	Immortalised cells	MDA-MB-231	Culture	2D/3D	Spheroids	Biopsies	Disease mechanism (exp./theor.)	WNT5b, MCL1, migration, viability, cyclin E, cyclin D1, caspase 3, caspase 8, OXPHOS	Low	Yes	Supportive	10.1186/1471-2407-14-124	Yang, L.	2014
450	BC	BC	Tumor Landscape	In vitro	Cell free	n/a	n/a	n/a	n/a	n/a	Biopsies	Diagnosis of disease	DNA Copy Number alteration	Low	Yes	Supportive	10.1016/j.tranon.2015.08.004	Kirkizlar, Eser	2015
451	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	BT474, SKBR3, NCI-N87,SNU-I, MDA-MB-453, HCC1419 , HCC1519	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	MiR-16, CCNJ, FUBP1, cytotoxicity	Low	Yes	Direct	10.1038/onc.2016.151	Venturutti, L.	2016
454	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.); Model/method develop. (exp.)	morphology, SNAIL, AKT, COL1A1, migration, EMT	Low	Yes	Direct	10.1038/s41598-018-23833-1	Chen, Andy	2018
458	BC	BC	Cancer Initiation and Development	In vitro/In silico	Ex vivo/Algorithms	n/a	BC	n/a	n/a	n/a	Organ slice	Model/method develop.(exp.)	morphology	High	Yes	Direct	10.1038/s41379-018-0073-z	Bejnordi, Babak Ehteshami	2018
460	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7 , MDA-MB-231	Culture	3D	Spheroids	n/a	Model/method develop.(exp.)	morphology, metabolic activity, TGF-β1, SDF-1	Low	Yes	Direct	10.3390/cancers10090292	Bray, Laura J.	2018
461	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MDA-MB-231, MCF7	Co-culture	3D	Scaffolds	n/a	Disease mechanism (exp./theor.); Model/method develop. (exp.)	cell adhesion	Low	Yes	Direct	10.1016/j.actbio.2014.12.008	Zhu, Wei	2015
462	BC	BC	Cancer Initiation and Development	In vitro	Cells	Primary cell culture	BC	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.); Model/method develop. (exp.)	morphology, Epithelial membrane antigen, Cytokeratin 18, Cytokeratin 5/6, Estrogen receptor, Progesterone receptor, HER2/neu, P53, Vimentin, karyotype, aneuploidy, migration, CD44, CD24	Low	Yes	Direct	10.1186/1475-2867-14-14	Pandrangi, Santhi Latha	2014
465	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity, migration, invasion, MMP-9, MUC1, N-cadherin, Twist, VEGF	Low	Yes	Supportive	10.1016/j.jep.2018.12.041	Baraya, Yusha'u Shuaibu	2019
467	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells/Primary cell culture	SUM159, BT549, MDA-MB-231, MDA-MB-468, HCC1937; T47D, MCF7, BT474, HER2, HCC1937 , SKBR3	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	genome-wide MiR profile, MiR-1287-5p, Pi3K, morphology, proliferation	Low	Yes	Supportive	10.1186/s13058-019-1104-5	Schwarzenbacher, Daniela	2019
468	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells/Stem-cell like	MCF‐7R , MCF‐7	Culture	3D	Scaffolds	n/a	Drug develop./testing; Model/method develop. (exp.)	proliferation, cytotoxicity	Low	Yes	Direct	10.1002/term.2729	Ding, Yanfang	2018
469	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MCF7	Culture	3D	Scaffolds	n/a	Disease mechanism (exp./theor.); Model/method develop. (exp.)	biocompatibility, cell attachment, proliferation, E-cadherin, MMP2, EMT	Low	Yes	Direct	10.1088/1758-5090/aa5510	Janani, G.	2017
470	BC	BC	Cancer Initiation and Development	In vitro	Cells/Ex vivo	Immortalised cells	MCF10A, MCF7, T47D, SKBR3, MDA-MB-435, BT474	Culture	2D	n/a	Biopsies	Disease mechanism (exp./theor.)	LKB1, R/PR status, HMW-CK, α-SMA, migration, GM130, morphology	Low	Yes	Supportive	10.1186/s13046-014-0070-0	Li, Juan	2014
471	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	CD44, CD24, invasion, XBP-1, ATF6, CHOP	High	Yes	Direct	10.1016/j.etp.2016.06.004	Nami, Babak	2016
472	BC	BC	Cancer Initiation and Development	In vitro	Cells/Ex vivo	Immortalised cells	MDA‐MB‐231	Culture	2.5D	n/a	Biopsies	Disease mechanism (exp./theor.)	MiR profile, MicroRNA‐409‐3p, cell invasion, ZEB1, migration	Low	Yes	Supportive	10.1002/iub.1494	Ma, Zhenhai	2016
473	BC	BC	Cancer Initiation and Development	In vitro/In silico	Cells/Simulation	Immortalised cells	MDA-MB-231 , MCF7	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	microRNA-193b, DNAJC13, RAB22A, proliferation, migration, invasion	Medium	Yes	Direct	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270560/	Zhaoying Yang	2014
475	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells/Stem-cell like	MDA-MB-231, MDA-MB-453 , MCF7	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	CD44, CD24, HSP90	Low	Yes	Supportive	10.1080/15384047.2016.1195041	Stivarou, Theodora	2016
477	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	HCC1937, primary fibroblasts	Co-culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	Vimentin, CD10, FAP, αSMA, FSP, CK-14, proliferation, invasion, migration, SDF1, E-cadherin, MMP9, morphology, cytotoxicity, EMT	Medium	Yes	Direct	10.1038/s41598-018-32370-w	Hemalatha, Sreelatha K.	2018
478	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7 , MDA-MB- 231	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	OCT4	Low	Yes	Direct	10.2174/1871520616666160923093229	Lopes, Juliana Ramos	2017
480	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Primary cell culture	BC	Culture	3D	Organoids	n/a	Drug develop./testing	HIF-1α, morphology, cell branching, RNA profile, EMT	Low	Yes	Direct	10.1093/toxsci/kfy112	Rocco, Sabrina A.	2018
482	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells/Primary cell culture	MCF, CAFs , NFs	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	α-SMA, protein profiling, invasion, CD44, CD24, ALDH1	Low	Yes	Direct	10.7717/peerj.4805	Wang, Bixiao	2018
484	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MDA-MB-231BO, MCF7	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	cell-cycle, Ki-67, P21, proliferation	Low	Yes	Direct	10.1093/abbs/gmy126	Chen, Xiaoyan	2018
485	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MCF7, BT20, BT474, MDA-MB-468, T-47D, SK-BR-3,	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	CDH1, IL1-beta, FAK, MAPKK, morphology, genome-wide RNA profile, migration, cytotoxicity	Low	Yes	Direct	10.1186/s13287-015-0123-0	Al-toub, Mashael	2015
486	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	SKBR3, T47-D	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	nucleostemin, invasion, migration, cell-cycle	Low	Yes	Direct	10.7314/APJCP.2014.15.5.2291	Guo, Yu	2014
487	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF10A, H‐Ras MCF10A, MCF‐7, MDA‐MB‐231	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	H‐Ras, DDr1, E-Cadherin, ZEB1, EMT	Low	Yes	Direct	10.1002/ijc.29154	Koh, Minsoo	2015
488	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	H3K4me3, H3K27me3	Low	Yes	Direct	10.1186/s13072-016-0090-4	Adriaens, Michiel E.	2016
489	BC	BC	Cancer Initiation and Development	In vitro/In silico	Ex vivo/Computational	n/a	n/a	n/a	n/a	n/a	Biopsies	Model/method develop.(exp.); Model/method qualification	angiogenesis, TNF-α, PlGF, ANG-2, TGF-β,	Low	Yes	Direct	10.1371/journal.pcbi.1004050	Guex, Nicolas	2015
490	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, T47D, HCC1428, SUM44 , ZR75.1	Culture	2D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	genome-wide RNA profile, genome-wide protein profile, ER, correlation with clinical outcome, proliferation	Low	Yes	Direct	10.1186/s13058-016-0713-5	Simigdala, Nikiana	2016
492	BC	BC	Cancer Initiation and Development	In silico	Computational	n/a	n/a	n/a	n/a	n/a	n/a	Model/method develop.(theor.)	Temperature	Low	Yes	Direct	10.1007/978-981-10-3147-2_11	Ramirez-Torres, A.	2017
494	BC	BC	Pharmacological/Physical Treatment	In silico	Mathematical	n/a	n/a	n/a	n/a	n/a	n/a	Drug develop./testing; Model/method develop. (exp.)	Temperature	Low	Yes	Supportive	10.1016/j.jtherbio.2016.04.002	Singh, Sundeep	2016
495	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.1155/2019/6146972	Figueroa, Daniela	2019
496	BC	BC	Cancer Initiation and Development	In vitro	Cells/Ex vivo	Immortalised cells	MDA-MB-231 , BT549	Culture	2D	n/a	Biopsies	Disease mechanism (exp./theor.)	PinX1, NF-κB, MMP-2, MMP-9, TIMP-1, TIMP-2, migration, invasion, NF-κB	Low	Yes	Supportive	10.1186/s12943-015-0332-2	Shi, Meilin	2015
497	BC	BC	Drug Discovery and/or Testing	In silico	Computational	n/a	n/a	n/a	n/a	n/a	n/a	Model/method develop.(theor.)	Linear Discriminant Analysis (LDA)	High	Yes	Direct	https://sciforum.net/manuscripts/3106/manuscript.pdf	Prado-Prado, F.J.	2016
498	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7, MDA-MB-231, SK-BR-3	Culture	3D	Spheroids	n/a	Drug develop./testing	cytotoxicity, morphology, PD-L1, Nanog	High	Yes	Direct	10.1155/2019/9078209	Zhang, Xiaobei	2019
501	BC	BC	Cell culture strategy	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7	Culture	3D	Spheroids	n/a	Model/method develop.(exp.)	morphology, cytotoxicity, CD44, CD24, EMT	High	Yes	Direct	10.1186/s12935-017-0392-z	Choi, Hack Sun	2017
502	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells/Stem-cell like	SUM159, T49D	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	IMP3, miRNA-34a, colony formation, CD44, CD24, ESA	Low	Yes	Direct	https://www.europeanreview.org/wp/wp-content/uploads/2688-2696.pdf	Huang, QD	2018
503	BC	BC	Cell culture strategy	In vitro	Cells	Immortalised cells	MCF12A, Hs 578Bst	Culture	3D	Organoids	n/a	Model/method develop.(exp.)	morphology, E-cadherin, α-SMA	Low	Yes	Supportive	10.4155/fsoa-2018-0010	Weber-Ouellette, Anne	2018
504	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells/Primary cell culture	BT20, INFs-CM, CAFs-CM	Co-culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	cell migration, cytotoxicity, EMT	Low	Yes	Supportive	10.1371/journal.pone.0164661	Hsu, Hsiang-Chi	2017
507	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	T47D, MDA-MB-231, MCF7, SK-BR-3 , HCC1937	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	miR-506, IQGAP1, cell proliferation, invasion, adhesion, ERK1/2	Medium	Yes	Supportive	10.3892/ijo.2015.3161	Sun, Guang	2015
508	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231, BT549 , MDA-MB-453	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	E2F5, invasion, migration, microRNA-154, correlation	Low	Yes	Supportive	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931156	Xu, H	2016
509	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	ME-MB-231	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	TLR9, cellular uptake of DNA, invasion, protease activity, mRNA and protein profile, LL-37	Low	Yes	Supportive	10.1007/s10549-016-3683-5	Tuomela, Johanna M.	2016
510	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	SNX9, invasion, migration, RhoGTPases, CD44, RhoA-ROCK pathway, N-WASP	Low	Yes	Supportive	10.1091/mbc.E16-02-0101	Bendris, Nawal	2016
511	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231 , MDA-MB-468	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	annexin A3, cytotoxicity, invasion, proliferation, NFκB drug uptake	Low	Yes	Supportive	10.1038/s41419-017-0143-z	Du, Ruikai	2018
513	BC	BC	Pharmacological/Physical Treatment	In vitro/In silico	Cells/Simulation	Immortalised cells	MDA-MB-231	Culture	2.5D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Supportive	10.1155/2015/474597	Talhouk, Rabih S.	2015
514	BC	BC	Microenvironment-Tumor Interactions	In silico	Computational/Simulation	n/a	n/a	n/a	n/a	n/a	n/a	Model/method develop.(theor.)	cell adhesion	Low	Yes	n/a	10.1109/TBME.2016.2607183	Picco, Noemi	2017
515	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MDA-MB-231 , MCF7	Co-culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	IL-8/CXCL8, MCP-1, proliferation, ERK	Low	Yes	Direct	10.1038/bjc.2017.414	Khazali, Ahmad S.	2018
516	BC	BC	Cell culture strategy	In vitro	Cells	Immortalised cells	MCF10A or MDA-MB-231	Culture	3D	Scaffolds	n/a	Model/method develop.(exp.)	viability, morphology, proliferation, integrin alpha 2, cytotoxicity	Low	Yes	Supportive	10.1155/2017/8074890	Rijal, Girdhari	2017
517	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells/Primary cell culture	DA-MB-231 , T47D cells	Co-culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	RNA profile	Low	Yes	Supportive	10.1016/j.gdata.2016.02.009	Roudnicky, Filip	2016
518	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231, MDA-MB-468 , BT549	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.); Drug develop./testing	morphology, cytotoxicity, invasion, migration, CRK, ENOLASE, ABL kynase, RAC1, TRIO	Low	Yes	Direct	10.1371/journal.pone.0118854	Chevalier, Clement	2015
519	BC	BC	Cell culture strategy	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2.5D	n/a	n/a	Model/method develop.(exp.)	migration, cell-adhesion, CXCL12	Low	Yes	Supportive	10.1016/j.actbio.2014.11.033	Kojima, Taisuke	2015
520	BC	BC	Cancer Initiation and Development	In vitro/In silico	Ex vivo/Algorithms	n/a	BC	n/a	n/a	n/a	Organ slice	Diagnosis of disease	intratumor heterogenicity	Low	Yes	Direct	10.1016/j.ebiom.2017.12.026	Khosravi, Pegah	2018
521	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2D	n/a	n/a	Drug develop./testing	proliferation, migration, cell-adhesion, MMP-2, MMP-9, TIMP-1, TIMP-2, morphology	Low	Yes	Direct	10.22034/APJCP.2017.18.4.905	Mali, A.V.	2017
522	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	184-hTERT polyclon/al infection pool mammary epithelial cell	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	morphology, cell-adhesion, PROCR, LPAR3, LPAR1, LPAR2, genome-wide RNA profile	High	Yes	Supportive	10.1186/s13058-014-0510-y	Burleigh, Angela	2015
524	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	BT549, MDA-MB-231, MDA-MB-468 cell lines, CAFs	Co-culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	VIMENTIN, E-Cadherin, aplphaSMA, Beclin I, LC·, P62, migration, CAF autophagy, EMT	Low	Yes	Direct	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565237/	Wang, M	2017
529	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells/Stem-cell like	MDA-MB-468 cells	Culture	2D/3D	Spheroids	n/a	Drug develop./testing	Silibinin, apoptosis, BAX, CASPASE3, BCL2, SURVIVIN, cell-cycle, morphology, CD133, NANOG, OCT4, SOX2, ALDH, c-Myc, KLF4	Low	Yes	Direct	10.1097/CAD.0000000000000205	Abdollahi, Pegah	2015
530	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells/Ex vivo	Immortalised cells	MCF7 , MDA-MB-231, CAFs	Culture	3D	Spheroids	Biopsies	Disease mechanism (exp./theor.)	Leptin, morphology, genome-wide RNA profile, correlation with clinical outcome	Low	Yes	Supportive	10.18632/oncotarget.6014	Giordano, Cinzia	2016
531	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231/Luc	Culture	3D	Spheroids	n/a	Drug develop./testing	cytotoxicity	High	Yes	Direct	10.1177/2472555217692321	Fitzpatrick, P. A.	2017
532	BC	BC	Cell culture strategy	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7	Culture	3D	Spheroids	n/a	Model/method develop.(exp.)	proliferation, colony formation	Low	Yes	Direct	10.1016/j.procir.2017.03.341	Rabionet, Marc	2017
533	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.2147/IJN.S159942	Foglietta, Federica	2018
534	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7, 184B5,	Culture	2D/3D	Spheroids	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.3892/ijo.2018.4357	Zhao, Yuxue	2018
535	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	2D/3D	Spheroids	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.21873/anticanres.12450	Uematsu, Nami	2018
537	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MDA-MB-231, MCF7, MCF10A	Culture	3D	Scaffolds	n/a	Model/method develop.(exp.)	migration, invasion, cell protrusion	Low	Yes	Direct	10.1016/j.biomaterials.2015.11.039	Peela, Nitish	2016
538	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	3D	Spheroids	n/a	Model/method develop.(exp.)	chemotactic transmigrating motilities	Low	Yes	Direct	10.1002/bit.25270	Park, Sung Jun	2014
539	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	21PT	Co-culture	3D	Scaffolds	n/a	Model/method develop.(exp.)	cytotoxicity	Low	Yes	Direct	10.1021/acsbiomaterials.8b01277	Wang, Ying	2018
540	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231 TNBC , MCF10A	Culture	2D	n/a	n/a	Drug develop./testing	proteolysis, cytotoxicity	Low	Yes	Direct	10.1021/jacs.8b08853	Arora, Karan	2018
541	BC	BC	Cell culture strategy	In vitro	Cells	Immortalised cells/Stem-cell like	MDA-MB-231	Culture	3D	Scaffolds	n/a	Model/method develop.(exp.)	proliferation	Low	Yes	Direct	10.3390/ijms19103148	Polonio-Alcala, Emma	2018
542	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7, CAFs	Co-culture	2D/3D	Spheroids	n/a	Drug develop./testing	MTT standard curves, metabolic activity	Low	Yes	Direct	10.1186/s12935-015-0218-9	Qayyum, Muqeem A.	2015
544	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7	Culture	2D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	RNA profile	Low	Yes	Supportive	10.1371/journal.pone.0157997	Vantangoli, Marguerite M.	2016
545	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231	Co-culture	3D	Spheroids	n/a	Model/method develop.(exp.)	cell-adhesion, CCL4, oestrogen receptor-α, glycoprotein mucin 1	Low	Yes	Supportive	10.1016/j.jim.2015.07.003	Augustine, Tanya N.	2015
546	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231, HCC1395	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	HSP90, TPH1, 5-HT7 receptor-dependent serotonin, correlation with clinical outcome, PI3K/Akt and Ras/Raf/MAPK signaling pathways	High	Yes	Supportive	10.1007/s10549-016-4027-1	Gautam, Jaya	2017
547	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	cytokines, MMP9, NFkappaB and MAPK signaling pathways	Low	Yes	Direct	10.1089/jmf.2013.3077	Im, Nam-Kyung	2014
548	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-435, MCF7	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	EDH2, migration, invasion	Low	Yes	Supportive	10.1007/s13277-014-3011-9	Yang, Xiaojing	2015
549	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-468	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	genome-wide screen for EMT regulators, migration, invasion, EMT	High	Yes	Direct	10.18632/oncotarget.11314	Skalamera, Dubravka	2016
550	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF10, MDA-MD-231,	Culture	2.5D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	cell-adhesion, Tpm4, RAC1, migration, morphology	Medium	Yes	Supportive	10.18632/oncotarget.16825	Jeong, SukYeong	2017
551	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231 , MCF7, SKBR3	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	MMP2, AKT, NF-ĸB, P38 MAPK, MK2, invasion	Low	Yes	Direct	10.1016/j.biopha.2018.05.155	Das, Kaushik	2018
555	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231, SUM159, MCF7, T47D,	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	NDY1/KDM2B, proliferation, PRC1, PRC2, ALDH and CD44, CD24	Low	Yes	Supportive	10.1158/0008-5472.CAN-13-2733	Kottakis, Filippos	2014
556	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	BT474, SK-BR-3, MCF7, MDA-MB-231, HCC1806 , HCC1937	Culture	2D	n/a	n/a	Drug develop./testing	HER2, CD44, CD24, NK-cell activity	Low	Yes	Supportive	10.1038/cddis.2014.115	Diessner, J.	2014
557	BC	BC	Cell culture strategy	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7	Culture	3D	Scaffolds/Spheroids	n/a	Model/method develop.(exp.)	mammosphere forming index	Low	Yes	Direct	10.3390/molecules21040537	Palomeras, Sonia	2016
558	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells/Stem-cell like	MCF10DCIS	Culture	3D	Spheroids	n/a	Drug develop./testing	cytotoxicity, CD44, CD24, CD49f, CD24, OCT4, KFL4	Low	Yes	Direct	10.1016/j.jsbmb.2014.10.016	Wahler, Joseph	2015
560	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	BT20 , MCF7,	Culture	2D/3D	Spheroids	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.1371/journal.pone.0111487	Chandrasekaran, Siddarth	2014
561	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	SUM159	Culture	3D	Spheroids	n/a	Drug develop./testing	cytotoxicity, OCT4, CD44, LAMA5, Notch1, Notch2, Notch3, JAG1, JAG2, HES1, NFκB, C18, CK5	Low	Yes	Direct	10.1016/j.jsbmb.2016.12.001	Shan, Naing Lin	2017
562	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells/Primary cell culture	BT474 , SK-BR-3,MCF7 , MDA-MB-231, PBMCs, BC	Co-culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	HER2, CD14, CD56, cytotoxicity	Low	Yes	Direct	10.1186/s12885-015-1041-3	Suzuki, Eiji	2015
563	BC	BC	Cancer Initiation and Development	In vitro	Cells	Primary cell culture	BC	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	E‐selectin ligand, cell proliferation, ERK1/2 and p38 MAPK, migration	Low	Yes	Direct	10.1002/1878-0261.12163	Carrascal, Mylene A.	2018
564	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	3D	Spheroids	n/a	Drug develop./testing	morphology, apoptosis, ER, cytotoxicity	Low	Yes	Direct	10.18632/oncotarget.21610	Shafran, Yana	2017
565	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MCF7 or SKBR3, CAFs , NFs	Co-culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	mir29b, cell viability, cytokines, CCL11 and CXCL14, p38-STAT1	Low	Yes	Direct	10.18632/oncotarget.17136	Liu, Yonglei	2017
566	BC	BC	Cell culture strategy	In vitro	Cells	Immortalised cells	MDA-MB-231, MCF7	Culture	2D	n/a	n/a	Model/method develop.(exp.)	cell migration	Low	Yes	Direct	10.1186/1756-0500-7-183	Chen, Hui	2014
567	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	BRSM1, TGF-β1 pathway, HIF-1, SNAIL, TWIST, invasion, SLUG, EMT	Low	Yes	Direct	10.1186/s12885-015-1864-y	Cho, Kyung Hwa	2015
568	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	mir-19b, MYLIP, cell adhesion, migration, correlation with clinical outcome	Low	Yes	Supportive	10.18632/oncotarget.19278	Zhao, Luqing	2017
569	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-468	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity, cell proliferation, migration, invasion, EMT	Low	Yes	Direct	10.1016/j.biopha.2017.11.139	Yin, Yukun	2018
570	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity, apoptosis	Low	Yes	Direct	10.1039/c8nj03248c	Tokala, Ramya	2018
571	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	LCC2, LCC9, MCF7, T-47D, SKBR3, MDA-MB-453, DU4475, MCF10A,	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	microRNA-645, DCDC2, migration invasion	Low	Yes	Direct	https://www.europeanreview.org/wp/wp-content/uploads/4129-4136-MiR-645-in-breast-cancer.pdf	Cai, Y	2017
572	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	cytotoxicity, alpha2-adrenoceptor/ERK signaling pathway, migration, invasion, proliferation	Low	Yes	Supportive	http://www.europeanreview.org/wp/wp-content/uploads/3500-3506-Dexmedetomidine-regulate-the-malignancy-of-breast-cancer-cells-by-activating-%EF%81%A12-adrenoceptorERK-signaling-pathway.pdf	Xia, M	2016
573	BC	BC	Pharmacological/Physical Treatment	in vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2.5D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	http://medicinabiomolecular.com.br/biblioteca/pdfs/Cancer/tramadol-inibidor-alfa-2.pdf	Xia M	2016
574	BC	BC	Cancer Initiation and Development	In vitro	Cells	Primary cell culture	BC	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	E-cadherin, vimentin, alpha-smooth muscle actin, proliferation, morphology	Low	Yes	Direct	http://dspace.nbuv.gov.ua/handle/123456789/138000	Bezdieniezhnykh, N	2016
575	BC	BC	Cell culture strategy	In vitro	Cells	Immortalised cells	MCF7	Culture	2.5D	n/a	n/a	Model/method develop.(exp.)	morphology, viability	Low	Yes	Direct	10.1021/acsomega.8b03212	Saeednia, Leyla	2019
580	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7 , MDA-MB-231	Culture	2.5D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	caveolin-1, β-catenin/ABCG2 signaling pathway, cytotoxicity, cell proliferation 	High	Yes	Supportive	10.1093/carcin/bgu155	Wang, Zhiyu	2014
582	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.1097/CAD.0000000000000581	Dos Santos, Flaviana Alves	2018
583	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MMC	Culture	2.5D/3D	Scaffolds	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.1021/mp5002119	Tsao, Ching-Ting	2014
587	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA‑MB‑231 , MCF‑7	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	miR-124-3p, migration, invasion, PDCD6, correlation with clinical outcome	Low	Yes	Supportive	10.3892/ol.2017.7358	Zhang, Ling	2018
588	BC	BC	Cell culture strategy	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	3D	Scaffolds	n/a	Model/method develop.(exp.)	migration	Low	Yes	Direct	10.1007/s12195-014-0324-0	Sun, Wei	2014
589	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, BCAP 37, BT474, MDA-MB-231, MDA-MB-231BO MDA-MB-231HM, MDA-MB-436, MDA-MB468, MCF10A, BC	Culture	2D	n/a	Biopsies	Disease mechanism (exp./theor.)	Cyclin D3, correlation with clinical outcome, actin, invasion	Low	Yes	Direct	10.1186/s12935-015-0245-6	Chi, Yayun	2015
594	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA‑MB‑231	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	CXCR7, CCX771, angiogenesis, invasion, CXCL12, cell adhesion, secreted VEGF	Medium	Yes	Supportive	10.3892/mmr.2017.8286	Qian, Tingting	2018
595	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231,MDA-MB-468	Culture	2D/2.5D	n/a	n/a	Drug develop./testing	cell invasion, morphology, cytotoxicity	Low	Yes	Supportive	10.1016/j.biomaterials.2018.01.032	Fisher, Stephanie A.	2018
596	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231, MCF10A	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	FOXN2, migration, invasion, SLUG, EMT	Low	Yes	Supportive	10.2147/CMAR.S176938	Ye, Hui	2019
599	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity, Vav2	Low	Yes	Direct	10.1016/j.phymed.2014.02.002	He, Zhongmei	2014
600	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231, MDA-MB-436, MCF10A	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.18632/oncotarget.2083	Bridges, Kathleen A.	2014
601	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	SKBR3/CSCs, MCF7/CSCs, BC	Culture	2D	n/a	Biopsies	Disease mechanism (exp./theor.)	MiR profile, MicroRNA-1, cell proliferation, migration, Wnt/β-catenin pathway, ESA, CD44, CD24, lin	Medium	Yes	Supportive	10.18632/oncotarget.5873	Liu, Tong	2015
602	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells/Stem-cell like	MDA-MB-231 , SUM159	Culture	3D	Spheroids	n/a	Drug develop./testing	cytotoxicity, morphology, CD44, CD24, aldefluor	High	Yes	Direct	10.1186/s13058-015-0662-4	Tanei, Tomonori	2016
603	BC	BC	Pharmacological/Physical Treatment	In vitro/In silico	Cells/Simulation	Immortalised cells	SKBR3 , BT474	Culture	2D	n/a	n/a	Drug develop./testing	ADMET (absorption, distribution, metabolism, excretion and toxicity), cytotoxicity	Medium	Yes	Direct	10.3390/ijms17071055	Li, Jianzong	2016
604	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	T47D	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Medium	Yes	Supportive	10.3390/molecules23071520	Vollar, Martin	2018
605	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MCF10DCIS	Co-culture	3D	Organoids	n/a	Model/method develop.(exp.)	cell motion	Low	Yes	Direct	10.1364/OPTICA.2.000877	Oldenburg, Amy L.	2015
607	BC	BC	Cancer Initiation and Development	In vitro/In silico	Cells/Simulation	Immortalised cells	U87, T47D, MCF7, U251	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	DiRas1, SmgGDS	Low	Yes	Supportive	10.1074/jbc.M115.696831	Bergom, Carmen	2016
608	BC	BC	Cell culture strategy	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2.5D	n/a	n/a	Drug develop./testing	drug uptake	Low	Yes	Direct	10.1016/j.jiec.2016.07.033	Kim, Jieun	2016
612	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.1016/j.msec.2018.12.085	Wojtowicz, Agata	2019
613	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2.5D	n/a	n/a	Model/method develop.(exp.)	cytotoxicity	Low	Yes	Direct	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139963/	Delphi, L	2016
614	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	mir-301a, cell migration, invasion, Wnt/β-catenin signaling	Low	Yes	Direct	10.1016/j.gene.2013.11.035	Ma, Fei	2014
615	BC	BC	Cancer Initiation and Development	In vitro	Ex vivo	n/a	n/a	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	ELAFIN, ER, PR, Ki67, correlation with clinical outcome	Low	Yes	Supportive	10.1186/s13058-014-0497-4	Caruso, Joseph A.	2014
617	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7, SKBR3	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	Let-7a, Ras/NF-κB pathway, Ras/MAPK/ERK pathway, viability, colony formation	Low	Yes	Supportive	10.1080/15384101.2015.1030547	Xu, Chongwen	2015
618	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	fluorescent protoporphyrin IX accumulation and sub-cellular localisation	Low	Yes	Supportive	10.1016/j.jphotobiol.2017.04.029	Herceg, Viktorija	2017
619	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231, MCF10A	Culture	2D/2.5D	n/a	n/a	Drug develop./testing	cytotoxicity, invasion, cell adhesion	Low	Yes	Direct	10.1016/j.ijbiomac.2017.01.064	Guimaraes, Denise de Oliveira	2017
620	BC	BC	Tumor Detection and Classification	In silico	Algorithms	n/a	n/a	n/a	n/a	n/a	n/a	Diagnosis of disease; Model/method develop. (theor.)	ZNF154	Medium	Yes	Direct	10.1016/j.jmoldx.2015.11.004	Margolin, Gennady	2016
621	BC	BC	Tumor Detection and Classification	In silico	Algorithms	n/a	n/a	n/a	n/a	n/a	n/a	Diagnosis of disease	RNA profile	Low	Yes	Direct	10.1016/j.compbiomed.2018.08.006	Turki, Turki	2018
622	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	3D	Spheroids	n/a	Drug develop./testing	drug release rate	Low	Yes	Direct	10.1021/acsami.6b03041	Davoodi, Pooya	2016
624	BC	BC	Tumor Detection and Classification	In silico	Algorithms	n/a	n/a	n/a	n/a	n/a	n/a	Diagnosis of disease; Model/method develop. (theor.)	copy number variations (CNVs)	Low	Yes	Direct	10.1016/j.gpb.2017.01.004	Zou, Jinfeng	2017
625	BC	BC	Metastasis	In vitro	Cells	Immortalised cells	MDA-MB-231, Hs578T	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	ERβ1, cell migration, invasion, E-Cadherin, N-Cadherin, AR, correlation with clinical outcome	Low	Yes	Supportive	10.1186/s13046-017-0545-x	Song, Wei	2017
626	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7	Culture	3D	Spheroids	n/a	Drug develop./testing	MiR-200c cellular uptake, cytotoxicity	Medium	Yes	Direct	10.2147/IJN.S111647	Liu, Jingwen	2016
627	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231, HUVEC	Co-culture	3D	n/a	n/a	Drug develop./testing	cytotoxicity, VEGFR2, angiogenesis	Low	Yes	Supportive	10.3389/fphar.2017.00963	Li, Qi	2018
628	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	ELF5, lumen formation, colony formation, CEACAM1	Low	Yes	Direct	10.1016/j.yexcr.2017.08.008	Chean, Jennifer	2017
629	BC	BC	Metastasis	In vitro	Cells	Immortalised cells	NM-2C5 , M-4A4,	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	CYB5R3, LDHA, NPC1, NRH2, correlation, TGFβ and HIFα pathways, apoptosis	Low	Yes	Supportive	10.1074/mcp.M115.050385	Lund, Rikke R.	2015
631	BC	BC	Circulating Cancer Cells/DNA Identification and Profiling	In vitro	Cell free	n/a	liquid biopsy	n/a	n/a	n/a	n/a	Diagnosis of disease; Model/method develop. (exp.)	Methylation profile, RASSF1A, HIST1H3C, RASGRF2, COL6A2, HOXB4, AKR1B1, cytotoxicity	Low	Yes	Direct	10.1158/0008-5472.CAN-13-3392	Fackler, Mary Jo	2014
632	BC	BC	Metastasis	In vitro	Cells	Immortalised cells	MCF7, T47D, MDA-MB-231, MCF10A	Culture	2D	n/a	n/a	Drug develop./testing	migration, cytotoxicity, DNMT1, methylation profile	Low	Yes	Direct	10.1021/jf4056924	Wang, Sheng-Chao	2014
636	BC	BC	Cancer landscape	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	Ruk/CIN85, Tks4	Low	Yes	Direct	10.7124/bc.00087A	Kosova, A. A.	2015
638	BC	BC	Tumor Detection and Classification	In vitro/In silico	Cells/Algorithms	Immortalised cells	MDA-MB-231, HCC1806, MCF7, MCF10A	Culture	2D	n/a	n/a	Model/method develop.(exp./theor.)	velocity increment differences through multiconstriction channels	High	Yes	Direct	10.1021/acssensors.8b00301	Ren, Xiang	2018
639	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	SKBR3, BT474, MCF7	Culture/Co-culture/MPS	2D	n/a	n/a	Disease mechanism (exp./theor.)	RNA profile	Low	Yes	Supportive	10.1007/s10544-016-0083-x	Regier, Mary C.	2016
640	BC	BC	Drug Discovery and/or Testing	In silico	Simulation	n/a	n/a	n/a	n/a	n/a	n/a	Model/method develop.(theor.)	antiproliferative activity	Low	Yes	Direct	10.1016/j.jmgm.2018.12.010	Kovacevic, Strahinja Z.	2019
641	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells/Stem-cell like	ZR75-1, MCF7, BT20, HS587-T, MDA-MB-231	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	let-7 miRNA, cyclin D1/Akt1/Wnt1 signaling pathway, cell proliferation	Low	Yes	Direct	10.3892/mmr.2016.5656	Sun, Huifang	2016
643	BC	BC	Pharmacological/Physical Treatment	In vitro	Ex vivo	n/a	BC	n/a	n/a	n/a	organ slice	Model/method develop.(exp.)	cell proliferation, EdU assay, cytokeratin, cytotoxicity, apoptosis	Low	Yes	Direct	10.1186/s12885-016-2119-2	Naipal, Kishan A. T.	2016
645	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MDA-MB-231, MC3T3-E1	Co-culture	3D	Scaffolds	n/a	Disease mechanism (exp./theor.)	cell metabolic activity, viability, cell proliferation	Low	Yes	Direct	10.3390/jfb9040072	James-Bhasin, Mark	2018
646	BC	BC	Lumenogenesis	In vitro	Cells	Immortalised cells	MCF7	Culture	2.5D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	SASH1, NOTCH1, DLK1, CEACAM1, lumen formation	Low	Yes	Direct	10.1016/j.yexcr.2017.08.022	Stubblefield, Kandis	2017
647	BC	BC	Cancer Initiation and Development; Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	3D	Spheroids	n/a	Drug develop./testing; Model/method develop. (exp.)	lumen formation, ELF5, cytotoxicity, CEACAM1	Low	Yes	Direct	10.1016/j.dib.2015.09.037	Itou, Junji	2015
649	IBC	IBC	Anti-cancer drug delivery system	In vitro	Cells	Immortalised cells	SUM149, MCF10A	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.1002/bit.26022	Ross, Nikki L.	2016
651	BC	BC	Anti-cancer drug delivery system	In vitro	Cells	Immortalised cells	MDA-MB-231	Co-culture	3D	Scaffolds	n/a	Drug develop./testing	cRGD-modified solid lipid nanoparticles uptake, cell adhesion, invasion, cytotoxicity	Low	Yes	Supportive	10.1007/s13346-014-0210-2	Shan, Dan	2015
652	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231, SKBR3	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	MiR-144, viability, apoptosis, invasion, migration, AKT	Low	Yes	Direct	10.3892/or.2015.4173	Yu, Lei	2015
653	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231, MCF10A	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	miR-106b, proliferation, invasion, migration, AKT, PTEN	Low	Yes	Supportive	http://www.ijcep.com/files/ijcep0039688.pdf	Gao, YZ	2016
654	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7,	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	MyD88, WST-1, NF-κB via PI3K/Akt, cytotoxicity	Low	Yes	Supportive	10.1007/s13277-015-4436-5	Xiang, Fenfen	2016
655	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MDA-MB-231, MCF10A	Culture	2.5D	n/a	n/a	Drug develop./testing	CHEK2, SDF1, IL-6, α-SMA, P53, migration/invasion of stromal fibroblasts, cell proliferation of epithelial cells, migration, invasion	Medium	Yes	Direct	10.1186/s12885-016-2614-5	Al-Rakan, Maha A.	2016
656	BC	BC	Metastasis	In vitro	Cells	Immortalised cells	MCF7	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	AKR1B10, ERK, migration, invasion	Low	Yes	Direct	10.18632/oncotarget.16624	Li, Jia	2017
657	BC	BC	Cancer Initiation and Development	In vitro	Ex vivo	n/a	n/a	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	RECK, correlation	Low	Yes	Direct	10.1016/j.genrep.2018.05.005	AbouGhalia, Azza Hassan	2018
658	BC	BC	Metastasis	In vitro	Cells	Immortalised cells	578Bst SKBR3, ZR-75-30, T47D, MDA-MB-231	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	α1-antitrypsin, viability, cell proliferation,  PI3K/Akt/mTOR pathway	Low	Yes	Direct	10.12659/MSM.910665	Zhao, Zhijing	2018
659	BC	BC	Metastasis	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	miR-361-5p, invasion, migration, RQCD1, EGFR/PI3K/Akt pathway	Medium	Yes	Direct	10.17305/bjbms.2018.3399	Han, Jianjun	2019
660	BC	BC	Metastasis	In vitro	Cells	Immortalised cells	MDA-MB-468	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	COX-2, prostacyclin, IP, PI3K-p38 MAPK, invasion, migration	Low	Yes	Direct	10.1016/j.bcp.2015.06.002	Allison, Sarah E.	2015
661	BC	BC	Cancer Initiation and Development	In vitro	Cells/Cell free	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.); Model/method develop. (exp.)	P53	High	Yes	Supportive	10.1016/j.ijbiomac.2017.11.006	Hasanzadeh, Mohammad	2018
662	BC	BC	Cancer Initiation and Development	In vitro	Cell free	n/a	MCF7	n/a	n/a	n/a	n/a	Model/method develop.(exp.)	Carcinoma Antigen 15-3 (CA 15-3)	Low	Yes	Direct	10.1016/j.ijbiomac.2018.06.091	Hasanzadeh, Mohammad	2018
665	BC	BC	Pharmacological/Physical Treatment	In vitro	Ex vivo	n/a	BC	n/a	n/a	n/a	Organ slice	Disease mechanism (exp./theor.)	TAZ, HER2, correlation	Low	Yes	Direct	10.18632/oncotarget.2449	Vici, Patrizia	2014
667	BC	BC	Cancer Initiation and Development	In vitro	Cell free	n/a	liquid biopsy	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	HER2, correlation	Medium	Yes	Direct	10.1002/jso.23510	Kim, Hyun-Ah	2014
669	BC	BC	Cancer Initiation and Development	In vitro	Ex vivo	n/a	BC	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	Y-box-binding Protein 1 (YB1), CD44/CD24	High	Yes	Direct	10.1016/j.ejso.2013.09.008	Mylona, E.	2014
670	BC	BC	Cell culture strategy	In vitro	Cells	Immortalised cells	MCF7	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	RNA profile, methylation profile, MLH, PTEN, RUNX, RASSF, CDH1, MGMT and P1	Low	Yes	Direct	10.3892/mmr.2018.8735	Wang, Shibao	2018
672	BC	BC	Anti-cancer drug delivery system	In vitro	Cells	Immortalised cells	MCF7	Culture	2D/3D	Spheroids	n/a	Drug develop./testing	IFNα-2b, migration, proliferation,  expression of epithelial and mesenchymal marker, Vimentin, CK and EpCAM	Low	Yes	Direct	10.3906/biy-1808-36	Herheliuk, Tetiana	2019
673	BC	BC	Anti-cancer drug delivery system	In vitro	Cells	Immortalised cells	MCF7	Culture	2D/3D	Spheroids	n/a	Drug develop./testing	viability, morphology, nanoparticle uptake, cytotoxicity, HIF-1α	Medium	Yes	Supportive	10.7150/ijms.28135	Bonafe, Francesca	2019
674	BC	BC	Angiogenesis	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231, BT20 , ZR-75-1	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	exosome small RNA content, let-7a, miR-21, miR-23b, miR-27b,  miR-320b, secreted VEGF, tube formation, Rab27A	Medium	Yes	Direct	10.1186/s12943-015-0400-7	Hannafon, Bethany N.	2015
675	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells/Ex vivo	Immortalised cells	MDA-MB-453, CAFs	Co-culture	2D	n/a	Biopsies	Disease mechanism (exp./theor.)	Cytokines profile, 17βHSD2, 17βHSD5,  5α-Reductase1. IL-6 and HGF, correlation, α-SMA	Low	Yes	Supportive	10.1007/s10549-017-4464-5	Kikuchi, Kyoko	2017
676	BC	BC	Pharmacological/Physical Treatment; Metastasis	In vitro	Cells	Immortalised cells	HCC38, HCC70, HCC1143, HCC1187, HCC1008, HCC1937, MDA-MB-231, MDA-MB468, BT20, BT549, Hs578t, MDA-MB157, MDA-MB-436, SUM102, SUM149, MCF7, BT474, BTH474, SKBr3	Culture	2.5D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	CTNNB1, APC and DVL1, beta-catenin, migration, cytoskeletal structure, lamelipodia/filopodia, cytotoxicity	Low	Yes	Supportive	10.18632/oncotarget.8988	De, Pradip	2016
677	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells/Stem-cell like	BT474, SK-BR-3, SUM149 , SUM159	Culture	2.5D/3D	Spheroids	n/a	Drug develop./testing	ALDH, CD44, CD24, cytotoxicity, ROS, p38 MAPK	Low	Yes	Direct	10.3892/or.2018.6337	Lin, Chang-Ching	2018
680	BC	BC	Cancer Initiation and Development	In vitro	Ex vivo	n/a	n/a	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	Methylation profile, correlation	Low	Yes	Direct	10.1186/s13058-014-0423-9	Pang, Jia-Min B.	2014
681	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231, MDA-MB-468, SW480	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	MACC1, correlation, c-Met, HGF	Low	Yes	Supportive	10.3892/ijo.2015.2907	Sueta, Aiko	2015
682	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2D	n/a	n/a	Drug develop./testing	nanoparticle uptake, cytotoxicity	Low	Yes	Supportive	10.1016/j.colsurfb.2018.06.056	Cacicedo, M. L.	2018
683	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	mir-520e, cell migration, proliferation, apoptosis	Medium	Yes	Supportive	10.3892/ol.2016.5085	Yi, Ming	2016
684	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7, Hs578t , MDA-MB-231	Culture	2.5D	n/a	n/a	Drug develop./testing	microRNA-205, ZEB1, migration, invasion, cytotoxicity, EMT	Low	Yes	Supportive	10.1016/j.jnutbio.2015.01.005	Su, Chih-Ming	2015
685	IBC	IBC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	SUM149 , SUM159	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	mir-33a, HDL-induced radiation sensitivity	Low	Yes	Supportive	10.1016/j.ijrobp.2016.01.025	Wolfe, Adam R.	2016
687	BC	BC	Anti-cancer drug delivery system	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity, apoptosis	Low	Yes	Direct	10.1016/j.ijpharm.2018.10.001	Roointan, Amir	2018
689	BC	BC	Metastasis	In vitro	Cells	Immortalised cells	MDA‐MB‐231Br	Culture	3D	Scaffolds	n/a	Disease mechanism (exp./theor.)	cell adhesion, spreading, proliferation,  migration	Low	Yes	Direct	10.1002/jbm.a.36379	Narkhede, Akshay A.	2018
691	BC	BC	Pharmacological/Physical Treatment	In vitro	Cell free	n/a	n/a	n/a	n/a	n/a	n/a	Disease mechanism (exp./theor.)	MASTL, cell proliferation, DNA damage signaling, cell death	Low	Yes	Supportive	10.18632/oncotarget.2565	Wang, Ling	2014
692	BC	BC	Anti-cancer drug delivery system	In vitro	Cells	Immortalised cells	MCF‐7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.1002/jbm.a.36096	Saeednia, Leyla	2017
695	BC	BC	Patient stratification	In silico	Algorithms	n/a	BC	n/a	n/a	n/a	n/a	Model/method develop.(theor.)	collagen-I/fibronectin, correlation, live-fluorescent biomarker	Medium	Yes	Supportive	10.1038/s41551-018-0285-z	Manak, Michael S.	2018
696	BC	BC	Metastasis	In vitro	Cells	Immortalised cells	MDA-MB-231, MCF7	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	miR-219a-5p, cell migration, myocardin-related transcription factor A, Vimentin, E-Cadherin, N-Cadherin, viability, MRTF-A, EMT	Medium	Yes	Direct	10.1093/abbs/gmx114	Zhuang, Chunyu	2017
697	BC	BC	Cancer Initiation and Development	In vitro	Cell free	n/a	SKBR3	n/a	n/a	n/a	n/a	Disease mechanism (exp./theor.)	ERBB2/neu/Her2 in cell lysates	Low	Yes	Direct	10.1016/j.bios.2017.02.012	Sinibaldi, Alberto	2017
698	BC	BC	Cancer Initiation and Development; Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2D	n/a	n/a	Drug develop./testing	CCND2, cell proliferation, migration, cytotoxicity	Medium	Yes	Direct	10.3390/ijms19103096	Hung, Chin-Sheng	2018
700	BC	BC	Metastasis	In vitro	Cells	Immortalised cells	MDA‐MB‐231	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	P38 MAPK, metabolomic profile, proliferation, migration, apoptosis	Low	Yes	Direct	10.1016/j.biocel.2018.11.002	Chen, Hongshen	2019
701	BC	BC	Patient stratification	In vitro	Cells	Immortalised cells	MCF7, 47D, ZR75-1,	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	TK1, correlation	Medium	Yes	Direct	10.18632/oncotarget.24700	Bonechi, Martina	2018
703	BC	BC	Drug Discovery and/or Testing	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7, T47D	Culture	3D	Spheroids	n/a	Drug develop./testing	NFκB, cytotoxicity, P65, IKKalpha, IKKbeta, ICAM, CCL2, TNF, CD44, CD24	Low	Yes	Supportive	10.1186/s12885-015-1868-7	Kastrati, Irida	2015
704	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	2.5D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	CDK4, SMAD3, Survivin, cell proliferation, cytotoxicity, apoptosis	Medium	Yes	Direct	10.4161/cbt.29693	Tarasewicz, Elizabeth	2014
709	BC	BC	Patient stratification	In vitro	Ex vivo	n/a	liquid biopsy	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	HER2 abnormalities in circulating tumor cells, correlation	Low	Yes	Direct	10.1007/s10549-016-3969-7	Hainsworth, John D.	2016
711	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2D	n/a	n/a	Drug develop./testing	XCR4/NF-κB/Smo, viability, apoptosis, migration cytotoxicity	Low	Yes	Direct	10.1007/s11033-017-4115-2	Mahjoub, Mohammad Amin	2017
713	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	MiR-155, proliferation, migration, SOCS1, MMP16	Low	Yes	Direct	10.26355/eurrev_201811_16269	Zhang, W	2018
717	BC	BC	Patient stratification	In silico	Simulation	n/a	n/a	n/a	n/a	n/a	n/a	Model/method develop.(exp.)	spectral mammography	Low	Yes	Direct	10.1002/mp.12230	Ghammraoui, Bahaa	2017
718	IBC/BC	IBC/BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	SUM149, MDA-MB-231 , SUM159	Culture	3D	Spheroids	n/a	Drug develop./testing	GLI1, proliferation, emboli formation	Low	Yes	Direct	10.1016/j.canlet.2017.09.033	Oladapo, Helen O.	2017
719	BC	BC	Cancer landscape	In silico	Computational	n/a	n/a	n/a	n/a	n/a	n/a	Model/method develop.(theor.)	somatic copy number alterations and loss of heterozygosity	Low	Yes	Direct	10.1093/bioinformatics/btu174	Li, Yi	2014
723	BC	BC	Tumor Landscape	In silico	Computational	n/a	n/a	n/a	n/a	n/a	n/a	Model/method develop.(theor.)	DNA sequences	Low	Yes	Direct	10.1093/annonc/mdx517	Dang, H. X.	2017
724	BC	BC	Patient stratification	In silico	Algorithms	n/a	n/a	n/a	n/a	n/a	n/a	Model/method develop.(theor.)	age, ER status, tumor grade, tumor size, number of positive lymph nodes, presentation,  type of adjuvant therapy 	Low	Yes	Direct	10.1158/1078-0432.CCR-17-3542	Karapanagiotis, Solon	2018
725	BC	BC	Cancer Initiation and Development	In vitro	Ex vivo	n/a	n/a	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	PD-1/PD-L1, correlation, CNVs, mutation load	Low	Yes	Direct	10.1186/s13058-018-1004-0	Barrett, Michael T.	2018
727	BC	BC	Cancer Initiation and Development; Patient Stratification	In vitro	Ex vivo	n/a	BC	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	tumor-infiltrating lymphocytes (TIL), correlation	Low	Yes	Direct	10.1038/modpathol.2017.43	Buisseret, Laurence	2017
729	BC	BC	Metastasis; Patient Stratification	In vitro	Ex vivo	n/a	BC	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	breast osteoblast-like cells (BOLCs) counting, BMP-2/4 and PTX3, RANKL and Vitamin D receptor	Low	Yes	Direct	10.1016/j.clbc.2017.11.020	Scimeca, Manuel	2018
730	BC	BC	Tumor Detection and Classification	In vitro	Ex vivo	n/a	BC	n/a	n/a	n/a	Biopsies organ slice	Disease mechanism (exp./theor.)	ER, HER2, PR, Ki-67, correlation	Low	Yes	Direct	10.1309/AJCP9KFVM2GZMNDV	Petrau, Camille	2015
731	BC	BC	Tumor Detection and Classification	In vitro	Cell free	n/a	liquid biopsy	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.); Model/method develop. (exp.)	Genome-wide DNA profile, correlation	Low	Yes	Direct	10.1093/annonc/mdu288	Rothe, F.	2014
732	BC	BC	Patient stratification	In vitro	Ex vivo	n/a	BC	n/a	n/a	n/a	Organ slice	Model/method develop.(exp.)	HER2 	Low	Yes	Direct	10.1371/journal.pone.0123201	van der Logt, Elise M. J.	2015
733	BC	BC	Cancer Initiation and Development	In vitro	Ex vivo	n/a	n/a	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	estrogen receptor (ER), progesterone receptor (PR), HER2,  Ki-67, ESR1, PGR, ERBB2,  MKI67	Low	Yes	Supportive	10.18632/oncotarget.18006	Stefanovic, Stefan	2017
734	BC	BC	Pharmacological/Physical Treatment; Metastasis	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7	Culture	2.5D/3D	Spheroids	n/a	Drug develop./testing	morphology, CD44, CD24, cytotoxicity, migration, invasion, EMT	Medium	Yes	Supportive	10.1371/journal.pone.0150407	Goncalves, Naiane do Nascimento	2016
735	BC	BC	Pharmacological/Physical Treatment; Metastasis	In vitro	Cells	Immortalised cells	MDA-MB-231BO	Culture	2.5D	n/a	n/a	Drug develop./testing	cell invasion, cytotoxicity, CCL5 and IL-17B 	Low	Yes	Direct	10.1016/j.jep.2014.12.036	Han, Xiang-hui	2015
738	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells/Stem-cell like	MCF‐7, MDA‐MB‐231	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	miR‐99a, morphology, cell migration, invasion, HIF‐1α, PI3K/AKT	High	Yes	Supportive	10.1111/cpr.12146	Yang, Z.	2014
739	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells/Stem-cell like	SUM149PT, SUM159PT, SUM1315MO2, BT549, Hs578T, MCF7,SUM102PT, SUM225CWN	Culture	2.5D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	ADAM12, cytotoxicity, CD44, CD24, genome-wide RNA profile, EGFR pathway, correlation	Medium	Yes	Direct	10.1186/s12943-017-0599-6	Duhachek-Muggy, Sara	2017
740	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Medium	Yes	Direct	10.1186/s12885-017-3514-z	Alileche, Abdelkrim	2017
741	BC	BC	Cancer Initiation and Development	In vitro	Cells/Ex vivo	Immortalised cells/Primary cell culture	BT549, MDA-MB-453, MDA-MB435, SKBR3, Bcap37, MCF7, ZR-75-30, T47D/ BC	Culture	2.5D/3D	Spheroids	Organ slice	Disease mechanism (exp./theor.)	TIMELESS, MYC, correlation, migration, invasion, CD44, CD24	Medium	Yes	Direct	10.1186/s13058-017-0838-1	Chi, Limin	2017
742	BC	BC	Pharmacokinetic study	In vitro/In silico	Cells/Computational	Immortalised cells	MDA-MB-468	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	cell count, proliferation rate	Medium	Yes	Direct	10.1007/s10439-018-2001-2	McKenna, Matthew T.	2018
743	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells/Ex vivo	Immortalised cells	MCF10DCIS.com (DCIS.com) , SUM225, BC	Culture	2.5D/3D	Spheroids	Biopsies	Disease mechanism (exp./theor.)	FAK, viability, cytotoxicity	Medium	Yes	Direct	10.1002/stem.1843	Williams, Kathryn E.	2015
744	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells/Stem-cell like	MDA-MB-231 , MCF7	Culture	2.5D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	PTPRD, CD44, CD24, morphology, migration, Vimentin, E-Cadherin, IL-6/STAT3 ,ALDH1, OCT4, EMT	Low	Yes	Direct	10.18632/oncotarget.22000	Yu, Xiaotang	2017
746	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231	Co-culture/MPS	3D	Scaffolds	n/a	Model/method develop.(exp.)	cell dormancy, EdU, protein profiling, proliferation	Low	Yes	Direct	10.1074/mcp.RA117.000370	Clark, Amanda M.	2018
748	BC	BC	Cancer Initiation and Development	In vitro	Cells	Primary cell culture	BC	Culture	2D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	CD24, CD44, CA9, HIF1α, metabolic activity, extracellular O2 consumption	Medium	Yes	Direct	10.1590/1414-431x20176538	Wanandi, S.I.	2017
749	BC	BC	Cancer stem cells	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	IKKε, TNF/NF-κB, CD44, CD24, ALDH1A3, NANOG,  KLF4, viability	Medium	Yes	Direct	10.1016/j.bbamcr.2019.01.002	Orlova, Zhanna	2019
750	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231 , MCF7	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	miRNA-106a, Cell Proliferation, Clonogenicity, Migration, Invasion, Apoptosis and Chemosensitivity, p53, Bax, Bcl-2, RUNX3,  ABCG2	Medium	Yes	Supportive	10.1089/dna.2018.4282	You, Faping	2019
753	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231 , ZR75-1	Culture	2.5D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	microRNA-206, TBX3, correlation, cell proliferation, apoptosis, invasion, viability	Medium	Yes	Direct	10.1038/bjc.2016.73	Amir, Sumaira	2016
754	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7, T47D, MDA-MB-231	Culture	2.5D/3D	Spheroids	n/a	Drug develop./testing	Notch1 and PI3K/Akt signaling pathways, migration, cytotoxicity, invasion, colony formation	Medium	Yes	Direct	10.3892/ijmm.2018.3741	Cao, Longbin	2018
756	BC	BC	Metastasis	In vitro	Cells/Ex vivo	Immortalised cells	MDA-MB-231, MCF7, MDA-MB-436, T47D, MCF10A, BC	Culture	2D	n/a	Biopsies	Disease mechanism (exp./theor.)	Long non-coding RNA TUG1, proliferation, migration, invasion	Medium	Yes	Supportive	10.1007/s12282-016-0736-x	Li, Teng	2017
758	BC	BC	Metastasis	In vitro	Cells/Ex vivo	Immortalised cells	MCF7, BC	Culture	2.5D/3D	Spheroids	Biopsies	Disease mechanism (exp./theor.)	MicroRNA‐34a, NOTCH1, proliferation, migration, colony formation, correlation, CD44, ALDH1, PTX, cytotoxicity	High Medium	Yes	Direct	10.1111/cas.12656	Kang, Le	2015
759	BC	BC	Metastasis	In vitro	Cells	Primary cell culture	BC	Culture	2.5D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	ALDH, CD44, CD24, invasion, migration, colony formation, OCT4, HIF‐1α	High	Yes	Supportive	10.1111/cas.13147	Shiraishi, Akira	2017
760	BC	BC	Cancer stem cells; Metastasis	In vitro	Cells	Immortalised cells	SUM159PT	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	miR205, VEGF-A, ErbB3, ZEB1, Fyn, Lyn A/B, P27, PARP. MYC, cyclin D1, CD44, TWIST, SNAIL, TAZ, E2A.E12, migration, invasion, EMT	Low	Yes	Direct	10.1371/journal.pone.0188637	Mayoral-Varo, Vitor	2017
761	BC	BC	Cancer stem cells	In vitro	Cells	Immortalised cells/Stem-cell like	BT474, Hs578T, MDA-MD-468,	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	GPNMB, OX2, NANOG, OCT4, CD44, CD133,  FOXO3, SNAIL, SLUG, ZEB1, ZEB2, CD44, CD24, EMT	Low	Yes	Supportive	10.1158/0008-5472.CAN-18-0599	Chen, Chen	2018
762	BC	BC	Metastasis	In vitro	Cells	Immortalised cells	MDA-MB-231, MDA-MB-436, BT549, SKBR3, ZR75-1, HCC1954	Culture/Co-culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	Osteoprotegerin, IL1B, p38 and p42/44 MAPK signaling pathway, invasion	Medium	Yes	Direct	10.1186/s12943-017-0606-y	Chung, Stephanie Tsang Mui	2017
766	BC	BC	Metastasis	In vitro	Cells	Immortalised cells	MDA‐MB‐231, T47D	Co-culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	TIMP‐1 and TIMP‐2, invasion, migration, secreted MMPs 	Low	Yes	Supportive	10.1002/mc.22178	Clarke, Mitchell R.	2015
767	BC	BC	Anti-cancer drug delivery system	In vitro/In silico	Cells/Computational	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Supportive	10.3390/ijms19092612	Ismail, Eman H.	2018
769	BC	BC	Pharmacological/Physical Treatment	In silico	Computational	n/a	n/a	n/a	n/a	n/a	n/a	Drug develop./testing	disease burden	Low	Yes	Direct	10.1016/j.cma.2016.08.024	Weis, Jared A.	2017
771	BC	BC	Pharmacological/Physical Treatment; Metastasis	In vitro	Cells	Immortalised cells	SKBR3, BT549, MDA-MB-231, MCF7 , MDA-MB-453	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	FUNDC1, viability, NFATC1, migration, BMi1, correlation	Medium	Yes	Supportive	10.1016/j.ebiom.2019.02.032	Wu, Lianpin	2019
772	BC	BC	Pharmacological/Physical Treatment; Metastasis	In vitro	Cells	Immortalised cells	MCF7	Culture	2.5D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	Nicastrin, Notch4, vimentin, CD44, IQGAP1, RAC1, CDC42, SNAIL, TWIST, ZEB2 and mir200c, cytotoxicity, E-Cadherin, EMT	Medium	Yes	Direct	10.1186/bcr3675	Lombardo, Ylenia	2014
777	BC	BC	Cancer Initiation and Development	In silico	Computational	n/a	n/a	n/a	n/a	n/a	n/a	Drug develop./testing	Estrogen-related receptor α	Low	Yes	Direct	10.1016/j.comtox.2019.01.005	Klimenko, K.	2019
778	BC	BC	Anti-cancer drug delivery system	In vitro	Cells	Immortalised cells	MCF7	Culture	2.5D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.1021/acsomega.8b01691	Kouser, Rabia	2018
781	BC	BC	Immunotherapy	In vitro	Cell free	n/a	HCC1500	n/a	n/a	n/a	n/a	Drug develop./testing	NK cell activating receptors (NKp30, NKp44, NKp46, 2b4, CD16, NKG2D), cytokine production, NK CD107a	Low	Yes	Supportive	10.1093/bja/aeu200	Buckley, A.	2014
782	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231, HMEC-1	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	TGF-beta, invasion, ERK1/2, migration, angiogenesis	Medium	Yes	Direct	https://europepmc.org/article/med/25555875	Wang, XG	2014
783	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF‐7	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	UCH‐L1, invasion, Akt signaling pathway	Low	Yes	Direct	10.1002/jcb.26232	Luo, Yanhong	2018
784	BC	BC	Metastasis	In vitro	Cells	Immortalised cells	MDA‑MB‑231	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	JWA, proliferation, migration, invasion, apoptosis, p38	Medium	Yes	Supportive	10.3892/mmr.2015.3188	Chen, Xiang	2015
785	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	BRC-17, BRC-31, BRC-32, BRC-36, BRC-196	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	Integrin-uPAR, FRA-1 phosphorylation, invasion, FAK, E-cadherin (cdh1), cytokeratin-8 (krt8)) and mesenchymal (N-cadherin (cdh2), fibronectin (fn1) and vimentin (vim), RNA profile, ERK2, Vitronectin, correlation 	Medium	Yes	Supportive	10.1186/s13058-018-0936-8	Annis, Matthew G.	2018
786	BC	BC	Pharmacological/Physical Treatment; Metastasis	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2.5D	n/a	n/a	Drug develop./testing	PTHrP pathway, cytotoxicity	Medium	Yes	Supportive	10.3892/ijmm.2018.3515	Zheng, Xiao	2018
787	BC	BC	Pharmacological/Physical Treatment; Cancer Stem Cells	In vitro	Cells	Immortalised cells	MCF‐7	Culture	3D	Spheroids	n/a	Drug develop./testing	viability, cytotoxicity, Caspase-7, caspase-8,  caspase-9, nuclear factor kappa B (NF-κB) activity, CD44, CD24	Low	Yes	Direct	10.2147/DDDT.S72127	Ahmadipour, Fatemeh	2015
788	BC	BC	Metastasis	In vitro/In silico	Cells/Algorithms	Immortalised cells	MDA-MB-231, MDA-MB-468, T47D, MCF7,	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	MiR-224, Caspase-9, proliferation, migration, invasion, apoptosis, Caspase-3/7 Activation	Medium	Yes	Direct	10.1155/2019/7378967	Zhang, Li	2019
789	BC	BC	Cancer Initiation and Development	In silico	Computational	n/a	n/a	n/a	n/a	n/a	n/a	Model/method develop.(exp.)	ADLH, metabolic and transcriptomic profile	Low	Yes	Direct	10.1109/CONCAPAN.2016.7942349	Edwin, B.-V.	2017
791	BC	BC	Metastasis	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7, MDA-MB-231	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	mir-29a, migration, invasion, H4K20, SUV420H2, CD44, CD24, morphology	Low	Yes	Direct	10.1038/s41419-019-1437-0	Wu, You	2019
792	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7, MDA-MB-231	Culture	3D	Organoids	n/a	Disease mechanism (exp./theor.)	mir-142, mir-150, APC, AGO, WNT signaling pathway, morphology, cell proliferation, Annexin V, number of cell branches, 	Medium	Yes	Supportive	10.7554/eLife.01977	Isobe, Taichi	2014
794	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231, MCF7	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	Runx2, secreted IL-12 and IFN-γ in T cells, morphology, cytotoxicity	Medium	Yes	Direct	10.3892/ol.2018.9001	Tang, Mi	2018
795	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231	Culture	2D	n/a	n/a	Drug develop./testing	ERE, cell proliferation, ERα and ERβ, cytotoxicity	Low	Yes	Direct	10.1016/j.bbrc.2014.06.130	Payton-Stewart, Florastina	2014
797	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	BT20, SUM149	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	P-Cadherin, HIF-1α, GLUT1, CAIX, MCT1, MCT4 and CD147	Low	Yes	Supportive	10.1186/1471-2407-14-734	Sousa, Barbara	2014
798	BC	BC	Tumor Detection and Classification	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7 , MCF10A	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	CD44, CD24	Low	Yes	Direct	10.3233/CBM-140450	Lu, Min	2015
799	BC	BC	Cell culture strategy	In vitro	Cells	Primary cell culture	BC	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	CD44, CD24, ALDH, morphology, CNV, P24, EMT	High	Yes	Direct	10.1371/journal.pone.0175223	Tiran, Verena	2017
800	BC	BC	Cell culture strategy	In vitro	Cells	Immortalised cells	MCF7	Culture	2.5D	n/a	n/a	Model/method develop.(exp.)	viability	Low	Yes	Direct	10.1039/c3lc51247a	Liu, Na	2014
801	BC	BC	Cell culture strategy	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	morphology, P-gp and BCRP	High	Yes	Direct	10.4238/2015.March.27.20	Dong, Y.	2015
802	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity, RAS, E-Cadherin, ERK, AKT	Low	Yes	Direct	10.1371/journal.pone.0197422	Beckwitt, Colin H.	2018
803	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Primary cell culture	BC	Culture	2D	n/a	n/a	Model/method develop.(exp.)	mir-34, C22ORF28, nanoparticle delivery, colony formation, telomerase activity, cytotoxicity, miR profiling	High	Yes	Direct	10.7150/thno.20771	Lin, Xiaoti	2017
805	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	Osteopontin, Aromatase, TNFα	Low	Yes	Supportive	10.1007/s10549-015-3603-0	Leitner, Lukas	2015
806	BC	BC	Metastasis	In vitro	Cells	Immortalised cells	MDA-MB-231, SUM159	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	CYR6, extravasation, anoikis, AMPKα signaling, AKT, FAK, ERK1/2, migration	Low	Yes	Supportive	10.18632/oncotarget.13677	Huang, Yu-Ting	2017
807	BC	BC	Metastasis	In silico	Simulation	n/a	n/a	n/a	n/a	n/a	n/a	Model/method develop.(theor.)	R-α, IGF-1R and EGFR, BRCA1, p53, Mdm2	Low	Yes	Direct	10.7717/peerj.2542	Khalid, Samra	2016
808	BC	BC	Cancer Initiation and Development	In vitro/In silico	Cells/Algorithms	Immortalised cells	MDA-MB-231, Hs578T, SKBR3, BT474, MCF7	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	miR-498, BRCA-1	Medium	Yes	Direct	10.18632/oncotarget.7705	Matamala, Nerea	2016
809	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells/Stem-cell like	MCF10A, MDA-MB-231, HCC38, T47D, ZR751	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	TAZ, CD44, CD24, cytotoxicity	Low	Yes	Supportive	10.18632/oncotarget.2570	Frangou, Costa	2014
810	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	RNA profile, C44, CD24, cytotoxicity	Low	Yes	Direct	10.3892/ol.2017.7029	Erol, Ayse	2017
811	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231, fibroblasts	Co-culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	COX-2, IDO, EP4/STAT3 signaling pathway, E-Cadherin, AhR and Skp2, correlation	Low	Yes	Supportive	10.1186/s13058-014-0410-1	Chen, Jing-Yi	2014
812	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MDA‐MB231, MCF‐7, MCF10, MSCs	Co-culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	proliferation, cytokine profile, migration, bFGF, PI3K, AKT, 	Low	Yes	Supportive	10.1002/stem.2384	Dhawan, Abhishek	2016
813	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells/Stem-cell like	SUM159PT, BT549, MDA-MB-231, Hs578T	Culture	2D/3D	Spheroids	n/a	Drug develop./testing	SLUG, ZEB1, SNAIL and VIMENTIN, LRP6, β-catenin and cyclin D1, CD44, CD24, Wnt/β-catenin, EMT	Low	Yes	Direct	10.1007/s00394-018-1864-1	Cruz-Lozano, Marina	2018
814	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231, MCF7, MCF10A	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	MicroRNA-3646, proliferation, migration, invasion, RhoA	Low	Yes	Supportive	http://www.ijcep.com/files/ijcep0042085.pdf	Lei, Pei	2017
815	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7	Culture	3D	Scaffolds	n/a	Model/method develop.(exp.)	morphology, MFGE8, MUC1, GATA-3, KRT5, KRT8, CDH1, VIM, GM130, SNAI1, WISP2, MFGE8, AREG, lumen formation, apoptosis, autophagy	Low	Yes	Direct	10.1371/journal.pone.0135426	Vantangoli, Marguerite M.	2015
816	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MCF10, MDA-MB-231	MPS	3D	Scaffolds	n/a	Model/method develop.(exp.)	E-Cadherin, lumen formation, invasion	Low	Yes	Direct	10.1039/c7lc00191f	Fan, Qihui	2017
817	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells/Ex vivo	Immortalised cells	MCF7 bCSCs, T47D, BC	Culture	3D	Spheroids	Biopsies	Disease mechanism (exp./theor.); Drug develop./testing	cytotoxicity, E-cadherin, Cyclin-D1, c-Myc, Slug and Snail, CD44, CD24, OCT4, NANOG, Sox-2, ABCG-2, MRP-1ALDH1, FAK, migration, EMT	Low	Yes	Supportive	10.1186/scrt506	Mukherjee, Shravanti	2014
818	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, T47D, MDA-MB-231	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	RNA profile, Hipoxia, PKH26, anoikis	High	Yes	Direct	10.1016/j.stemcr.2015.12.006	Akrap, Nina	2016
819	BC	BC	Cancer Initiation and Development	In vitro	Cells/Ex vivo	Immortalised cells	MCF10A.NeuT, MCF10A / BC	Culture	3D	Spheroids	Organ slice	Disease mechanism (exp./theor.)	ErbB2, viability, apical-basal polarity, DLG1, ezrin–radixin–moesin, EMT	Low	Yes	Direct	10.1080/15384101.2018.1511510	Li, Song	2018
820	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MCF10	Culture	2.5D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	morphology, viability, invasion, migration, PI3K, RAC1	Low	Yes	Direct	10.1007/s12195-016-0468-1	Stowers, Ryan S.	2017
826	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	hTERT-HME1, HME, MCF10A, MCF7, DCIS.com, Hs578T	Culture	2D	n/a	n/a	Drug develop./testing	VDR, CYP24A1, gene expression	Low	Yes	Supportive	10.1016/j.jsbmb.2014.09.014	Beaudin, Sarah G.	2015
827	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7R	Culture	2D	n/a	n/a	Drug develop./testing	apoptosis, caspase activities, DNA fragmentation, intracellular reactive oxygen species, human topoisomerase I, invasion, cytotoxicity	Low	Yes	Direct	10.1016/j.jinorgbio.2015.06.009	Tan, Yee Seng	2015
828	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	miR-3646, proliferation, migration, invasion, cell-cycle, CDK1/CDC2, cyclin B1, p21Waf1/Cip1, p27 Kip1, p53	Medium	Yes	Supportive	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859896/	Tao, S	2016
829	BC	BC	Metastasis	In vitro	Cells	Immortalised cells/Stem-cell like	MCF10A-Tr, MCF10-A	Culture	2.5D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	SURVIVIN, WNT/β-CATENIN pathway, quiescience exit, EMT	Low	Yes	Direct	10.1007/s10585-016-9809-7	Siddharth, Sumit	2016
830	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7	Culture	3D	Spheroids	n/a	Drug develop./testing	Glucosamine, ALDH, STAT3, CD44, CD24, IL-6, 	Low	Yes	Direct	10.3892/ol.2018.9222	Hosea, Rendy	2018
831	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	T47D, MCF7, ERBB2, BT474, MDA-MB-231	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	genome-wide RNA profile	Low	Yes	Direct	https://europepmc.org/article/med/26537079	Murat Dogan, S	2015
833	BC	BC	Cancer Initiation and Development	In vitro	Ex vivo	n/a	n/a	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	CD44, CD24, correlation, telomerase activity, proliferation, invasion, EMT	Low	Yes	Direct	10.4137/CPath.Ss19615	Jaafar Makki	2014
834	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-468, HCC1806, MCF7	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	mir-142-3p, Bod1, KLF4,  Oct4 in sorted CD44, CD24, β-catenin, WNT, colony formation assay	High	Yes	Direct	10.1177/1010428318791887	Troschel, Fabian M	2018
835	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB157 , MDA-MB-468, MCF10	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	ALDH1, GLO, viability	Medium	Yes	Direct	10.18632/oncotarget.26369	Shoma Tamori	2018
838	BC	BC	Cancer Initiation and Development; Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	morphology, CD44, CD24, ALDH, proliferation, migration,  invasion, miR profile, cytotoxicity	Medium	Yes	Direct	10.7150/ijbs.12777	Boo, Lily	2016
841	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells/Stem-cell like	MDA‑MB‑231, SK-BR-3	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	Rab27A, cytotoxicity, CD44, CD24	Low	Yes	Direct	10.3892/ol.2017.6542	Feng, Feixue	2017
842	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7, MDA-MB-468	Culture	2.5D/3D	Spheroids	n/a	Drug develop./testing	Oct4, Sox2, Nanog, CD44, cytotoxicity, EMT	Medium	Yes	Direct	10.1080/15384101.2016.1241929	Zhang, Le	2017
843	BC	BC	Cancer Initiation and Development	In vitro	Ex vivo	n/a	BC	n/a	n/a	n/a	Biopsies Organ slice	Disease mechanism (exp./theor.)	CD44, ALDH, Ki67	Low	Yes	Direct	10.21873/anticanres.11013	Paula, Arnaud Da Cruz	2016
844	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7	Culture	3D	Spheroids	n/a	Model/method develop.(exp.)	HPI/AMF, CD44, ALDH1A3, Oct 3/4, proliferation, migration, invasion, CD44, ALDH1A, p38 MAPK, Oct3/4, wnt/β-catenin, SNAIL, MMP-1, vimentin, EMT	Low	Yes	Direct	10.1016/j.bbamcr.2017.06.015	Gallardo-Perez, Juan Carlos	2017
845	BC	BC	Cancer Initiation and Development; Immunology	In vitro	Cells	Immortalised cells	MDA-MB-231	Co-culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	RNA profile, angiogenesis, IP10, CCL22, PDL1, PDL2, VCAM-1, CD206	Low	Yes	Supportive	10.1371/journal.pntd.0006404	Narasimhan, Prakash Babu	2018
846	IBC	IBC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	SUM149, SUM190, MDA-IBC3 (generated de novo), PCMB	Co-culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	IL-4, IL-13, STAT6, cytotoxicity	Low	Yes	Direct	10.1016/j.ijrobp.2017.11.043	Rahal, Omar M.	2018
847	BC	BC	Cancer Initiation and Development; Angiogenesis	In vitro	Cells	Immortalised cells	SUM149, MDA-MB-231	Culture	2D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	TAFI, endothelial cell proliferation, cell invasion, cell migration, tube formation, collagen degradation	Medium	Yes	Direct	10.1007/s10585-017-9837-y	Bazzi, Zainab A.	2017
848	BC	BC	Metastasis	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2D	n/a	n/a	Model/method develop.(exp.)	proportion of tumor cells entering dormancy	Low	Yes	Direct	10.1039/c6lc01171c	Clark, A. M.	2017
849	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	HMT-3522, S1, T4-2, MCF10A	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	ROS, monocyte infiltration, morphology, RAC1, NF-κB activity, 	Low	Yes	Direct	10.1242/jcs.186031	Li, Linzhang	2017
851	BC	BC	Microenvironment-Tumor Interactions	In vitro	Ex vivo	n/a	BC	n/a	n/a	n/a	Organ slice	Disease mechanism (exp./theor.)	Beclin-1, invasion, correlation, IL-1, DD2R, IL-10RB, genome-wide profile 	Low	Yes	Direct	10.1371/journal.pone.0125762	Morikawa, Akemi	2015
852	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells/Ex vivo	Immortalised cells	MDA-MB-231, human macrophages	Co-culture	2D	n/a	Biopsies	Disease mechanism (exp./theor.)	lactic acid, CCL5 in human macrophages, Notch signaling, TGF-β signaling, aerobic glicolysis, AMPK signaling, EMT	Low	Yes	Direct	10.18632/oncotarget.22786	Lin, Sensen	2017
853	BC	BC	Cancer Initiation and Development; Angiogenesis	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231, T47-D	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	ADAM12, VEGF, MMP-9, EGFR, STAT3, Akt, tube formation	Medium	Yes	Direct	10.1158/1541-7786.MCR-17-0188	Roy, Roopali	2017
854	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	T47D, MCF7	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	prolactin, ERK1/2 and FAK, STAT5	Low	Yes	Direct	10.18632/oncotarget.10137	Barcus, Craig E.	2016
855	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231-TXSA	Culture	2.5D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	cytotoxicity	Medium	Yes	Direct	10.1021/acs.biomac.6b00786	Kumeria, Tushar	2016
856	BC	BC	Cancer Initiation and Development	In vitro	Ex vivo	n/a	BC	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	TWIST, iNOS	Low	Yes	Direct	10.1007/s11010-015-2606-9	Ranganathan, Santhalakshmi	2016
857	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF‐7, SKBR‐3, MDA‐MB‐468, MDA‐MB‐231, Hs578T, T47D	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	COX‐2, EP4, PI3K, AKT, NOTCH, WNT, correlation, viability, EMT	Low	Yes	Supportive	10.1002/stem.2426	Majumder, Mousumi	2016
858	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells/Stem-cell like	SK-BR-3, T47-D, ZR-75-1, ZR-75-30, BT20, BT549, MDA-MB-231, MDA-MB-453, MDA-MB-468, HCC1143 , HS-578T	Culture	3D	Spheroids	n/a	Drug develop./testing	mTOR, MnSOD and Akt, cytotoxicity	Low	Yes	Direct	10.3892/ijmm.2015.2441	Lai, Yuanhui	2016
859	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7	Culture	3D	Spheroids	n/a	Drug develop./testing	cell proliferation ,CD44, CD24, RNA profile, BRCA1, BRCA2, p15, p16, p53,  PTEN, cytotoxicity	High	Yes	Direct	10.2147/OTT.S96291	Nhan Lu-Chinh Phan	2016
860	BC	BC	Cancer Initiation and Development; Angiogenesis	In vitro	Cells	Immortalised cells	MDA-MB-231, MDA-MB-468, MDA-MB-361, MDA-MB-436, BT474, T47D, MCF7	Culture	2.5D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	WSB-1, MMP proteins, VEGF, angiogenic potential	Medium	Yes	Direct	10.1038/s41416-018-0056-3	Poujade, Flore-Anne	2018
863	BC	BC	Cancer Initiation and Development	In vitro	Cells/Cell free	Immortalised cells	MCF7, MDA-MB-231, BC	Culture	3D	Spheroids	Biopsies	Disease mechanism (exp./theor.)	six2, RNA profile, CYP4Z1, CYP4Z2P, PI3K/Akt and ERK1/2 pathways, ceRNET_CC	Low	Yes	Supportive	10.1186/s13045-019-0697-6	Zheng, Lufeng	2019
864	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7 , MDA-MB-231	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	miR-140-5p, proliferation, WNT1, viability, proliferation	Low	Yes	Supportive	10.1038/s41417-018-0035-0	Wu, Dawei	2018
865	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA‐MB‐231, T‐47D,	Culture	2.5D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	β1 integrin, fascin, cell adhesion, colony formation, RNA profile,	Medium	Yes	Direct	10.1002/ijc.32183	Barnawi, Rayanah	2019
866	BC	BC	Pharmacological/Physical Treatment	In vitro/In silico	Cells/Algorithms	Immortalised cells	T47D	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity, cell proliferation	Low	Yes	Direct	10.1016/j.tiv.2017.08.017	Schlotz, Nina	2017
867	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	JIMT-1, HCC1937	Culture	3D	Spheroids	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.1021/cb5002153	Huang, Xiaoli	2014
868	BC	BC	Cancer Initiation and Development	In vitro	Cells	Primary cell culture	BC	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	ER, PR, HER2, allele frequences, CD44, CD24, ALDH, DNA profile	High	Yes	Direct	10.1186/bcr3687	Klevebring, Daniel	2014
869	BC	BC	Metastasis	In vitro	Cells	Immortalised cells/Primary cell culture/Stem cells	MDA-MB-231	Culture	2.5D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	TAZ, cell proliferation, morphology, migration, invasion	Low	Yes	Direct	10.1038/onc.2014.5	Bartucci, M.	2015
870	BC	BC	Cancer stem cells	In vitro	Cells	Immortalised cells/Stem-cell like	MDA‐MB‐231, T‐47D	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	PD-L1, NANOG, OCT4, PI3K/AKT pathway	High	Yes	Supportive	10.1002/stem.2473	Barnawi, Rayanah	2016
871	BC	BC	Cancer stem cells	In vitro	Cells	Immortalised cells/Stem-cell like	MDA‐MB‐231, T‐47D	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	PD-L1, OCT4, NANOG, AKT, RNA profile, protein profile, EMT	Low	Yes	Supportive	10.1002/ijc.30834	Almozyan, Sheema	2017
872	BC	BC	Microenvironment-Tumor Interactions; Angiogenesis	In vitro	Cells	Immortalised cells	SKBR3, MDA-MB-468, HL60,U937	Co-culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	ID4, macrophage migration, tube formation, correlation, miR-10, granulin (GRN)	Low	Yes	Direct	10.1186/s13058-018-0990-2	Donzelli, Sara	2018
873	BC	BC	Metastasis	In vitro	Cells	Immortalised cells	MDA-MB-231, HTB-126, SUM149, MCF10A, MCF10CA1a	Culture	2D/3D	Spheroids	n/a	Disease mechanism (exp./theor.); Drug develop./testing	CPB2 (TAFI) and THBD, cell invasion, migration, collagen proteolysis	Low	Yes	Direct	10.1186/s12885-016-2359-1	Bazzi, Zainab A.	2016
874	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231, MCF7, SUM159	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity, NOTCH2	Low	Yes	Direct	10.1007/s10549-014-3059-7	Sehrawat, Anuradha	2014
875	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.1016/j.bmcl.2016.03.071	Buduma, Komuraiah	2016
876	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Supportive	10.3390/molecules21060762	Eldehna, Wagdy M.	2016
877	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-453	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Supportive	10.2174/1871520616666161207155634	Zmejkovski, Bojana B.	2017
878	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.1002/asia.201700049	Parveen, Rumana	2017
880	BC	BC	Anti-cancer drug delivery system	In vitro	Cells	Immortalised cells	MCF‐7	Culture	2.5D	n/a	n/a	Model/method develop.(exp.)	cytotoxicity	Low	Yes	Direct	10.1002/mame.201700243	Noteborn, Willem E. M.	2017
881	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF‐7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Supportive	10.1016/j.ejmech.2014.12.010	Eldehna, Wagdy M.	2015
882	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	SUM149, MDA-MB-231Br, MDA-MB-468, MDA-MB-436	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Supportive	10.1093/neuonc/nox052	Van Swearingen, Amanda E. D.	2017
885	BC	BC	Metastasis	In vitro/In silico	Cell free/Computational	n/a	BC	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	DNA profile	Low	Yes	Supportive	10.1126/science.aat7171	Reiter, Johannes G.	2018
886	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	BT549, HCC1395, Hs578T, MDAKB2	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.); Drug develop./testing	FRK, Friend of GATA 1	Low	Yes	Supportive	10.18632/oncotarget.14546	Bagu, Edward T.	2017
888	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231	Culture	2.5D	n/a	n/a	Drug develop./testing	Apoptosis, PI3K/Akt/mTOR Signaling Pathway,PDK, D1, Bcl-2, survivin, VEGF, procaspase-3, PARP, cytotoxicity, CXCL12 AKT2	Low	Yes	Direct	10.1371/journal.pone.0153155	Mohan, Chakrabhavi Dhananjaya	2016
889	BC	BC	Tumor Detection and Classification; Patient Stratification	In silico	Algorithms	n/a	n/a	n/a	n/a	n/a	n/a	Disease mechanism (exp./theor.)	glutamate carboxypeptidase II, correlation	Low	Yes	Direct	10.1016/j.cancergen.2015.09.001	Naushad, Shaik Mohammad	2015
891	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, HS578T, MCF10A	Culture	2D	n/a	n/a	Model/method develop.(theor.)	RNA profile	Low	Yes	Direct	10.1186/s12859-017-1925-0	Castillo, Daniel	2017
892	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Supportive	10.1016/j.saa.2014.09.053	Tabrizi, Leila	2015
895	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	SK-BR-3, MCF7, MDA-MB-453, T47D, HCC1954,SUM149	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	mir-100, Cyclin B, CDK, apoptosis, p27, BAX, BCL-2, MTMR3, cell proliferation	Medium	Yes	Supportive	10.1038/srep11650	Gong, Yi	2015
896	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	BT20	Culture	2D	n/a	n/a	Drug develop./testing	Topoisomerase I activity, cytotoxicity	Low	Yes	Direct	10.1016/j.ejmech.2016.03.031	Alonso, Concepcion	2016
897	BC	BC	Anti-cancer drug delivery system	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity, drug uptake	Medium	Yes	Direct	10.1177/0885328218783969	Su, Hongying	2018
899	BC	BC	Tumor Detection and Classification	In silico	Computational	n/a	n/a	n/a	n/a	n/a	n/a	Model/method develop.(theor.)	Rayleigh to Compton scattering ratio (R/C) 	Low	Yes	Direct	10.1016/j.radphyschem.2012.12.048	Antoniassi, M.	2014
900	BC	BC	Tumor Detection and Classification	In silico	Computational	n/a	n/a	n/a	n/a	n/a	n/a	Model/method develop.(theor.)	Rayleigh to Compton scattering ratio (R/C) 	Low	Yes	Direct	10.1016/j.radphyschem.2018.06.011	Antoniassi, M.	2019
902	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, T47D	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	PARP1-NuA4, DNA damage	Low	Yes	Direct	10.1016/j.celrep.2014.08.009	Krukenberg, Kristin A.	2014
903	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2.5D	n/a	n/a	Drug develop./testing; Model/method develop. (exp.)	cytotoxicity, migration	Low	Yes	Direct	10.1098/rsif.2014.0638	Sun, Wei	2014
904	BC	BC	Immunosensor	In vitro	Cell free	n/a	SK-BR-3, MCF7, MDA-MB-436	n/a	n/a	n/a	n/a	Model/method develop.(exp.)	ErbB2	Low	Yes	Direct	10.1016/j.aca.2015.12.020	Eletxigerra, Unai	2016
905	BC	BC	Tumor Detection and Classification	In silico	Mathematical	n/a	n/a	n/a	n/a	n/a	n/a	Model/method develop.(exp.)	nomogram, correlation	Low	Yes	Direct	http://journal.waocp.org/article_28775_11db3a3f5add2b90c0e8052e18082a11.pdf	Koca, Bulent	2014
907	BC	BC	Metastasis	In vitro	Cells	Immortalised cells	MDA-MB-231, MCF7	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	C11, FGFR1, migration, invasion, angiogenesis, FGFR1, MMP2, MMP9	Low	Yes	Supportive	10.1038/s41401-018-0191-7	Boo, Lily	2018
908	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2.5D	n/a	n/a	Model/method develop.(exp.)	cell adhesion, protein synthesis, VEGF, MMP2, MMP9, secreted FN	Low	Yes	Direct	10.3233/CH-168040	Feng, Feixue	2016
909	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.4103/pm.pm_136_17	Zhang, Le	2017
910	BC	BC	Tumor Detection and Classification	In silico	Algorithms	n/a	n/a	n/a	n/a	n/a	n/a	Model/method develop.(theor.)	grayscale morphologic features, Doppler features	Low	Yes	Direct	10.1109/ULTSYM.2018.8579953	Paula, Arnaud Da Cruz	2018
913	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells/Stem-cell like	SKBR3 , BT474	Culture	2.5D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	CD44, cytotoxicity, RNA profile	Medium	Yes	Direct	10.1007/s10549-015-3414-3	Gallardo-Perez, Juan Carlos	2015
914	BC	BC	Cancer stem cells	In vitro	Cells	Immortalised cells	MCF7, T47D	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	Let-7c, WNT signaling pathway, ERα, ALDH1, colony formation, viability	Low	Yes	Supportive	10.1038/cgt.2016.3	Narasimhan, Prakash Babu	2016
915	BC	BC	Pharmacological/Physical Treatment; Cancer Stem Cells	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7	Culture	3D	Spheroids	n/a	Drug develop./testing	cytotoxicity, Nrf2, ROS, CD44, CD24	Low	Yes	Direct	10.3390/nu9070760	Rahal, Omar M.	2017
916	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells/Stem-cell like	SUM149	Culture	2D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	RBBP4/7, BCL11, H3, PRC2, NuRD,  SIN3A, ALDH	Low	Yes	Direct	10.1074/jbc.M117.811463	Bazzi, Zainab A.	2018
917	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7, MDA-MB-231	Culture	3D	Spheroids	n/a	Drug develop./testing	A2B adenosine receptor, ERK1/2, apoptosis, Bax, Bcl-2, cyclin-D1, CDK-4, cell-cycle	Low	Yes	Direct	10.1007/s13402-017-0359-z	Clark, A. M.	2018
918	BC	BC	Pharmacological/Physical Treatment; Cancer Stem Cells	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7	Culture	3D	Spheroids	n/a	Drug develop./testing	apoptosis, caspase 3/7 activity,  annexin-V, CD44, CD24	Low	Yes	Direct	10.1016/j.cbi.2017.12.003	Li, Linzhang	2018
919	BC	BC	Pharmacological/Physical Treatment; Cancer Stem Cells	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7, MDA-MB-231	Culture	3D	Spheroids	n/a	Drug develop./testing	c-Myc, CD44, SOX2,  OCT4, ALDH, CD24, cytotoxicity, colony formation	Low	Yes	Direct	10.3390/ijms19092528	Morikawa, Akemi	2018
922	BC	BC	Immunotherapy	In vitro	Cells	Immortalised cells	T47-D, ZR-75-1, SK-BR-3, MCF7, BT474, HCC38, MDA-MB-468, MDA-MB-231, MCF12A	Co-culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	T Helper Responses, PD-1 Ligands, CD4, CD25, CD127, Treg, secrete IL-2	Low	Yes	Supportive	10.1007/s10549-014-2984-9	Lin, Sensen	2014
923	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	exosomes, Wnt signaling pathway, miRNA profile	Low	Yes	Direct	10.1007/s13277-015-4402-2	Roy, Roopali	2016
924	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-23, Hs578t, GP2-293, T-47D	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	Cell Adhesion, Cell Migration, invasion, phosphatidylinositol 4-kinase IIIβ, PI(4)P	Low	Yes	Direct	10.1158/0008-5472.CAN-13-2441	Barcus, Craig E.	2014
926	BC	BC	Metastasis	In vitro	Ex vivo	n/a	liquid biopsy	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.); Model/method develop. (exp.)	plasma extracellular vesicle, proliferation, invasion migration, LB, A2M, CD9, ACTB, HSP70, 	Low	Yes	Direct	10.1080/20013078.2018.1458574	Kumeria, Tushar	2018
927	IBC/BC	IBC/BC	Cancer Initiation and Development	In vitro	Ex vivo	n/a	IBC, BC	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	incidence of human papillomavirus types 16 and 18 (HPV-16 and -18), human cytomegalovirus (HCMV), Epstein–Barr virus, human herpes simplex virus type 1 and 2,  human herpes virus type 8 (HHV-8), proliferation, Ki67	Low	Yes	Direct	10.1245/s10434-015-4888-2	Ranganathan, Santhalakshmi	2016
928	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity, apoptosis	Low	Yes	Direct	10.3390/molecules21101366	Majumder, Mousumi	2016
929	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells/Stem-cell like	HCC1806, HCC1937, MCF7	Culture	3D	Spheroids	n/a	Drug develop./testing	cytotoxicity, NANOG, STAT3 	Low	Yes	Direct	10.1016/j.biopha.2018.04.076	Lai, Yuanhui	2018
930	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells/Stem-cell like	MDA-MB-231, MCF7	Culture	3D	Spheroids	n/a	Drug develop./testing	cytotoxicity, proliferation assay and alkaline phosphatase, CD44, CD24	Low	Yes	Direct	10.4314/tjpr.v17i9.21	Nhan Lu-Chinh Phan	2018
931	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Medium	Yes	Direct	10.1021/acs.molpharmaceut.8b00367	Poujade, Flore-Anne	2018
932	BC	BC	Cancer Initiation and Development; Cancer Stem Cells	In vitro	Cells	Immortalised cells	MDA-MB-231,MDA-MB-468, SUM149, SUM159	Co-culture	3D	Scaffolds	n/a	Disease mechanism (exp./theor.)	CD44, migration, proliferation, OPN, SELL, ALDH	Low	Yes	Supportive	10.1593/neo.132076	Zheng, Lufeng	2014
934	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF10A derivatives (MCF10A, T1K , Ca1h)MDA-MB-231, MDA-MB-361, ZR-75-1, T47D, T47D-C42W, BT549	Culture	3D	Organoids	n/a	Disease mechanism (exp./theor.)	growth factor β1, E-Cadherin, TGF-β1, FGFR1, EMT	Medium	Yes	Supportive	10.1186/bcr3623	Wu, Dawei	2014
935	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF10A ER-Src, CAMA-1	Culture	3D	Spheroids	n/a	Drug develop./testing	cytotoxicity, metabolic profile	Low	Yes	Direct	10.1073/pnas.1409844111	Barnawi, Rayanah	2014
936	BC	BC	Pharmacological/Physical Treatment; Cancer Stem Cells	In vitro	Cells	Immortalised cells	BC	Culture	3D	Spheroids	n/a	Drug develop./testing	cytotoxicity, ALDH1A1, CXCR4, MUC1, EpCAM, proliferation,  invasiveness, viability	Low	Yes	Direct	10.12659/MSM.908022	Schlotz, Nina	2018
938	BC	BC	Cancer Initiation and Development; Pharmacological/Physical Treatment	In vitro	Cells	Primary cell culture	HCC1937, HCC1954	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	miR-205-5p ErbB/HER, EGFR ZEB1, cytotoxicity, P63	Low	Yes	Direct	10.1038/cddis.2015.192	Huang, Xiaoli	2015
940	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	HCC1569, HCC1954, HER2, BT474, SKBR3	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	p63, EGF, SCR, HAS3, Cd44, correlation	Low	Yes	Direct	10.1038/s41389-018-0073-3	Klevebring, Daniel	2018
948	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF‐7, MDA‐MB‐231, T47‐D, SKBR‐3	Culture	3D	Spheroids	n/a	Drug develop./testing	Cytokeratin (CK) 5/6, CK14,  epidermal growth factor receptor (EGFR), correlation, viability, colony formation, AKT	Low	Yes	Supportive	10.1016/j.clbc.2015.06.001	Bartucci, M.	2015
949	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells/Stem-cell like	BC	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	miR‐10b, PTEN, AKT, morphology, CD44, PIK3CA, correlation, EMT	Low	Yes	Supportive	10.15252/embr.201540678	Barnawi, Rayanah	2016
953	BC	BC	Cancer Initiation and Development	In vitro	Ex vivo	n/a	BC, NK-cells	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	RNA profile, CA12	High	Yes	Direct	10.1007/s13277-016-5351-0	Almozyan, Sheema	2016
954	BC	BC	Immunotherapy	In vitro	Cells	Primary cell culture	MDA-MB-231	Co-culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity, proinflammatory cytokines, interferon-γ,  tumor necrosis factor-α	Low	Yes	Supportive	10.1097/CJI.0000000000000192	Donzelli, Sara	2018
957	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MDA-MB-231, T47D, MCF7	Culture	2.5D	n/a	n/a	Model/method develop.(exp.)	metabolic activity, proliferation	Low	Yes	Direct	10.1016/j.biomaterials.2018.04.046	Bazzi, Zainab A.	2018
958	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Primary cell culture	BC	Culture	2D	n/a	n/a	Drug develop./testing	RNA profile	Low	Yes	Direct	10.21873/anticanres.12512	Sehrawat, Anuradha	2018
959	BC	BC	Cancer Initiation and Development; Angiogenesis	In vitro	Cells	Immortalised cells	MCF7	Culture	2D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	CD44, ERK, HIF, MAPK, PH3, TIMP-2, MT1/2-MMP, viability, tumor vascolarization, migration	Low	Yes	Supportive	10.1016/j.yexcr.2016.11.019	Buduma, Komuraiah	2017
961	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-321, SK-BR-3, CCD-1126Sk	Culture	2D	n/a	n/a	Model/method develop.(exp.)	IR absorbance, lipid and phosphate change	Low	Yes	Direct	10.1371/journal.pone.0111137	Eldehna, Wagdy M.	2014
962	BC	BC	Angiogenesis	In vitro	Cells	Immortalised cells	MCF7, MDA-453, MDA-231,HUVECs	Co-culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	tube formation, β2-AR-PKA-mTOR pathway, VEGF, Notch, Jagged 1	Low	Yes	Supportive	10.1530/ERC-14-0236	Zmejkovski, Bojana B.	2014
964	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231, MCF7	Culture	2.5D	n/a	n/a	Drug develop./testing	viability, CDH1, YAP cytotoxicity	Low	Yes	Direct	10.3389/fonc.2018.00337	Parveen, Rumana	2018
965	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7, SUM149	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	SURVIVIN, BIRC5, correlation, cleaved Caspase 3, colony formation	Low	Yes	Direct	10.1371/journal.pone.0120719	Noteborn, Willem E. M.	2015
966	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MCF7, MDA-231, SKBR3, SUM102, ZR75B,BT474, fibroblast	Co-culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	EMMPRIN, miR-106a/b, STAT3 and HIF-1α, 	Low	Yes	Direct	10.1038/srep28329	Eldehna, Wagdy M.	2016
967	BC	BC	Cancer Initiation and Development	In vitro	Cells/Cell free	Immortalised cells	SUM159PT, MCF10DCIS.com	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	PDI, ERp44, or ERp57, colony formation, viability	Low	Yes	Supportive	10.1007/s10549-016-3820-1	Van Swearingen, Amanda E. D.	2016
968	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	SKBR3	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	Darpp, SURVIVIN, BIM, cytotoxicity	Medium	Yes	Direct	10.18632/oncotarget.5311	Reiter, Johannes G.	2015
969	BC	BC	Metastasis	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231, ZR-75-30	Culture	2D/3D	Spheroids	n/a	Drug develop./testing	invasion, cell adhesion, IL-1α, IL-6, IL-8,  TNF-α, MMP-1, TIMP-1, TIMP-2	Low	Yes	Direct	10.1080/15384047.2016.1195047	Bagu, Edward T.	2016
970	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Primary cell culture	BC	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	TGFBR3, secreted cytokines	Low	Yes	Direct	10.3390/cancers8110100	Mohan, Chakrabhavi Dhananjaya	2016
972	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	PL45, MDA-MB-231, MDA-MB-468, BT20, MCF7, MCF10A	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	BRCA2, miR-19a and miR-19b, miR-17/92	Low	Yes	Direct	10.3389/fgene.2016.00143	Naushad, Shaik Mohammad	2016
974	BC	BC	Tumor Detection and Classification	In vitro	Ex vivo	n/a	n/a	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	SOX10, GATA3, GCDFP15, rogen receptor,  mammaglobin	Low	Yes	Direct	10.1097/PAS.0000000000001216	Castillo, Daniel	2019
978	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.3390/molecules23061459	Tabrizi, Leila	2018
981	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	Wt-MCF7, wt-HCC1428, wt-ZR75.1, wt-SUM44	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	ESR1	Low	Yes	Supportive	10.1038/s41467-017-01864-y	Gong, Yi	2017
982	BC	BC	Drug Discovery and/or Testing	In silico	Mathematical	n/a	n/a	n/a	n/a	n/a	n/a	Model/method develop.(theor.)	ADMET Profile 	Low	Yes	Direct	10.7314/APJCP.2016.17.4.2291	Alonso, Concepcion	2016
983	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF10, BT474, MCF7, T47D, HCC1428, MDA-MB-453, SKBR3, MDA-MB-231, HCC70	Culture	3D	Spheroids	n/a	Drug develop./testing	HOXA6, A13, B2, B4, B5, B6, B7, B8, B9, C5, C9, C13, D1,  D8, viability, cell proliferation	Medium	Yes	Supportive	10.1007/s12033-013-9682-4	Su, Hongying	2014
985	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231, MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity, regulation of Bcl-2, apoptosis, caspase-3 	Medium	Yes	Direct	10.3390/molecules23061420	Antoniassi, M.	2018
987	BC	BC	Tumor Detection and Classification	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing; Diagnosis of disease; Model/method develop. (exp.)	MUC1	Low	Yes	Direct	10.1016/j.snb.2014.04.040	Antoniassi, M.	2014
988	BC	BC	Tumor Detection and Classification	In vitro	Cells	Immortalised cells	MDA-MB-231, MCF7	Culture	2D	n/a	n/a	Drug develop./testing; Diagnosis of disease; Model/method develop. (exp.)	VEGF	Low	Yes	Direct	10.1016/j.aca.2017.10.033	Krukenberg, Kristin A.	2018
990	BC	BC	Pharmacological/Physical Treatment	In silico	Computational	n/a	n/a	n/a	n/a	n/a	n/a	Disease mechanism (exp./theor.)	Trastuzumab/HER2 complexes	Low	Yes	Direct	10.3390/ijms20051076	Sun, Wei	2019
991	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7, MCF7/VP16, BT474, T47D, ZR-75-1, SKBR3, MDA-MB-468, MCF10A, BT20 , MDA-MB-231	Culture	2D	n/a	n/a	Drug develop./testing	CYP1, ANI-7, AhR, ARNT, cytotoxicity	Medium	Yes	Direct	10.1124/mol.117.109827	Eletxigerra, Unai	2018
995	BC	BC	Cancer Initiation and Development	In vitro	Cells	Primary cell culture	BC	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	ARID3B, ERBB2, ERα, EMT	Low	Yes	Direct	10.1007/s13402-014-0185-5	Erdogan, Ayse Selcen Oguz	2014
996	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7 , MDA-MB-468	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.1016/j.bmc.2013.12.029	Yoon, Yeong Keng	2014
997	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	BM-468, ZR-75-1	Culture	2D	n/a	n/a	Drug develop./testing	proliferation, apoptosis	Low	Yes	Direct	10.3109/15368378.2013.800104	Loja, Tomas	2014
999	BC	BC	Circulating Cancer Cells/DNA Identification and Profiling	In vitro	Cells	Immortalised cells	SKBR3, MDA-MB-453, T47D, MCF7, BT474, ZR-75-1, SUM149, SUM190, MDA-MB-231, Hs578T	Culture	2D	n/a	n/a	Model/method develop.(exp.)	EpCAM, HER2, CD45, CD31, cancer cells recovery rates, RNA profile	Low	Yes	Direct	10.18632/oncotarget.5977	Ring, Alexander	2015
1001	BC	BC	Patient stratification	In vitro	Ex vivo	n/a	n/a	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	ccf-DNA concentration, correlation	Low	Yes	Direct	https://rjpbcs.com/pdf/2017_8(4)/[138].pdf	Gavel, R	2017
1002	BC	BC	Tumor Detection and Classification	In vitro	Cell free	n/a	liquid biopsy	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	Methylation Profile, correlation	Low	Yes	Direct	10.1093/annonc/mdy119	Liu, L.	2018
1003	BC	BC	Cancer Initiation and Development	In vitro	Ex vivo	n/a	BC	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.); Model/method develop. (exp.)	oestrogen receptor-α, progesterone receptor-b, viability, correlation	Low	Yes	Direct	10.1038/s41416-018-0331-3	Snell, Cameron E.	2018
1009	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	SUM44	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	cytotoxicity, MAPK, GRM/mGluR, ESRRG (ERRgamma)	Low	Yes	Direct	10.1016/j.mce.2017.09.024	Stires, Hillary	2018
1011	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity, SQSTM1/p62, cell proliferation, morphology	Medium	Yes	Direct	10.3892/or.2018.6615	Alsamman, Khaldoon	2018
1012	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231, EVSA-T	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	TGF-β, TAK-1, NF-κB, p65 TNF-α, RIPK1	Low	Yes	Direct	10.1515/hsz-2018-0324	Schmidt, Nadine	2019
1013	BC	BC	Cancer Initiation and Development	In silico	Algorithms	n/a	n/a	n/a	n/a	n/a	n/a	Model/method develop.(theor.)	RNA profile, AGTR2, ZNF132, TFDP3 	Low	Yes	Direct	10.1016/j.compbiolchem.2015.08.007	Tovar, Hugo	2015
1016	BC	BC	Cancer Initiation and Development; Immunotherapy	In vitro	Cells	Primary cell culture	T Lymphocytes	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	HLA-DR, IFN-γ (F), IL-10, CD4	Medium	Yes	Direct	10.3389/fimmu.2018.02605	Saraiva, Diana P.	2018
1023	BC	BC	Metastasis	In vitro	Ex vivo	n/a	liquid biopsy	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	MMP-2, MMP-9, VEGF	Low	Yes	Direct	10.5507/bp.2017.022	Skerenova, Marketa	2017
1024	BC	BC	Cancer Initiation and Development; Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	A431, HCC-1937, HCC-1954, MCF-10A,T47D 	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	S6, AKT, 4EBPI, BRCA-I, BRCA-II, PI3K, cytotoxicity	Low	Yes	Supportive	10.1038/s41467-018-07002-6	Giedt, Randy J.	2018
1025	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA‐MB‐231	Culture	3D	Spheroids	n/a	Drug develop./testing	mitochondrial ROS, colony formation	Low	Yes	Direct	10.1002/bit.26406	Davoodi, Pooya	2017
1027	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7/S0.5 (MCF7), MCF7/TAMR-1 (TAMR-1) , MCF7/182R-6 (182R-6)	Culture	2D	n/a	n/a	Drug develop./testing	genome-wide RNA profile, CCNA2, CCNB2, CDC20, PTTG1 and BAX, DNA double strand breaks	Low	Yes	Direct	10.18632/oncotarget.3188	Luzhna, Lidiya	2015
1031	BC	BC	Cancer Initiation and Development	In silico	Mathematical	n/a	n/a	n/a	n/a	n/a	n/a	Model/method develop.(theor.)	Ki67 score	Low	Yes	Direct	10.1038/modpathol.2015.38	Polley, Mei-Yin C.	2015
1032	BC	BC	Cancer Initiation and Development	In vitro	Ex vivo	n/a	n/a	n/a	n/a	n/a	Biopsies	Model/method develop.(exp.)	genome-wide RNA profile	Low	Yes	Direct	10.1016/j.molonc.2015.03.011	Foukakis, Theodoros	2015
1036	BC	BC	Cancer Initiation and Development	In vitro	Ex vivo	n/a	n/a	n/a	n/a	n/a	Liquid biopsies	Diagnosis of disease	genome-wide DNA profile	Low	Yes	Direct	10.1007/s10549-017-4176-x	Bingham, Catherine	2017
1039	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7, MCF7/C6	Culture	2.5D	n/a	n/a	Drug develop./testing	CD44, CD24, ALDH, OCT3/4 and NANOG, invasion, migration, proliferation, cytotoxicity	Low	Yes	Direct	10.1186/s12906-016-1088-y	Yan, Yunwen	2016
1042	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells/Stem-cell like	Human BCSCs (CD24−/CD44+)	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	HIF-1α, HIF-2α, Oct-4, ALDH1, KLF4,  c-MYC, SURVIVIN, proliferation, cell death	Low	Yes	Direct	10.1088/1742-6596/1073/3/032066	Sen, L.T.	2018
1044	BC	BC	Cancer Initiation and Development	In vitro	Cells	Primary cell culture/Stem cells	BC	Culture	2.5D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	morphology, proliferation, invasion, migration, CD24, D44, ALDH1	Low	Yes	Direct	10.3892/mmr.2016.5899	Shao, Jun	2016
1045	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	mitochondrial metabolism, glycolysis, ATP, cytotoxicity	Medium	Yes	Direct	10.18632/aging.101483	Bonuccelli, Gloria	2018
1046	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF‐7/LCC2, MCF‐7/LCC9	Culture	2D/2.5D	n/a	n/a	Drug develop./testing	cell invasion, cytotoxicity, AIB1 	Low	Yes	Direct	10.1111/1440-1681.12806	Manmuan, Suwisit	2017
1047	BC	BC	Pharmacological/Physical Treatment; Metastasis	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2D/3D	Scaffolds	n/a	Disease mechanism (exp./theor.)	cell migration, EGFR, cytotoxicity	Low	Yes	Direct	10.1371/journal.pone.0203040	Biswenger, Verena	2018
1049	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells/Stem-cell like	MDA-MB-231,MCF7	Co-culture	2D/3D	Spheroids	n/a	Drug develop./testing	E-cadherin, anti-inflammatory cytokines, VEGF, TGF-β, TNF-α, IFN-γ, IL-10, IL-6, IL-3β, Wnt/β-catenin signaling pathway, cytotoxicity, angiogenesis, EMT	Low	Yes	Direct	10.1016/j.biocel.2019.02.001	Mandal, Saurabh	2019
1052	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231 , SUM149	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	HIF-1a, HIF-2a, Lipin1, invasion, metastasis, metabolism and formation of lipid droplets	Low	Yes	Supportive	10.18632/oncotarget.4612	Shah, Tariq	2015
1053	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231 , MCF7 ,MDA-MB-361, MDA-MB-453,T47D	Culture	2.5D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	mDIA1, mDIA2, invasion, MT-MMP, MMP-2, CD44, CD133, MMP-9	Low	Yes	Direct	10.18632/oncotarget.7429	Kim, Daehwan	2016
1054	BC	BC	Cancer stem cells	In vitro	Cells	Immortalised cells/Stem-cell like	MDA-MB-231	Culture	3D	Spheroids	n/a	Model/method develop.(exp.)	 OCT4, nanog, SOX2, colony formation, CD44	Low	Yes	Direct	10.4067/S0717-95022016000400003	Ghanbari, Tara	2016
1055	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells/Stem-cell like	MDA-MB-231	Culture	2D/3D	Spheroids	n/a	Drug develop./testing	cytotoxicity, Stat3/IL‐6, CD24, CD44, ALDH1, OCT4, NANOG, SOX-2, colony formation, proliferation	Low	Yes	Direct	10.1002/mc.22870	Choi, Hack Sun	2018
1056	BC	BC	Angiogenesis	In vitro	Cells	Primary cell culture	BC, endothelial cells	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	CD44. CD24, CD105, CD31, p53, CD31 and VEGF	High	Yes	Direct	10.3892/ol.2017.7238	Wang, Yu	2017
1057	BC	BC	Cancer Initiation and Development; Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells/Stem-cell like	MDA-MB-231, SUM149	Culture	2D/3D	Spheroids	n/a	Drug develop./testing	RSK, cytotoxicity, YB-1, CD44, CD49, proliferation	Low	Yes	Direct	10.18632/oncotarget.4135	Davies, Alastair H.	2015
1060	BC	BC	Cancer Initiation and Development; Pharmacological/Physical Treatment	In vitro	Cells	Primary cell culture/Stem cells	BC	Culture	3D	Spheroids	n/a	Drug develop./testing	SLC34A2, Bmi1, ABCC5, cytotoxicity	High	Yes	Direct	10.1007/s13277-015-4226-0	Ge, Guanqun	2016
1061	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7-T47D	Culture	2D/3D	Spheroids	n/a	Drug develop./testing	ABCG2, ALDH1, colony formation, membrane permeability, apoptosis	Medium	Yes	Supportive	10.1042/BSR20171137	Guo, Lijuan	2017
1063	BC	BC	Pharmacological/Physical Treatment; Cancer Stem Cells	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	CD44, CD24, ALDH1, ESA, colony formation, BMI1, NOTCH4, KLF4	Low	Yes	Supportive	10.1158/1940-6207.CAPR-13-0445	Kim, Su-Hyeong	2014
1066	BC	BC	Pharmacological/Physical Treatment	In vitro/In silico	Cells/Algorithms	Immortalised cells	MDA-MB-231 , MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity, RNA profile	Medium	Yes	Direct	10.1080/1062936X.2015.1076516	Konova, V.	2015
1068	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	T‐47D, SK‐BR‐3, SUM1315MO2, MDA‐MB‐231	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	c-SRC, Vimentin, viability, colony formation, migration, invasion, AKT, Cyclin E, Cyclin D1, CDK4, EMT	Low	Yes	Supportive	10.1111/cas.13572	Lou, Longquan	2018
1069	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2.5D	n/a	n/a	Model/method develop.(exp.)	viability, cell adhesion, migration	Low	Yes	Direct	10.1021/acsami.8b15036	Marrella, A.	2018
1071	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	A549, MCF7, T-47D, SK-BR-3, ZR 75.1, BT474, MDA-MB-468	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	AGR2, mTOR, PI3K	Low	Yes	Supportive	10.1016/j.yexcr.2017.04.011	Matoulkova, Eva	2017
1072	BC	BC	Cancer Initiation and Development	In vitro	Ex vivo	n/a	BC	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	 ATM, CDH1, CHEK2, ESR1, GATA3, MAP3K1, MSH2, PALB2, RB1, STK11, mutation profile	Medium	Yes	Direct	10.1111/cge.13063	Xie, Y.	2018
1077	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Supportive	https://web.b.ebscohost.com/abstract?direct=true&profile=ehost&scope=site&authtype=crawler&jrnl=15551431&AN=113146998&h=qjUJWcgBVd3cJ2T8MZnMTqPwd5R9Tgyq%2bkA5U66Q1yJHL75h%2fPKrw%2fWwLejyxuHaJa%2bJ3k%2fwj0j02%2buUW0pduA%3d%3d&crl=c&resultNs=AdminWebAuth&resultLocal=ErrCrlNotAuth&crlhashurl=login.aspx%3fdirect%3dtrue%26profile%3dehost%26scope%3dsite%26authtype%3dcrawler%26jrnl%3d15551431%26AN%3d113146998	Bharti, V.	2015
1079	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	SUM159, MDA-MB-469	Culture	2D	n/a	n/a	Drug develop./testing	YM55, p38 MAPK, CHOP, DR5, cytotoxicity, ROS, apoptosis	Low	Yes	Supportive	10.1002/ijc.28993	Pennati, Marzia	2015
1080	BC	BC	Microenvironment-Tumor Interactions; Metastasis	In vitro	Cells/Ex vivo	Immortalised cells	MCF7 , MDA-MB-231, adipose cells	Co-culture	2.5D	n/a	Biopsies	Model/method develop.(exp.)	invasion	Low	Yes	Direct	10.1088/1758-5090/aa6bad	Vinson, Benjamin T.	2017
1081	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	SNX9, podosomes, TKS5m, invadopodia, MT1-MMP, Src	Low	Yes	Direct	10.1242/jcs.188045	Bendris, Nawal	2016
1082	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231 , SUM1315	Culture	2D/2.5D	n/a	n/a	Disease mechanism (exp./theor.)	ALG3, CCK8, HSF2, invasion, migration, cell proliferation, EMT	Low	Yes	Direct	10.12659/MSM.904124	He, Jing	2017
1083	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7 , MDA-MB-231	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	mir628, SOS, migration, invasion, CD4, CD24	Low	Yes	Direct	10.2147/OTT.S164575	Lin, Chenghui	2018
1084	BC	BC	Cell culture strategy	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7 , MDA-MB-231	Culture	3D	Spheroids	n/a	Model/method develop.(exp.)	morphology, YAP/TAZ	Low	Yes	Direct	10.1371/journal.pone.0132377	Jabbari, Esmaiel	2015
1085	BC	BC	Metastasis	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	CXCR4, LL-37, migration	Low	Yes	Supportive	10.1016/j.bbadis.2018.09.008	Pan, Wen Liang	2018
1086	BC	BC	Anti-cancer drug delivery system	In vitro	Ex vivo	n/a	n/a	n/a	n/a	n/a	Biopsies	Drug develop./testing	annexin-V, proliferation, cytotoxicity, 	Low	Yes	Direct	10.1155/2016/7549372	Markeb, Ahmed A.	2016
1092	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells/Ex vivo	Immortalised cells	T47D, MDA-MB-231, Human monocytes	Co-culture	2D	n/a	Biopsies	Disease mechanism (exp./theor.)	RNA profile, ICOS, IFNA2, TNF, TLR3, CXCL12, CCL5, CXCL9 and CSF2, inflammatory response, CXCL10, IL-R2A and IL-3, cell proliferation	Low	Yes	Direct	10.1038/srep09188	Hollmen, Maija	2015
1093	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.1016/j.cej.2017.07.165	Ardekani, Sara Madadi	2017
1094	BC	Claudin-low BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA‐MB‐231 , Hs578T	Culture	2.5D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	lncRNA HOTAIR, integrin α2 and SRC kinase, HOXC11, H3K4, BRD4	Low	Yes	Direct	10.1002/1878-0261.12133	Li, Miao	2017
1095	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF10A , MCF7	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	PP2A, ERK, proliferation	Low	Yes	Direct	10.1007/s10549-017-4403-5	Watt, Lauren F.	2017
1096	BC	BC	Immunotherapy	In vitro	Cells	Immortalised cells/Primary cell culture	SKBR3, PBMCs, T-Cells	Co-culture	2D	n/a	n/a	Disease therapy develop.	ERBB2, Apoptosis, CD69, CD25, IFN-γ	Medium	Yes	Direct	10.3390/ijms18091797	Munisvaradass, Rusheni	2017
1097	BC	BC	Tumor Detection and Classification	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Model/method develop.(exp.)	cell attachment to the hydrogel	Low	Yes	Direct	10.1021/acs.bioconjchem.7b00360	Karimi, Fatemeh	2017
1098	BC	BC	Metastasis	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	MT1-MMP, ERK1/2, MMP2, MMP9, migration, invasion	Low	Yes	Direct	10.1007/s12079-016-0373-3	Cepeda, Mario A.	2017
1099	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells/Ex vivo	Immortalised cells	T47D, CF-7,MDA-MB-231, human monocyte	Co-culture	3D	Spheroids	Biopsies	Disease mechanism (exp./theor.)	RANTES, CCL5, MCP-1, CCL2,  G-CSF, (IL)-1β and IL-8, MMP10, inflammatory secretion profile 	Low	Yes	Direct	10.3389/fimmu.2017.00205	Adriana Espinoza-Sanchez, Nancy	2017
1100	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MDA‐MB‐231	Culture	2.5D	n/a	n/a	Model/method develop.(exp.)	cell proliferation, cell invasion	Low	Yes	Direct	10.1002/adfm.201502778	Fisher, Stephanie A.	2015
1102	BC	BC	Cancer Initiation and Development	In vitro	Ex vivo	n/a	n/a	n/a	n/a	n/a	Biopsies	Model/method qualification	REV3 DNA Polymerase Zeta, OXPHOS, mitochondrial DNA Polymerase γ, mitochondrial DNA damage, migration, invasion	Low	Yes	Supportive	10.1371/journal.pone.0140409	Singh, Bhupendra	2015
1103	BC	BC	Metastasis	In vitro	Cells	Immortalised cells	low‐metastatic breast cancer cells DB‐7	Culture	2D/2.5D	n/a	n/a	Disease mechanism (exp./theor.)	NUMB6, SLUG, E-Cadherin, β‐catenin,  fibronectin, MMP9, migration, invasion, AKT, cytotoxicity, EMT	Low	Yes	Direct	10.1002/jcb.25628	Karaczyn, Aldona A.	2017
1104	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF10A, MDA-MB-231, SKBR3, MCF7, MDA-MB-468	Culture	2D/2.5D	n/a	n/a	Disease mechanism (exp./theor.)	MT1JP, mir243p, proliferation, invasion, cytotoxicity	Medium	Yes	Direct	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357327/	Zhu, DL	2019
1107	IBC	IBC	Cancer Initiation and Development	In silico	Computational	n/a	n/a	n/a	n/a	n/a	n/a	Model/method develop.(theor.)	NFAT5, RNA profile, WNT/β-catenin signaling	Low	Yes	Supportive	10.1186/s12967-015-0492-2	Remo, Andrea	2015
1108	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231 , SUM159	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	KT, r GLUT‐1, cytotoxicity, apoptotic	Low	Yes	Supportive	10.1002/mc.22988	Roy, Ruchi	2019
1109	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Primary cell culture	CAFs, MCF-Her2	Co-culture	3D	Organoids	n/a	Disease mechanism (exp./theor.)	CXCL16 and CXCL12, PDGFα, CD44, CD90, CD105, CD166,  CD140β, RNa profiling, protein profiling, migration, cancer cell recruitment rate	Low	Yes	Direct	10.1038/s41523-017-0008-8	Chung, Brile	2017
1111	BC	BC	Pharmacological/Physical Treatment; Patient Stratification	In vitro/In silico	Cells/Algorithms	Immortalised cells	HCC1937, HCC1143, MDA-MB-231, MDA-MB-468	Culture	2D	n/a	n/a	Model/method qualification	cytotoxicity, MCL1, BAX, BCL2, BCL(X)L, BAK, correlation	Low	Yes	Supportive	10.1038/s41419-017-0039-y	Lucantoni, Federico	2018
1113	BC	BC	Cancer Initiation and Development; Pharmacological/Physical Treatment	In vitro	Cells	Primary cell culture	BC	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	PARP1, correlation	Low	Yes	Direct	10.1016/j.prp.2014.11.004	Zhai, Lili	2015
1114	BC	BC	Metastasis	In vitro	Cells	Immortalised cells	MDA‐MB‐231	Culture	2D	n/a	n/a	Model/method qualification	morphology, viability, podosomes and invadopodia, migration, invasion	Low	Yes	Direct	10.1002/cyto.a.23316	Lam, Van K.	2018
1115	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231,HB-2	Culture	2D	n/a	n/a	Drug develop./testing	caveolae-dependent endocytosis pathway	Low	Yes	Direct	10.1039/c6ra14935a	Mauro, N.	2016
1116	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	T47D, MCF7, MDA-MB-231, 3T3-L1	Co-culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	Adipocyte secreted protein profile, cell protrusion, CAP1, migration	Medium	Yes	Direct	10.3389/fendo.2018.00689	Rosendahl, Ann H.	2018
1119	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.1016/j.ejmech.2018.07.063	Carolina Ruberte, Ana	2018
1120	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	SUM159, MCF7	Culture	2D	n/a	n/a	Drug develop./testing	E-selectin, Temperature, tumoritropic particle flow and accumulation	Low	Yes	Supportive	10.1371/journal.pone.0086489	Kirui, Dickson K.	2014
1122	BC	BC	Cancer landscape	In vitro/In silico	Ex vivo/Mathematical	n/a	liquid biopsy	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	DNA profile and variant identification	Low	Yes	Direct	10.1038/s41598-017-02388-7	Weerts, Marjolein J. A.	2017
1123	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA‐MB‐231	Culture	2D	n/a	n/a	Drug develop./testing	BRD4, c-MyC, cytotoxicity	Low	Yes	Direct	10.1016/j.ejmech.2018.11.018	Xing, Jing	2019
1124	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Primary cell culture	MCF-7, T47D, BC	Culture	2D	n/a	n/a	Drug develop./testing	ESR1, TAM, EGF1R, PIK3R1/PIK3R3	Low	Yes	Direct	10.1007/s10549-016-3829-5	Gelsomino, Luca	2016
1125	BC	BC	Tumor Detection and Classification	In vitro	Cells	Immortalised cells	SUM159 invasive, SUM159 noninvasive, HC1143 , DCIS	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	Protein profile, ALDH1A1, ALDH1A3	Low	Yes	Direct	10.2217/nnm.13.152	Panneer, Anjan	2014
1126	BC	BC	Cancer Initiation and Development; Patient Stratification	In vitro	Ex vivo	n/a	BC	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	L1CAM, rogen receptor, PR, ER, ERBB2, AR, correlation	Low	Yes	Direct	10.1186/1471-2407-14-958	Doberstein, Kai	2014
1127	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7,SUM159, MDA-MB-231	Culture	2D	n/a	n/a	Drug develop./testing	Mitochondrial Dynamics, cytotoxicity, apoptosis	Low	Yes	Direct	10.1016/j.mito.2019.01.003	Sehrawat, Anuradha	2019
1130	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7, SUM159	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity, ALDH1, cell proliferation	Medium	Yes	Direct	10.3390/molecules21040514	Shi, Ye-Hui	2016
1131	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MCF7 , MDA-MB-231	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	BDNF, TrKB signaling, migration, COX2, MMP2, MMP9,  MMP13, VEGFA, BEGFR2, eNOS 	Low	Yes	Direct	10.1016/j.bioce1.2017.12.013	Visweswaran, M	2018
1132	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7, SUM159PT	Culture	2D	n/a	n/a	Drug develop./testing	 radiosensitive αTC, βTC, αCSC, βCSC	Low	Yes	Direct	10.1016/j.radonc.2017.08.019	Qi, Xiangrong Sharon	2017
1133	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-361, T47D	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	GM130, migration, invasion, polarity, golgi morphology, viability, correlation	Low	Yes	Direct	10.1080/15384101.2015.1007771	Baschieri, Francesco	2015
1134	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	Photochemotherapeutic effects of UV-C, ROS	Low	Yes	Direct	10.1371/journal.pone.0178173	Tsai, Yi-Fang	2017
1135	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity, fluorescence of AO,	Low	Yes	Direct	10.1039/c4ra01647e	Pitchaimani, Arunkumar	2014
1136	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity, morphology, LC3BI, LC3BII, autophagy	Medium	Yes	Direct	10.1186/1472-6882-14-175	Silva, Dulcelena Ferreira	2014
1139	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231 , SUM159PT	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.); Drug develop./testing	BM1I, DNA Damage, autophagy	Low	Yes	Direct	10.3892/or.2017.5478	Griffith, James	2017
1140	BC	BC	Tumor Detection and Classification	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Model/method develop.(exp.)	CA 15-3, immunosensor displayed sensitivity and specificity	Low	Yes	Direct	10.1016/j.ijbiomac.2018.03.183	Hasanzadeh, Mohammad	2018
1142	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-468 , T-47D	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity, proliferation	Low	Yes	Direct	10.1016/j.bmcl.2018.11.021	Kaur, Manpreet	2019
1145	BC	BC	Cancer Initiation and Development	In vitro/In silico	Cells/Computational	Immortalised cells/Primary cell culture	MCF7, MDA-MB-436, BC	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	mir-155, thiamine levels, metabolomic profile, SLC19A2, SLC25A19,  TPK1 	Low	Yes	Supportive	10.1016/j.canlet.2014.11.058	Kim, Sinae	2015
1146	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells/Stem-cell like	SUM159 , MCF7	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.); Drug develop./testing	cytotoxicity, Sonic Hedgehog and Wnt/β-catenin pathways,CD44, ALDH1A1, Nanog,  Oct4, proliferation, apoptosis	Low	Yes	Direct	10.1097/CAD.0000000000000584	Li, Xiaoting	2018
1148	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2D	n/a	n/a	Drug develop./testing	drug cellular uptake, cytotoxicity	Medium	Yes	Direct	10.1073/pnas.1517402113	Pribisko, Melanie	2016
1149	BC	BC	Cancer landscape	In vitro	Cells/Ex vivo	Immortalised cells	DU4475, SW527, HCC1806, MDA-MB-436, MCF10A, HCC38, HCC1143, HCC1937, BT20, MDA-MB-468, BT549, HS578T, MDA-MB-231, MDA-MB-157, BC	Culture	2D	n/a	Biopsies	Disease mechanism (exp./theor.)	Proteomic landscape	Low	Yes	Direct	10.1016/j.celrep.2015.03.050	Lawrence, Robert T.	2015
1151	BC	BC	Metastasis; Angiogenesis	In vitro	Ex vivo	n/a	BC	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	vessel formation, PSMA 	Low	Yes	Direct	10.1007/s10585-018-9878-x	Kasoha, Mariz	2017
1154	BC	BC	Cancer Initiation and Development; Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2D	n/a	n/a	Drug develop./testing	STAT1, Indoleamine 2,3-Dioxygenase, T lymphocytes activity, PDL1, HLA,B, C, cytotoxicity, IFN-γ	Low	Yes	Direct	10.1371/journal.pone.0099211	Hanafi, Laila-Aicha	2014
1155	BC	BC	Tumor Detection and Classification	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Diagnosis of disease	microRNA (miRNA)-141 and miRNA-21 expression levels	Low	Yes	Direct	10.1021/ac503860d	Wang, Shuo	2014
1156	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7, SKBR3, T47D, MDA-MB-361, BT474	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity, RNA profile, ROS	Low	Yes	Direct	10.1089/ars.2014.6189	Chiaradonna, Ferdinando	2015
1158	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF10A, 226L, MCF7, T47D, SKBR3,	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	CD44, CD24, CXCR4, anoikis, colony formation, SDF1	Low	Yes	Supportive	10.18632/oncotarget.1169	Ablett, Matthew P.	2014
1159	BC	BC	Drug Discovery and/or Testing	In vitro	Cells	Immortalised cells	TNBC	Culture	2.5D	n/a	n/a	Drug develop./testing	cytotoxicity (as a selective screen application)	Low	Yes	Direct	10.1021/acscombsci.8b00026	Chen, Luxi	2018
1162	BC	BC	Metastasis	In vitro	Cells	Immortalised cells	MDA-MB-231, HS578T	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	TAK1, p38, IL1α or IL1β	Low	Yes	Supportive	10.1038/s41467-018-04460-w	Iriondo, Oihana	2018
1163	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231, HTB-26, 47-D (HTB-113, ATCC), MDA-MB-436 (HTB-130, ATCC), MDA-MB-134 (HTB-23, ATCC), MDA-MB-175 (HTB-25, ATCC), MDA-MB-330 (HTB-127, ATCC), MDA-MB-361 (HTB-27, ATCC), MDA-MB-468 (HTB-132, ATCC), BT483 (HTB-121, ATCC), BT474 (HTB-20, ATCC), BT20 (HTB-19, ATCC), BT549 (HTB-122, ATCC), HCC38 (CRL-2314, ATCC), HCC70 (CRL-2315, ATCC), HCC1143 (CRL-2321, ATCC), HCC1187 (CRL-2322, ATCC), HCC1500 (CRL-2329, ATCC), HCC1954 (CRL-2338, ATCC), MCF10A, MCF12A	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	adipocyte triacylglycerol	Low	Yes	Direct	10.1186/s40170-016-0163-7	Balaban, Seher	2017
1165	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	2.5D	n/a	n/a	Drug develop./testing	cytotoxicity, apoptosis, BCL-2, BAX	Low	Yes	Supportive	10.1155/2017/3656193	Wu, Huimin	2017
1167	BC	BC	Microenvironment-Tumor Interactions	In vitro	Cells	Immortalised cells	MDA-MB-231, MCF7	Culture	3D	Spheroids	n/a	Model/method develop.(exp.)	morphology, cell movements, f-actin, MCT1, MCT4, MMP2	Low	Yes	Direct	10.1186/s12935-014-0108-6	Ivers, Laura P.	2014
1168	BC	BC	Metastasis	In vitro	Cells	Immortalised cells	MCF10A, MCF7	Culture	2.5D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	TRIM29, TWIST-1, N-cadherin,  vimentin, E-cadherin, EpCAM, invasion, EMT	Low	Yes	Direct	10.1158/0008-5472.CAN-13-3579	Ai, Lingbao	2014
1169	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF10A	Culture	2.5D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	TAZ, IRS1, proliferation	Low	Yes	Direct	10.1016/j.cellsig.2018.08.012	van Rensburg, Helena J. Janse	2018
1170	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231, DT22, DT28, MCF10A	Culture	2D/2.5D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	secretome profile, morphology, correlation	Low	Yes	Supportive	10.1371/journal.pone.0158296	Ziegler, Yvonne S.	2016
1172	BC	BC	Pharmacological/Physical Treatment	In vitro	Ex vivo	n/a	BC	n/a	n/a	n/a	Biopsies	Drug develop./testing	cytotoxicity	Low	Yes	Supportive	10.18632/oncotarget.11345	Zhang, Yingchao	2016
1174	BC	BC	Cancer Initiation and Development	In vitro	Ex vivo	n/a	BC	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	genome-wide RNA profile	Low	Yes	Direct	10.1007/s10549-015-3333-3	Salhia, Bodour	2015
1175	BC	BC	Metastasis	In vitro	Ex vivo	n/a	BC	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	genome-wide protein profile, invasion, ALDH2 and GDIR2 	Low	Yes	Direct	http://cgp.iiarjournals.org/content/12/2/89.short	Milioli, HH	2015
1176	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231, SUM159PT	Culture	2D/2.5D	n/a	n/a	Disease mechanism (exp./theor.)	Cyr62, Src, P27, Cyclin D1, migration, invasion	Low	Yes	Supportive	10.18632/oncotarget.3760	Sanchez-Bailon, Maria Pilar	2015
1177	BC	BC	Metastasis; Patient Stratification	In vitro	Cells	Immortalised cells	MDA-MB-231 , MCF7, MDA-MB-231BrM-2a, CN34 , CN34-BrM2c	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	mir509, RhoC and TNF-α, MMP9, correlation	Medium	Yes	Supportive	10.1038/onc.2014.412	Xing, F.	2015
1178	BC	BC	Metastasis	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-468 , MDA-MB-435s	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	SCN4B, migration, correlation, invasion, RhoA, morphology	Low	Yes	Supportive	10.1038/ncomms13648	Bon, Emeline	2016
1179	BC	BC	Cancer Initiation and Development	In vitro	Cells	Primary cell culture	BC	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.); Drug develop./testing	Advanced glycation end products (AGEs), MMP9, ERK, NF-κB, invasion, migration	Medium	Yes	Direct	10.1016/j.bbrc.2017.11.182	Lee, Kyung Jin	2018
1182	BC	BC	Tumor Detection and Classification; Patient Stratification	In vitro	Ex vivo	n/a	n/a	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	BRCA1, BRCA2	Low	Yes	Direct	10.1158/1078-0432.CCR-17-0544	Weigelt, Britta	2017
1183	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Supportive	10.1016/j.ejmech.2014.06.076	Romano, Beatriz	2014
1184	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Supportive	10.1016/j.bmc.2015.02.048	Romano, Beatriz	2015
1187	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF10A, MCF7, MDA-MB-231, SK-BR-3,	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	EphA7	Low	Yes	Supportive	http://www.ijcep.com/files/ijcep0024622.pdf	Liu, Z	2016
1189	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF-7	Culture	2.5D	n/a	n/a	Drug develop./testing	cytotoxicity, IL-8, IL-6, IL-19, VEGF, MMP-2, MMP-9, CD44	Low	Yes	Direct	10.1002/jcp.25587	Quagliariello, Vincenzo	2017
1191	BC	BC	Cancer Initiation and Development	In vitro	Ex vivo	n/a	BC	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	Protein profile, EGFR1/3, ESR1, AKT1, ATF, Fos,  SRC, aurora kinases, p53, RAD52, BRCA1, MAPKAPK-2, ATF-1, ICAM1,  NF-kappaB, correlation	Low	Yes	Direct	10.1159/000438533	Gutierrez, Christina Marie	2015
1193	BC	BC	Pharmacological/Physical Treatment	In silico	Simulation	n/a	n/a	n/a	n/a	n/a	n/a	Model/method develop.(theor.)	specific absorption rate (SAR) 	Low	Yes	Direct	http://www.journals-jd.upm.edu.my/Pertanika%20PAPERS/JST%20Vol.%2025%20(S)%20Jan.%202017/25-JTS(S)-0101-2016-4thProof.pdf	Lias, K	2017
1194	BC	BC	Metastasis	In vitro	Ex vivo	n/a	n/a	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	EMSY, morphology	Low	Yes	Direct	10.7314/APJCP.2014.15.4.1783	Madjd, Zahra	2014
1198	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7, T47D, SUM159PT	Culture	2D	n/a	n/a	Drug develop./testing	SNCG, P53, P21	Low	Yes	Direct	10.18632/oncotarget.25415	Tian, Lu	2018
1199	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, T-47D , ZR75.1,	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	phosphoprotein profile, DLC1, correlation, cell-cycle, apoptosis, colony formation, invasion, correlation	Low	Yes	Supportive	10.1371/journal.pone.0204658	Gokmen-Polar, Yesim	2018
1206	BC	BC	Cancer Initiation and Development	In vitro	Ex vivo	n/a	BC	n/a	n/a	n/a	Organ slice	Disease mechanism (exp./theor.)	miR-222, miR-29a, miR-34a, miR-130a, miR-90b, miR-200b, miR-452, miR-197, miR-138, miR-210, miR-423, miR-4298, miR-4644, miR-139, miR-1246, miR-1268a, miR-140, miR-149, miR-3178, miR-3613, miR-4258, miR-574, miR-671, miR-6780b, miR-7107, miR-744, miR-7847, correlation	Low	Yes	Direct	10.1016/j.gene.2016.10.015	Chen, Xiu	2016
1208	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231, MCF7	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	ROS, NOS, DNA damage, iNOs, cytotoxicity, Src	Low	Yes	Supportive	10.1186/s13058-017-0823-8	Flaherty, Renee L.	2017
1209	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	CEACAM1, Calmodulin Kinase IID, lumen formation, apoptosis	Low	Yes	Direct	10.1074/jbc.M113.496992	Tung Nguyen	2014
1210	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231 , MCF7	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	P53, PRIMA-1 (lysate)	Medium	Yes	Direct	10.1074/jbc.RA118.004671	Rangel, Luciana P.	2019
1211	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	IF4E, migration, invasion	Low	Yes	Supportive	10.1158/0008-5472.CAN-14-1996	Pettersson, Filippa	2015
1212	BC	BC	Tumor Detection and Classification	In vitro	Cell free	n/a	liquid biopsy	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	ALU and LINE1 repetitive DNA elements cell-free DNA (cfDNA) / cfDNA integrity (cfDI)	Low	Yes	Direct	10.1007/s10549-014-2946-2	Madhavan, Dharanija	2014
1214	BC	BC	Cancer Initiation and Development; Metastasis	In vitro	Cells	Immortalised cells	MDA-MB-231, Hs578T , BT549, MCF7, CAMA-1, T-47D, ZR-75-1, SKBR3 , BT474	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	IRX2, chemokines RNA profile, migration	Low	Yes	Direct	10.1186/s12885-015-1907-4	Werner, Stefan	2015
1215	BC	BC	Tumor Detection and Classification	In vitro	Cells	Immortalised cells	MCF‐7 , MDA‐MB‐436	Culture	2D	n/a	n/a	Model/method develop.(exp.)	 PR, ERα	Low	Yes	Direct	10.1002/elan.201501090	Eletxigerra, U.	2016
1216	BC	BC	Circulating Cancer Cells/DNA Identification and Profiling	In vitro	Ex vivo	n/a	n/a	n/a	n/a	n/a	Liquid biopsies	Disease mechanism (exp./theor.)	genome-wide DNA profile	Low	Yes	Direct	10.5858/arpa.2016-0483-OA	Rodriguez-Lee, Mariam	2018
1217	BC	BC	Circulating Cancer Cells/DNA Identification and Profiling	In vitro	Cell free	n/a	liquid biopsy	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	 PR/ERα	Low	Yes	Direct	10.1186/s12943-018-0808-y	Takeshita, Takashi	2018
1222	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells/Primary cell culture	HCC1954 , HCC2218, HCC1428, HCC1937, HCC1143, HCC1187, HCC1599, HCC1395, patient-derived lymphoblastoid	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.); Drug develop./testing	cytotoxicity, correlation	Medium	Yes	Direct	10.18632/oncotarget.9521	Morrison, Gladys	2016
1225	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, HB2	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	MiR-19b, HuR, ABCB1/P-glycoprotein, mRNA profile	Low	Yes	Direct	10.1016/j.bbagrm.2018.08.005	Thorne, James L.	2018
1226	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-468, MDA-MB-231, HCC1937, SKBR3, T47D , MCF7	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	FGFR4, FGF19, viability, proliferation, PARP, AKT, cytotoxicity	Low	Yes	Supportive	10.18632/oncotarget.9328	Tiong, Kai Hung	2016
1228	BC	BC	Metastasis	In vitro	Cells	Primary cell culture	BC	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	PDK-1, metabolic profile, HIF-1α	Low	Yes	Supportive	10.1016/j.cmet.2015.08.007	Dupuy, Fanny	2015
1230	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Medium	Yes	Direct	https://www.ingentaconnect.com/content/ben/acamc/2016/00000016/00000003/art00009	Victorasso Jardim-Perassi, Bruna	2014
1232	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231, SUM149	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	 Chk‐α, cell viability, proliferation, choline phospholipid, lipid metabolism, lipid droplet formation, apoptosis	Low	Yes	Direct	10.1002/nbm.3429	Mori, Noriko	2015
1235	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF‐7, SK‐BR‐3, MDA‐MB‐231	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	p53/Mieap, mitochondrial-driven apoptosis, caspase‐3/7 and caspase‐9 	Low	Yes	Direct	10.1111/cas.13824	Gaowa, Siqin	2018
1237	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231	Co-culture	2.5D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Supportive	10.1016/j.msec.2017.04.013	Niu, Xiaoyun	2017
1242	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231, CN34 HCC1395 HCC38, MDA-MB-453, SK-BR-3, ZR-75-1, MCF7	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	oncRNAs, T3P, NUPR1, PANX2	Low	Yes	Supportive	10.1038/s41591-018-0230-4	Fish, Lisa	2018
1243	BC	BC	Cancer Initiation and Development	In vitro	Ex vivo	n/a	BC	n/a	n/a	n/a	Organ slice	Disease mechanism (exp./theor.)	ERCC1, correlation	Low	Yes	Direct	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314004/	Deng, Qiuhua	2014
1244	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	T47D, MCF7, HCC1954, MDA-MB-468, BT549 , HCC114,	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	Elafin, genome instability, TP53, correlation	Medium	Yes	Supportive	10.1038/onc.2013.562	Labidi-Galy, S. I.	2015
1245	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231, SUM159	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	NF-κB, AP-1, CR1, proliferation, invasion, CD44	Medium	Yes	Direct	10.1371/journal.pone.0106966	Smith, Shannon M.	2014
1246	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231, MDA-parental, MDA-LM2, CN34-parental, CN34-LM1A	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	TMEM2, SOX4, migration, invasion	Low	Yes	Supportive	10.1158/0008-5472.CAN-15-2322	Lee, Hyeseung	2016
1248	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-468, MCF7, HCC2998, KM12	Culture	2D	n/a	n/a	Drug develop./testing	DNA adduct, DNA damage, γ-H2AX foci, cytotoxicity	Low	Yes	Direct	10.1016/j.bmc.2015.09.052	Stone, Erica L.	2015
1249	BC	BC	Pharmacological/Physical Treatment; Patient Stratification	In vitro	Ex vivo	n/a	BC	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	LAPTM4B, correlation	Low	Yes	Direct	10.1007/s00280-018-3602-z	Rusz, Orsolya	2018
1250	BC	BC	Cancer Initiation and Development	In vitro	Ex vivo	n/a	BC	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	genome-wide DNA profile	Low	Yes	Direct	10.18632/oncotarget.5569	Song, Fangfang	2015
1252	BC	BC	Metastasis	In vitro	Ex vivo	n/a	BC	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	collagen	Low	Yes	Direct	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038064/	Sun, C	2018
1253	BC	BC	Cancer Initiation and Development	In vitro/In silico	Ex vivo/Computational	n/a	BC, liquid biopsy	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	mutation profile (MAMMASEQ)	Low	Yes	Direct	10.1186/s13058-019-1102-7	Smith, Nicholas G.	2019
1256	BC	BC	Cancer Initiation and Development	In vitro	Ex vivo	n/a	BC	n/a	n/a	n/a	Biopsies	Model/method qualification	genome-wide RNA profile, HER2	Low	Yes	Direct	10.1371/journal.pone.0179223	Liu, Jeffrey C.	2017
1258	BC	BC	Microenvironment-Tumor Interactions	In vitro	Ex vivo	n/a	BC	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	TIL numbers, CD4, CD8, Foxp3, PD-L1, PD-L2,  HLA class I, correlation	Low	Yes	Supportive	10.18632/oncotarget.22110	Ogiya, Rin	2017
1260	BC	BC	Cancer Initiation and Development	In vitro	Cells	Primary cell culture	BC	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	Oct 4, SOX2, Nanog, ALDH1A1, CD44, CD24	Medium	Yes	Direct	10.1016/j.biocel.2018.10.005	Nasr, Mostafa	2018
1261	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells/Primary cell culture	T2, MDA-MB-231	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	morphology, HER2, Shh pathway, viability, apoptosis, migration	Medium	Yes	Supportive	10.3390/ijms19051375	Jeng, Kuo-Shyang	2018
1262	BC	BC	Pharmacological/Physical Treatment	In silico	Computational	n/a	n/a	n/a	n/a	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.1016/j.bioorg.2018.07.004	Mendes, Joseane A.	2018
1264	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, MDA-MB-231, BT549 , SK-BR-3, SUM149PT , SUM159PT	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	β/Smad Signaling, correlation, migration	Medium	Yes	Direct	10.1186/s13058-014-0476-9	Guo, Jimin	2014
1265	BC	BC	Cancer Initiation and Development	In vitro	Cells	Primary cell culture	MCF7, T47D, BT20, MDA-MB-436, BT474,	Culture	2D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	growth differentiation factor (GDF) 15, colony formation, sox2, nanog, oct4, smad, erk2/2	Medium	Yes	Supportive	10.18632/oncotarget.15276	Sasahara, Asako	2017
1266	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells/Stem-cell like	MCF7	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	CD95, FAS, STAT1, Type I Interferon Response	Low	Yes	Supportive	10.1016/j.celrep.2017.02.037	Qadir, Abdul S.	2017
1267	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells/Primary cell culture	MCF7, MCF12A, MCF10A, BT20, T47D, MDA-MB-231, BC-051 , BC-052	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	mir-125a, LIFR, CD44, CD24, JAK2-STAT3, HIPPO	Low	Yes	Supportive	10.18632/oncotarget.3953	Nandy, Sushmita Bose	2015
1269	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231, SKBR3, MCF7	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	KRT19, β-catenin, RAC1, NUMB, NOTCH, SCRAMBLE, SOX2, NANOG, OCT4, MIGRATION	Medium	Yes	Direct	10.1038/onc.2016.221	Saha, S. K.	2017
1270	BC	BC	Metastasis	In vitro	Cells	Immortalised cells	MDA-MB-231, MCF10DCIS.com	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	CLIC3, MT1-MMP, invasion, correlation, endosomes, lysosomes	Low	Yes	Supportive	10.1242/jcs.135947	Macpherson, Iain R.	2014
1271	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7 , MDA-MB-231	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	Serine protease, beta-catenin, neogenein	Low	Yes	Direct	10.1080/15384047.2018.1529109	McNair, Kara	2019
1273	BC	BC	Metastasis	In vitro	Cells	Immortalised cells	MCF7, T-47D, SK-BR-3, BT549, Hs578T, MDA-MB-231 , MDA-MB-453	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	Mir-149, GIT-1, migration, invasion	Low	Yes	Supportive	10.1038/onc.2014.10	Chan, S-H	2014
1274	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF12A, MCF7 , MDA-MB-231	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	POLG1, invasion	Low	Yes	Supportive	10.1371/journal.pone.0139846	Singh, Bhupendra	2015
1278	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells/Primary cell culture	MDA-MB-453, T47D, MCF7, ZR-75-30, MDA-MB-231 , BT549	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	cell-adhesion, colony formation, KIF11	Medium	Yes	Supportive	10.3892/ol.2017.7053	Pei, Yuan-Yuan	2017
1281	BC	BC	Cancer stem cells	In vitro	Cells	Immortalised cells/Stem-cell like	SUM149, T47D, SW620, SW480, SK-BR-3	Culture	3D	Spheroids	n/a	Drug develop./testing	PDE5, ADLH	High	Yes	Direct	10.1038/s41419-017-0202-5	Klutzny, Saskia	2018
1283	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7 , MDA-MB-231, MCF10A	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity, cyclin D1, D3, CDK‐4, CDK‐6, p18 INK4c, p21 CIP1/Waf‐1 and p27 KIP1, caspase‐3, caspase‐9	Low	Yes	Direct	10.1002/ptr.5408	Roy, Anita	2015
1285	BC	BC	Immunotherapy	In vitro	Ex vivo	n/a	n/a	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	CXCR4, T-lymphocyte infiltration	Low	Yes	Supportive	10.1073/pnas.1815515116	Chen, Ivy X.	2019
1286	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	Hs578T , MDA-MB-231, MCF7	Culture	2D	n/a	n/a	Model/method develop.(exp.)	proliferation, IL-6	Low	Yes	Direct	10.1016/j.bbamcr.2014.10.004	Itou, Junji	2015
1287	BC	BC	Metastasis	In vitro	Cells	Immortalised cells	HCC38	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	ZEB1, SLUG, extravasation, EMT	Low	Yes	Direct	10.1111/cas.13246	Yamamoto, Mizuki	2017
1289	BC	BC	Drug Discovery and/or Testing	In vitro	Cells	Immortalised cells	MCF7	Culture	2.5D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.1016/j.ijbiomac.2019.01.122	Fathi, Marziyeh	2019
1290	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	genome-wide protein profile, protein stability	Low	Yes	Direct	10.1021/acs.jproteome.7b00795	Meng, He	2018
1291	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	BT474	Culture	2D	n/a	n/a	Drug develop./testing	drug cellular uptake	Low	Yes	Supportive	10.1038/s41598-018-21283-3	Honarvar, Hadis	2018
1292	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	HCC38HCC1599HCC1187, HCC2218, MCF10	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	NOTCH1, UBC9, E1-activating complex SAE1/UBA2	Low	Yes	Direct	10.1038/onc.2014.319	Licciardello, M. P.	2015
1293	BC	BC	Immunotherapy	In vitro	Cells	Primary cell culture	monocyte-derived immature DCs	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	 dendritic cell maturation, CD40, CD80,  CD86	Low	Yes	Supportive	10.7603/s40730-016-0028-2	Phong Minh Le	2016
1294	BC	BC	Cancer Initiation and Development; Patient Stratification	In vitro	Cells	Immortalised cells/Stem-cell like	MDA-MB-157, MDA-MB-231, HCC38, HCC1806, HCC1143, HS578T, BT549, MDA-MB-468, SUM159, SUM149	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	ITGB4, ZEB1, TAp63α, SNAIL, CDH1, CDH3, p63, FN1, AKT, COXIV, ERK1/2, correlation	High	Yes	Supportive	10.1073/pnas.1618298114	Bierie, Brian	2017
1295	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	SKBR3 , SUM159	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.1007/s00044-018-2247-0	Shi, YeHui	2018
1296	BC	BC	Cancer Initiation and Development; Patient Stratification	In vitro	Cells	Immortalised cells	MDA-MB-231,	Culture	3D	Spheroids	n/a	Disease mechanism (exp./theor.)	KRT19, Wnt/NOTCH, NUMB, correlation, ALDH1	Low	Yes	Supportive	10.3390/ijms19051423	Saha, Subbroto Kumar	2018
1297	BC	BC	Cancer Initiation and Development; Patient Stratification	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	LKB1, metERα/Src/PI3K, correlation	Low	Yes	Direct	10.1002/ijc.28781	Bouchekioua-Bouzaghou, Katia	2014
1298	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	NAMPT/visfatin, p53, SIRT1, NAD, proliferation	Low	Yes	Direct	10.1002/cbf.3279	Behrouzfar, Kiarash	2017
1300	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	184A1, HMEC, HCC1428, T47D, ZR7530, AU565, HCC202, HCC70, UACC3199, DU4475, HCC1937, HS578T, HCC38, MDA-MB-231	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	MiR-29c, cytotoxicity	Low	Yes	Direct	10.1371/journal.pone.0142224	Poli, Elizabeth	2015
1305	BC	BC	Drug Discovery and/or Testing	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.1016/j.ijpharm.2014.11.005	Abdel-Bar, Hend Mohamed	2014
1306	BC	BC	Cancer Initiation and Development	In vitro	Ex vivo	n/a	n/a	n/a	n/a	n/a	Biopsies	Diagnosis of disease; Disease mechanism (exp./theor.)	Neogenin, correlation	Low	Yes	Direct	10.1186/1477-7819-12-352	Xing, Wanying	2014
1307	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231, SUM149PT, SUM1315MO2,	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	mir17, BER1, APEX1/REF1, OGG1 NTHL1, XRCC1, PARP1 	Medium	Yes	Direct	10.1038/cddis.2014.30	De Summa, S.	2014
1309	BC	BC	Cancer Initiation and Development	In vitro	Ex vivo	n/a	BC	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	STC1, STC2, correlation	Low	Yes	Direct	10.1158/1055-9965.EPI-17-0905	Brantley, Kristen D.	2018
1310	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF10A, HCC38, SK-Br3, MCF7, MDA-MB-231, HCC1806	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Direct	10.1186/s12967-016-0797-9	Iida, Joji	2016
1311	BC	BC	Metastasis	In vitro	Ex vivo	n/a	BC	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	IGFBP-5 and VN, αv integrin, P-AKT, ERK1/2 and SHARP-2	Low	Yes	Direct	10.1186/1471-2407-14-627	Plant, Helen C.	2014
1312	BC	BC	Cancer Initiation and Development; Patient Stratification	In vitro	Cells	Immortalised cells	T-47D, BT474, BT549, MDA-MB-468, Hs 578 T , MCF7	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	CDH2, cytotoxicity, correlation	Low	Yes	Direct	10.1186/s13148-016-0309-z	Martin-Sanchez, Esperanza	2017
1315	BC	BC	Cancer Initiation and Development; Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	HCC38, HCC1937, MDA-MB-468, BT549, Hs-578T, MDA-MB-436, MDA-MB-231, MDA-MB-453, MCF7, T47D	Culture	2.5D/3D	Spheroids	n/a	Disease mechanism (exp./theor.)	PRMT1, EGFR methylation, AMI-1, colony formation, cell proliferation, cytotoxicity 	Low	Yes	Direct	10.1007/s12282-017-0790-z	Nakai, Katsuya	2018
1317	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2D	n/a	n/a	Drug develop./testing	migration, colony formation, apoptosis, cell cycle, cytotoxicity	Low	Yes	Supportive	10.1371/journal.pone.0135814	Al-Asmari, Abdulrahman Khazim	2015
1318	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Medium	Yes	Direct	10.3109/21691401.2014.982803	Zeighamian, Vahideh	2016
1320	BC	BC	Cancer Initiation and Development; Risk Determination 	In vitro	Ex vivo	n/a	n/a	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	PI3K, correlation	Low	Yes	Direct	10.1111/cas.12813	Takeshita, Takashi	2015
1321	BC	BC	Cancer Initiation and Development; Risk Determination 	In vitro	Ex vivo	n/a	n/a	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	cell-free DNA profile, correlation 	Low	Yes	Direct	10.1016/j.ejca.2018.10.012	Ye, Zhong	2019
1322	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231, MCF7	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	CDH5, genome-wide DNA profile, DNA methylation, correlation	Low	Yes	Supportive	10.3892/ol.2016.5147	Ma, Zhongliang	2016
1323	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	AurkA, wnt3a, miR-128, β-catenin nuclear/cytoplasmic localization, stat3, MPP9, SNAIL	Low	Yes	Supportive	10.1038/srep28436	Eterno, V.	2016
1324	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231, MCF10	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	CT20, cell-adhesion, apoptosis, mitochondrial aggregation, cytoskeleton structure, α5 and αV integrins, p38 MAPK CD29, CD61	Low	Yes	Direct	10.1038/cddis.2014.225	Lee, M. W.	2014
1327	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7, ZR-75-1, MDA-MB-231 , SUM1315	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	cytotoxicity, cell cycle, apoptosis, migration, AMPK/mTOR/p70s6k, MAPK/ERK 	Medium	Yes	Direct	10.1371/journal.pone.0131207	Liu, Zhao	2015
1328	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7 , SUM159	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	TRIM21, SALL4	Low	Yes	Direct	10.1074/jbc.RA117.000245	Itou, Junji	2018
1329	BC	BC	Cancer landscape	In vitro	Cells	Immortalised cells	MDA‐MB‐231	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	phosphoproteins profile	Low	Yes	Direct	10.1002/elps.201300586	Ye, Xiaoxia	2014
1330	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity, apoptosis	Low	Yes	Direct	10.1021/acsami.5b02452	Ujjwal, Rewati Raman	2015
1334	BC	BC	Cancer Initiation and Development; Patient Stratification	In vitro	Ex vivo	n/a	BC	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	mitochondrial DNA content, cytotoxicity, correlation	Low	Yes	Direct	10.1158/1078-0432.CCR-17-0032	Weerts, Marjolein J. A.	2017
1337	BC	BC	Cancer Initiation and Development	In vitro	Ex vivo	n/a	BC	n/a	n/a	n/a	Biopsies	Disease mechanism (exp./theor.)	ER, PR, genome-wide RNA profile, POMC, CALCR, AVPR1A,  GH1	Low	Yes	Direct	10.1007/s10549-016-4049-8	Daniels, Michael W.	2017
1338	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells/Ex vivo	Immortalised cells	MCF7, HCC1428, ZR75.1, T47D , SUM44 (ER+), BC	Culture	2D	n/a	Biopsies	Drug develop./testing	CXCR7, CXCR4, Ki67, cytotoxicity	Medium	Yes	Supportive	10.1186/s13058-014-0447-1	Ribas, Ricardo	2014
1339	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	HMEC, MEGM®	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	 O-GlcNAcomic profile	Low	Yes	Direct	http://cgp.iiarjournals.org/content/12/4/201.short	Netsirisawan, P	2015
1341	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA-MB-231	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	Secreted Cathepsin B and Cathepsin L	Low	Yes	Direct	10.1007/s12307-017-0196-7	Uhlman, Andrew	2017
1342	BC	BC	Tumor Detection and Classification	In vitro	Cell free	n/a	MCF10A, T47D, MDA-MB-231	n/a	n/a	n/a	n/a	Disease mechanism (exp./theor.)	Cathepsin B, normalized proteolysis curve of cell lysate	Low	Yes	Supportive	10.1016/j.nano.2015.04.014	Swisher, Luxi Z.	2015
1343	BC	BC	Cancer Initiation and Development; Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	SK-BR-3	Culture	2D	n/a	n/a	Drug develop./testing	protein profile	Low	Yes	Direct	10.3892/ijo.2014.2484	Pavlikova, Nela	2014
1344	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity	Low	Yes	Supportive	10.1002/pat.4512	Scrivano, Luca	2019
1352	BC	BC	Pharmacological/Physical Treatment	In vitro/In silico	Cells/Algorithms	Immortalised cells	HCC1143 , HCC1599 , HCC1937 , MDA-MB-468 , HDQ-P1 , CAL-85-1 , BT549, CAL-120 , CAL-51 , Hs-578T , MDA-MB-231, MDA-MB-436, DU-4475, CAL-148 , MFM-223, MDA-MB-453 , SK-BR-3, T-47D , ZR-75-1, MCF7, BT474, MCF10A	Culture	2D	n/a	n/a	Drug develop./testing	Kinase Inhibition Sensitivity Score	High	Yes	Supportive	10.1016/j.chembiol.2015.06.021	Szwajda, Agnieszka	2015
1353	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF7	Culture	2D	n/a	n/a	Drug develop./testing	cytotoxicity, glutamine, methionine and glutamic acid levels, apoptosis	Low	Yes	Direct	10.4149/BLL_2017_021	Saracligil, B.	2017
1354	BC	BC	Tumor Detection and Classification	In silico	Algorithms	n/a	n/a	n/a	n/a	n/a	n/a	Model/method develop.(theor.)	measurement of Accuracy, True Positive Rate (TPR), False Positive Rate (FPR) and EVL = TPR*	Low	Yes	Direct	10.3233/THC-171336	Wang, Huiya	2017
1355	BC	BC	Tumor Detection and Classification	In vitro	Cells	Immortalised cells	MDA-MB-231-ERβ	Culture	2D	n/a	n/a	Drug develop./testing; Model/method qualification	ERβ	Low	Yes	Supportive	10.1016/j.mce.2016.11.016	Nelson, Adam W.	2017
1356	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MDA‐MB‐231BR	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	genome-wide protein profile, STAU1, AT1B3, NPM1, hnRNP Q, hnRNP K, TUBB4B, TUBB5	Low	Yes	Supportive	10.1002/elps.201700027	Peng, Wenjing	2017
1358	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	normal‐like MCF‐10A, HRAS‐transformed MCF‐10AT1 (pre‐malign/ant), MCF‐10CA1a (malign/ant) cells,	Culture	2D	n/a	n/a	Disease mechanism (exp./theor.)	genome wide RNA profile, IGFL2‐AS1, migration	Low	Yes	Supportive	10.1002/jcp.25997	Tracy, Kirsten M.	2018
7610	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MCF-7	Culture	3D	Spheroids	n/a	Drug develop./testing	colony formation, cytotoxicity, apoptosis	Low	Yes	Direct	10.1038/s41598-017-13816-z	Leiva, MC	2017
9117	BC	BC	Pharmacological/Physical Treatment	In vitro	Cells	Immortalised cells	MDA-MB-231, MDA-MB-468	Culture	2D	n/a	n/a	Drug develop./testing	apoptosis	Medium	Yes	Direct	10.4103/0973-1482.154071 	Abdolahi, M	2016
24778	BC	BC	Cancer Initiation and Development	In vitro	Cells	Immortalised cells	MCF7, MDAMB231, SKBR3 and T47D	Culture	2.5D	n/a	n/a	Disease mechanism (exp./theor.)	colony formation, K641, R643,645,647E, 1K3R4E	Low	Yes	Direct	10.18632/oncotarget.8520 	Schammim Ray Amith	2016